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Abstract 
 
Large-conductance-Ca2+-activated potassium Slo1 channels are well characterised members 
of the Slo channel family. The other members, Slo3 and Slo2.χ, are less characterised and 
their physiological roles are elusive. Little is known of the pH-sensitive Slo3 channel, aside 
from a role regulating Ca2+ influx through CatSper channels during capacitation in 
spermatozoa. This thesis aims to investigate mSlo3 pharmacology and determine if mSlo3-
EST’s encode novel isoforms. Na+-activated Slo2.χ channels (Slo2.1/Slo2.2) are thought to 
mediate adaptation of neuronal action potential firing rate and slow afterhyperpolarisations 
following repetitive firing. We aim to characterise hSlo2.2a currents and their bithionol 
sensitivity, an activator of a rat isoform.  
 
Mutation of the conserved phenylalanine in the S6-domain (mSlo3-F304/hSlo1-F380) to 
tyrosine has similar effects on Slo channels, namely a negative shift in the voltage-
dependence of activation and an increase in membrane conductance. mSlo3 pharmacology 
matches the IKSper profile and suggests roles for mSlo3 as a pharmacological target in 
infertility treatment. This work identified a novel splice-variant of mSlo3; CV562866 lacks 
transmembrane domains and is more widely expressed than mSlo3. CV562866 protein is 
expressed in vivo, and contains the nominal RCK2 domain. CV562866 affects functional 
expression of mSlo3 and mSlo1 channels in Xenopus oocytes, decreasing and increasing 
expression respectively.  
 
This study examined the hSlo2.2a channel characteristics, which unlike the previously 
reported rSlo2.2a channel, mediates a non-rectifying K+ current. Bithionol activates hSlo2.2a 
channels with an EC50 of 1.29±0.12µM and activation was Na+ co-operative. We found a 
candidate bithionol binding site in the C-terminal domain near the “Cl- bowl”. Due to 
toxicity of hSlo2.1 expression; determination of the bithionol selectivity of Slo2.χ channels 
was unattainable. In vivo, Slo2.χ channels act as a background K+ conductance, activated by 
a variety of conditions, stabilising the resting membrane potential of the cell. This study 
suggests Slo2.χ are viable pharmacological targets for treatment of inflammatory pain. 
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Chapter I: Introduction  
 
1.1 Introduction to potassium channels 
 
1.1.1 General Introduction 
Potassium (K+) channels are the largest and most diverse super-family of highly selective 
ion channels, and form a selective pathway for K+ ions to rapidly traverse the cell 
membrane. Due to the physiological asymmetric gradient of [K+] across the cell membrane, 
created by the Na+/K+-ATPase pump, a Nernstian equilibrium potential (EK) is generated, 
this potential is generally ≈ -90 mV in excitable cells. Activation of K+ channels allows the 
efflux of K+ ions from the cell resulting in hyperpolarisation of the membrane to near EK, 
and away from the “threshold” potential at which the voltage gated Na+ channels open 
(Hille, 2001). In excitable cells, like neurons, there are two functions of K+ channels; 
repolarising the membrane after action potential firing and modulating the resistance to 
change via maintenance of the membrane potential with zero current flux (resting membrane 
potential). K+ channels affect not only the overall excitability of the cellular membrane but 
also can affect the duration, shape and rate of action potentials (Hille, 2001). K+ channels are 
generally grouped according to the pore forming alpha subunit topology. The three classes 
are the six transmembrane domain (like the voltage gated K+ (Kv) channels), the four 
transmembrane two pore and the two transmembrane inward rectifying subunits. Within 
these structural classes there are sub-families that are classified by channel function and 
structure. The focus of this thesis is devoted to the Slo channel sub-family, which are 
members of the six transmembrane (TM) K+ channel family, which have a distinctive large 
single channel-conductance.  
 
1.1.2 Generalised Structural Features of Six Transmembrane K+ channels 
1.1.2.1 Pore Domain 
The definitive feature of K+ selective channels is the conserved signature sequence of 
TXXTXG[Y/F]G (where X can be any amino acid) that forms the K+ selective filter of the 
ion conducting pore (Heginbotham et al., 1994; Doyle et al., 1998). The filter is located 
within a long extracellular loop between two TM domains, which partially re-enters the 
membrane. Mutagenesis of these conserved residues and the Y to F variant have been shown 
to lower the K+ selectivity of the channel (Heginbotham et al., 1994). Determination of the 
2 
 
crystal structure of KcsA, a two TM bacterial K+ channel α-subunit, at 2 Å demonstrated the 
mechanism of channel selectivity for K+ ions over smaller ions like Na+. This structure 
showed that the K+ ion is held in a square antiprism of eight water molecules in the 
intracellular vestibule, maintained in position by the negative charged amino acids at the 
base of the pore helices. This is mimicked by the carbonyl oxygen atoms within the 
selectivity filter, compensating for the energetic cost of dehydration of the K+ ions (Figure 
1.1). Smaller ions such as Na+ have differing hydration distances and thus are not able to 
coordinate with the carbonyl groups to form the correct orientations required to pass through 
the filter. This selectivity is re-enforced in a low K+ environment by the collapse of the 
selectivity filter (Zhou et al., 2001; MacKinnon, 2004). 
 
1.1.2.2 Voltage Sensor 
Many of the six TM K+ channel family are gated by voltage, the voltage sensor domain 
(VSD) is generally composed of the S1-S4 TM domains that contain a high density of 
charged residues that can respond to changes in TM potential. In particular the S4 TM 
domain contains a high density of positively charged arginine residues. However, there is 
still some contention as to the dynamics of voltage sensor activation in voltage gated K+ 
channels. There are currently two theories; firstly the “paddle model” which suggests that 
the S3-S4 of the VSD is moved across/through part of the lipid bilayer in response to a 
change in voltage (Jiang et al., 2003; Tao et al., 2010). The second model suggests that 
instead of the large movement suggested by the first model, the S4 helix movement is 
limited. This model suggests that in response to voltage, the S4 undergoes a significant 
rotation and tilting within the membrane causing an upward movement, allowing the channel 
gate to move and allow the flux of ions through the selectivity filter (Bezanilla, 2000; 
Chanda et al., 2005; Posson et al., 2005). 
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Figure 1.1 The selectivity filter of the K+ channel pore. Electron density map of the K+ 
selectivity filter from the 2Å crystal structure of the KcsA K+ channel. The conserved 
selectivity filter sequence is overlaid on the crystal structure to show the positions of these 
residues. The selectivity filter is visualised with K+ ions (green spheres) along the ion 
pathway, and water molecules (red spheres) in the vicinity. K+ ions are shown both 
dehydrated in positions 1-4 along the filter but also hydrated in the inner and outer vestibule. 
Modified from Y. Zhou et al. (2001). 
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1.2 Slo1 channels 
 
1.2.1. Discovery of a large conductance Ca2+ activated K+ current 
The Slo channel sub-family was first discovered by the convergence of two independent 
lines of research, electrophysiological studies of cellular membrane ion currents and 
Drosophila melanogaster neurogenetics. The first observation of the channel was a 
distinctive outward K+ current in snail neurons, with dual dependence on Ca2+ influx and 
depolarisation of the membrane for activation (Meech, 1974; Meech & Standen, 1975). The 
distinctive large unitary conductances recorded by the newly-developed patch clamp 
technique, led to the nomenclature “big” potassium (BKCa) channels or the pseudonym 
“Maxi-K” channels being attributed to these channels. Separately, a D. melanogaster 
mutant, slowpoke (slo) was identified, this mutant exhibited a highly lethargic phenotype 
and under ether anaesthesia this mutant displayed a similar but less extreme leg-shaking 
behaviour to Shaker mutants (a Kv1 channel mutation). Voltage clamp recordings of the 
dorsal longitudinal flight muscles, showed an abolition of the Ca2+ dependent element of the 
outward K+ current. This result demonstrated that the slo locus was the gene that encoded the 
BK channel protein (Elkins et al., 1986). Identification of the slo gene and subsequent 
cDNA sequence analysis predicted a protein (dSlo1), with resemblance to the Shaker (Kv1) 
α-subunit. The mammalian ortholog of the protein, mSlo1, was isolated using D. 
melanogaster slo cDNA probes against mouse brain and skeletal muscle cDNA libraries, 
and successfully expressed in a Xenopus oocyte expression system. The resulting 
macroscopic currents corresponded to activation of a Ca2+ activated K+ channel with a 
unitary conductance of 260 pS in symmetrical (160 mM) K+, in contrast Kv1.1 (the 
mammalian Shaker ortholog) has a unitary conductance of approximately 10 pS (Butler et 
al., 1993).  
 
1.2.2 Structure of the Slo1 α-subunit 
The Slo1 α-subunit has a similar structure to the Kv α-subunit, six TM segments (S1- S6), 
with the channel pore located between S5-S6 and a S4 domain with a series of three 
regularly spaced basic residues (Meera et al., 1997; Ma et al., 2006) (Figure 1.2.B). 
However, amongst the six TM K+ channel family, the Slo channel sub-family is unique due 
to the presence of an extra TM domain termed S0. The presence of this additional domain 
causes the N-terminus of these subunits to be extracellular rather than intracellular (Meera et 
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al., 1997). This S0 domain is essential for interactions of the Slo1 α-subunits with the Sloβ 
subunits (Wu et al., 2009), and correct trafficking to the cell surface (Liu et al., 2008). The 
Slo1 α-subunit also has a large cytoplasmic tail consisting of two paired domains S7-S8 and 
S9-S10 (Meera et al., 1997). These paired domains form a tandem arrangement of non-
identical “regulator of K+ conductance” (RCK) domain architecture in the large C-terminus 
tail that provides most of the physiological modulatory sites. Recent structural studies have 
confirmed that like other RCK containing channels; an octomeric gating ring is formed 
consisting of a tetramer with each subunit containing two RCK domains. This tetramer is 
found in close proximity to the TM ion conduction pore, and potentially forming a 
cytoplasmic ion conduction pathway for ions moving through the channel (Yuan et al., 
2010; Wu et al., 2010). The RCK domains are thought to undergo ligand dependent 
conformational changes that alter the kinetics of the transition between the open/closed 
states of the channel activation gate (Yuan et al., 2010; Wu et al., 2010). The Ca2+ sensitivity 
of the channel is conferred by two distinct sites in the C-terminal tail, D362, D367 and 
M513, in the RCK1 (S7-S8) structure are critical for the high-affinity Ca2+ sensitivity. The 
second site is the “calcium bowl”, located in the RCK2 (S9-10) domain. This is formed from 
five consecutive negatively charged aspartates (D894–D898) (Yusifov et al., 2008). The 
RCK1 and RCK2 domains are linked by an unstructured linker sequence that cannot be 
resolved in the crystal structure (Yuan et al., 2010). This linker region is known to contain at 
least three known sites for alternative splicing of the Slo1 α-subunit (Tseng-Crank et al., 
1994) and the linker length has been shown to affect channel activity with shorter lengths 
reducing channel activity (Lee et al., 2009). 
 
1.2.3 Formation of the Slo1 Channel 
The tetrameric nature of the Slo1 channel was first ascertained using co-injection of the 
extracellular tetraethylammonium (TEA) - insensitive dSlo1 α-subunit mutant (Y308V) with 
the wildtype dSlo1 cRNA in Xenopus oocytes. This experiment demonstrated unitary 
currents with four discrete amplitudes in the presence of 3 mM TEA; these four amplitudes 
corresponded to inhibitions of approximately 80%, 55%, 25% and 10% at + 40 mV (Shen et 
al., 1994). More recent investigations have shown that the tetramerisation in Slo1 is 
mediated by a conserved intracellular domain (BK-T1) located between the S6 TM domain 
and the S7 C-terminal domain (Quirk & Reinhart, 2001).  
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Figure 1.2 Schematic of the topology of six transmembrane K+ channel α-subunits. The 
general topology of a Kv channel is shown in (A), with the six TM domains, and the pore 
forming P-loop. Slo α-subunits have a distinctive large carboxy-tail, which contains the sites 
required for sensing cytostolic factors, such as the calcium bowl in Slo1 (B). The carboxy-
tail also contains the unifying structures for the Slo family, the two RCK domains separated 
by a non-conserved linker. Non-pore forming modulatory Sloβ subunits (C), however, have 
a general structure of two TM domains with intracellular N and C-terminal domains. Slo1 
(B) and Slo3 (D) are also distinctive from Kv (A) and Slo2.χ (E) subunits due to an extra 
TM domain S0, which leads to an extracellular N-terminus and allows interaction with Sloβ 
subunits. The weak voltage sensitivity of Slo2.χ (E) can be explained by the lack of positive 
residues in the S4 domain in comparison with the other subtypes.  
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1.2.4 Physiological relevance of Slo1 
The Slo1 channel has a large range of physiological relevance due to the ubiquitous 
expression in cells and tissues throughout the body. In vascular smooth muscle, Slo1 
channels have been shown to regulate contractility and cause vasodilatation due to rises in 
[Ca2+]i and depolarisation (Nelson et al., 1995; Brenner et al., 2000; Sausbier et al., 2005). 
In bladder smooth muscle, disruption of Slo1 function by toxins or knock out (KO) of the 
Slo1 α-subunit results in an increase action potential size and frequency causing an 
overactive bladder and incontinence (Petkov et al., 2001; Hashitani & Brading, 2003; 
Meredith et al., 2004). Due to the large conductance of this channel, Slo1 channels also play 
a crucial role in the regulation of neuronal excitability in the central nervous system. In 
cerebellar and hippocampal neurons, the Slo1 α-subunit has been shown to localise to the 
presynaptic terminals and axons of the neurons (Knaus et al., 1996; Misonou et al., 2006; 
Sausbier et al., 2006). Slo1 α-subunits have been found to co-localise with voltage gated 
Ca2+ channels in neurons, allowing Slo1 channels to contribute to the after-hyperpolarisation 
observed after an action potential that closes the voltage gated Ca2+ channels (Grunnet & 
Kaufmann, 2004; Berkefeld et al., 2006). Thus Slo1 channels play a vital role in controlling 
synaptic transmission and the after-hyperpolarisation; allowing control of spike frequency 
adaptation (Raffaelli et al., 2004; Gu et al., 2007). 
 
1.2.5 Modulation by Sloβ subunits  
Slo1 channel inherent function is not only modulated through splice variation of the Slo1 α-
subunit, but also by expression with the four modulatory Sloβ subunits (Sloβ1-4). Tissue 
specific expression of Sloβ subunits underlies many of the differences reported in Slo1 
channel characteristics and thus their diverse roles in differing cell types. Sloβ subunits have 
a general structure of two TM domains with intracellular N and C-terminal domains and are 
unable to form a distinct channel as they lack a pore loop (Figure 1.2.C) (Knaus et al., 
1994). Sloβ subunits are thought to physically interact through the S0 and S1/2 domains of 
the Slo1 α-subunit (Wu et al., 2009). Sloβ1 subunits were first observed by co-
immunoprecipitation with the Slo1 α-subunit from bovine tracheal smooth muscle (Knaus et 
al., 1994). Co-expression of Slo1/β1 in HEK cells generates currents that are activated at 
lower [Ca2+]i compared with solitary expression of Slo1 α-subunit. These currents also 
display slower rates of deactivation and reduced iberiotoxin sensitivity. Sloβ1 expression in 
smooth muscle therefore produces Slo1 channels that can be activated under physiological 
conditions (Lippiat et al., 2003).  
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Sloβ2 subunits are unique amongst the Sloβ subunits, as they cause N-type inactivation of 
Slo1 currents. This inactivation is due to the “ball” formed by the first 19 residues of N-
terminus of the Sloβ2; inactivation can be relieved by intracellular application of trypsin 
(Wallner et al., 1999; Lippiat et al., 2003). Removal of the inactivation ball by trypsin 
application revealed that the voltage and [Ca2+]i dependence of currents was similar to 
Slo1/β1 (Lippiat et al., 2003). The Sloβ3 subunit was first proposed to cause N-type 
inactivation of Slo1/β3 currents like the Sloβ2 subunit (Xia et al., 1999), however analysis of 
the sequence alignments determined that this original study was actually using the hSloβ2 
subunit. Studies of the Sloβ3 subunit did find that two of the four splice variants (Sloβ3a and 
Sloβ3c) did cause partial N-type inactivation. However, whilst the time constant for 
inactivation was the same as for Sloβ2 subunits the fractional inactivation of the currents 
was reduced. The Sloβ3b subunit was found to confer a small component of very fast 
inactivation causing the appearance of an apparent inward rectification of currents (Uebele et 
al., 2000). These inactivating Sloβ subunits mediate the inactivating Slo1 channels that are 
observed in adrenal cromaffin cells and pyramidal neurons of the hippocampus (Lippiat et 
al., 2003). The Sloβ3d isoform causes no inactivation, and does not appear to affect the 
[Ca2+]i or voltage range of activation (Uebele et al., 2000; Lippiat et al., 2003).  
 
The Sloβ4 subunit, which is expressed predominantly in neuronal tissues, confers 
insensitivity to iberiotoxin and charybdotoxin to the Slo1/β4 channel complex (Lippiat et al., 
2003). Slo1/β4 channels in HEK cells have decreased sensitivity to voltage, [Ca2+]i and 
slowed activation rates (Weiger et al., 2000). The Sloβ4 subunit has been associated with 
epilepsy and dyskinesia; KO of the Sloβ4 subunit shifts the activation of Slo1 channels back 
to the normal physiological range, thus increasing the channel’s contribution to action 
potential repolarization and increasing firing rates (Brenner et al., 2005; Petrik et al., 2011). 
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1.3 Slo3 channels 
 
1.3.1 Introduction to Slo3 channels 
With the advent of cDNA libraries and DNA sequence analysis, the next reported member of 
the Slo channel subfamily was identified in mouse cDNA via an expressed sequence tag 
(EST) from a promyelocytic WEHI-3 cell line with homology to the C-terminal “tail” of 
mSlo1. However, all of the isolated cDNA sequences from the WEHI-3 cell line were found 
truncated or incorrectly spliced. PCR analysis of a variety of tissues led to the discovery of 
the Slo3 encoded channel, mSlo3. Expression of mSlo3 cDNA was found to be highly 
restricted solely to spermatozoa and testis.  
 
Hydrophilicity plots of the mSlo3 and mSlo1 sequences indicated that like mSlo1, the mSlo3 
structure has 11 domains, S0 through S10. Akin to mSlo1, these can be split into the “core” 
(S0-S8) domain, which includes the TM domains (S0-S6) and the start of the intracellular C-
terminus (S7-S8), and “tail” domains (S9-S10) (Figure 1.2.D). The mSlo1 and mSlo3 
sequences have highest similarity in the “core” domain (S0-S8) sharing 56% sequence 
identity. The orthologues mSlo1 and dSlo1 share 62% identity through this “core” region. 
The “tail” domains (S9-S10), however, are more divergent and have only 39% identity 
between mSlo3 and mSlo1 sequences. The channels also differ in their physiological 
modulation; mSlo3 channels, when expressed in Xenopus oocytes, were found to be 
modulated by internal pH, with channel activation at low [H+] and voltage. Unlike mSlo1 
channels which are modulated by Ca2+ and voltage. mSlo3 channels displayed a lower 
unitary conductance (106 pS) in symmetrical K+ (160 mM) compared to mSlo1 channels. 
mSlo3 channels have a GFG sequence motif in the selectivity filter of the pore, rather than 
the GYG sequence motif observed in the mSlo1 sequence. This results in mSlo3 channels 
having a reduced selectivity for K+ over Na+ (PK/PNa ≈ 5) compared to mSlo1(PK/PNa > 50) 
(Schreiber et al., 1998).  
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1.3.2 Slo3 channel properties 
1.3.2.1 Endogenous Activators  
The original study noted that the mSlo3 channel had a short mean open time and a low open 
probability at physiological voltages (Schreiber et al., 1998). Further studies have attempted 
to better define the links between voltage or pH and activation of the Slo3 channel. Slo3 
activation by high pH was found to be the major determinant of the open probability (Po), 
this effect of pH on channel conductance, was found to be largely voltage independent 
(Zhang et al., 2006b). Estimates of Slo3 conductance at negative potentials predicted that 
Slo3 channel gating has weak intrinsic voltage dependence. This is believed to be due to a 
weaker coupling of the voltage sensor to the channel activation gate. This is possibly 
dependent on a more restricted motion through the membrane, in comparison to the Slo1 
voltage sensor (Zhang et al., 2006a). The weak voltage dependence of mSlo3 activation is 
exemplified by the requirement for a non-physiological range of positive voltages to activate 
the channel. Previous studies of mSlo3 have also shown that currents fail to reach a 
measurable GMax plateau in macroscopic patches pulled from oocytes at voltages up to +300 
mV (Zhang et al., 2006a; Tang et al., 2010b). Chimaeras made between the divergent mSlo3 
and bovine Slo3 (bSlo3) orthologues have suggested regions outside the S0-S6 TM domains 
influence the voltage dependence of channel activation, in oocytes. bSlo3 currents differ 
from mSlo3 currents by having a faster activation time constant (τ), more negative voltage 
range of activation, a higher selectivity for K+ (PK/PNa = 10) and are less sensitive to high 
pH. Using chimaeras, a region in the RCK1 of mSlo3, when replaced with the bSlo3 
sequence, was found to shift the voltage sensitivity to bSlo3 levels. This chimaera also 
conferred the mSlo3 currents with the characteristic faster τ of bSlo3 currents. Interestingly 
the inverse chimaera in bSlo3 did not shift the voltage activation to the more positive 
potential of mSlo3. This suggests that in bSlo3 there are other structural components that 
determine the voltage range of activation. As the region in the distal half of the mSlo3 RCK1 
contains two histidine residues, which are not present in bSlo3, these residues were mutated 
to test if these contribute to the reduced bSlo3 sensitivity to high pH. It was found that 
mutation of these two residues did not confer the reduced sensitivity to high pH to mSlo3 
currents. Thus it appears that in mSlo3 the RCK1 domain may influence the coupling of the 
voltage sensor to the channel pore (Santi et al., 2009). 
 
The dependence of channel activity on pH implicates a role for a “pH sensor” mechanism 
that directs gating in an allosteric manner, similar to Ca2+ regulation of Slo1, rather than 
effects on ion permeation (Zhang et al., 2006a). Activation of Slo3 was found to be limited 
to the range pH 7.4 - 9, illustrated in Figure 1.3. pH 9 is not a known physiological limit to 
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channel activation, as at pH values higher than 9, patch stability could not be maintained. 
Analysis of the effects of pH on Po of the channel suggested that multiple protonation sites 
exist on the Slo3 C-terminus tail (Zhang et al., 2006a). Interestingly, analysis of the 
activation and deactivation time courses of macroscopic currents exposed fast and slow 
exponential components. This suggested that there were two distinct inter-converting 
channel populations that are in differing kinetic states. Increasing pH was found to affect the 
amplitude of activation; whilst the time course of activation remained constant. This finding 
suggested a shift between populations was dependent on the level of protonation of the Slo3 
channel (Zhang et al., 2006a). An expectation of their theory is that the distinct populations 
would each have a discrete steady state Po, however this was not observed in their analysis 
of single channel traces (Zhang et al., 2006b). One curious aspect of the fast component of 
channel deactivation is the minimal dependence on pH. Therefore it was proposed that the 
fast deactivation of Slo3 represents a novel closing process that may be unrelated to the 
closing of the Slo3 S6 helix (Zhang et al., 2006a). However this was not observed in single 
channel traces which exhibit a rapid opening and closing that prevented simple definition of 
a unitary current level. Thus it was concluded that there is insufficient evidence to determine 
the effects of pH on the gating steps controlling Slo3 activation time course (Zhang et al., 
2006b). 
 
The structural determinants of the pH sensitivity have not been well defined. What little is 
known is predominantly due to production of chimaeras between Slo1 and Slo3. Studies of 
these chimaeras have focused on the effects on the Slo1 channel properties in contrast with 
wild type Slo1 (Xia et al., 2004). One of these chimaeras was an exchange between Slo1 and 
Slo3 of the entire post S6 inner helix C-terminal cytosolic domain. When the Slo3 C-
terminus was fused to the pore domain of Slo1, the resulting chimaera displayed regulation 
by pH (Xia et al., 2004). However, little current activation at + 300 mV was observed at pH 
7.4 in the chimaera; whereas in Slo3 activation at + 300 mV was observed from as low as 
pH 6.0. This difference in characteristics was shown to be due to differences in pore domain 
and cytosolic regulatory domain interactions being differentially effective at gating the 
channel dependent on the pore domain (Xia et al., 2004). Another study, investigating the 
structural determinants of carbon monoxide sensitivity in Slo1, made a more restricted 
chimaera in which the C-terminal tail of the hSlo1 protein was replaced only with the S9–
S10 module, equivalent to the “Ca2+ bowl” of Slo1, of mSlo3. The activity of this chimaera 
was not dependent upon intracellular pH. This observation suggests that the S9–S10 module 
(RCK2) of mSlo3 is not the pH sensor (Williams et al., 2008). 
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The mSlo3 channel has also been shown to be modulated by cAMP and PIP2 levels 
(Martínez-López et al., 2009; Tang et al., 2010a). When ooctyes injected with mSlo3 
mRNA were treated using forskolin and a phosphodiesterase inhibitor (IMBX), to increase 
cAMP levels, mSlo3 currents increased. This increase could be inhibited if oocytes were 
preincubated with H-89, an inhibitor of cAMP dependent kinases (PKA). This suggests that 
the cAMP increase of mSlo3 current is dependent on phosphorylation (Martínez-López et 
al., 2009). PIP2 depletion has been shown to inhibit mSlo3 currents in oocytes. PIP2 is 
thought to act through electrostatic interactions with two amino acids, K320 and K329, 
which are located on the C-terminus in the linker region between S6 and RCK1. Mutation of 
these two lysines to uncharged asparagine, individually or in tandem, increased the EC50 
values for DiC8-PIP2, a soluble homologue of PIP2, on mSlo3 currents (Tang et al., 2010a). 
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Figure 1.3 pH dependence of activation of mSlo3 macroscopic currents expressed in 
oocytes. Currents recorded from oocytes showing increased pH results in increased 
amplitude and speed of activation for a given voltage over the range -40 to +240 mV. 
Modified from X. Zhang, X. Zeng & Lingle (2006). 
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1.3.2.2 Expression Profile  
Unlike the ubiquitously expressed Slo1 α-subunit, Slo3 α-subunit expression appears to be 
highly restricted. PCR and northern blot analysis of a variety of tissues found that expression 
of full length mSlo3 cDNA was restricted to tissue isolated from testes. This seems contrary 
to the initial detection of an expressed sequence tag (EST), from the mouse promyelocytic 
WEHI-3 lympocyte cell line, with homology to the C-terminal “tail” of mSlo1. However all 
of the isolated cDNA sequences from the WEHI-3 cell line were found to be truncated or 
incorrectly spliced. In situ hybridisation probing of seminiferous tubules found a high level 
of hybridisation to the mSlo3 probe in more mature spermatocytes (those closest to the 
lumen). However, the study did acknowledge that the techniques used could not exclude 
restricted expression within tissues or low level expression (Schreiber et al., 1998). 
 
1.3.2.3 Pharmacology  
The pharmacology of mSlo3 differs from mSlo1; mSlo3 is largely insensitive to 
extracellular TEA with an IC50 of 49 mM in comparison to block of mSlo1 which has an 
IC50 of 0.14mM (Schreiber et al., 1998). This difference in TEA sensitivity is due to the lack 
of a tyrosine (Y294) on the S5 linker region. When this site is mutated in Slo1 the mutant 
results in mSlo3 levels of inhibition (Tang et al., 2010b). Most of the mSlo3 pharmacology 
was performed on a chimaeric mSlo3 α-subunit (MC13), which has residues 1-181 
substituted from the mSlo1 α-subunit. This chimaera was used because whilst the expression 
in oocytes was increased, the basic gating properties were unchanged. Like mSlo3, MC13 
currents are insensitive to the scorpion toxins, iberiotoxin and charybdotoxin, the “classical” 
Slo1 inhibitors.  
 
In contrast to extracellular TEA application where MC13 has a lower sensitivity than Slo1, 
MC13 currents were ≈25 times more sensitive to cytosolic TEA than mSlo1 currents. This 
value, however, is estimated as none of the blocking schemes fitted to the data with high 
fidelity. Thus the study was unable to firmly conclude the affinity at 0 mV of TEA to MC13. 
The MC13 chimaera was also tested against the non specific K+ channel inhibitors, 4-
aminopyridine (4-AP) and quinidine. Blockade of MC13 by 4-AP was negligible when 
applied to the extracellular side of the membrane but potent with intracellular application. 
This was suggested to be due to low permeation of 4-AP across the membrane at pH 7.0, as 
at this pH only ≈ 0.6% of 4-AP remains uncharged and thus able to cross the membrane. 
Quinidine block of MC13 was proposed to be due to the protonated form binding with a 
higher affinity to the closed state of the channel. However, the study acknowledges that for 
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cytosolic application of quinidine, no model of block fits the data with higher consistency 
than any of the other models (Tang et al., 2010b).  
 
1.3.3 Regulation of Slo3  
1.3.3.1 Sloβ Subunits 
Sloβ subunits are thought to physically interact through the S0 and S1/2 domains of the Slo1 
α-subunit, which is within the region that mSlo1 and mSlo3 have the highest sequence 
identity (Schreiber et al., 1998; Wu et al., 2009). A study of the interactions between mSlo3 
and Sloβ subunits found that all of the Sloβ subunits appear to be able to interact with mSlo3 
(Yang et al., 2009). Sloβ2 was found to functionally interact with mSlo3 and displayed 
trypsin-sensitive inactivation (Yang et al., 2009). Of the four Sloβ subunits, only Sloβ4 has a 
gain of function effect on mSlo3 currents (Yang et al., 2009). Sloβ4 co-expression with the 
mSlo3 α-subunit results in an eight-fold increase in the conductance recorded from 
macropatches and increased surface expression in oocytes. Expression of mSlo3 with Sloβ4 
did not modify the voltage dependence, single channel conductance or the Po of currents. 
This suggests that Sloβ4 only increases the surface expression level of the channels rather 
than the single channel electrophysiological properties. Sloβ4 was also found, using RT-
PCR, to be expressed to a similar level as mSlo3 in testes and spermatozoa. Interestingly, 
Sloβ4 KO mice had no change in the reproductive capacity, as quantified by litter size (Yang 
et al., 2009). This evidence suggests that there are other as yet unknown regulatory subunits 
that effect mSlo3 expression and channel function in vivo. 
 
1.3.4 Physiological relevance of Slo3  
1.3.4.1 IKSper 
The alkaline activated IKSper (K+ channel of Sperm) current was first identified through patch 
clamp recordings from mouse CatSper1 KO mature spermatozoa (Navarro et al., 2007). The 
properties of this current are similar to the mSlo3 channel mediated current, including the 
shape of the I/V curve, the potentiation of the current over a similar pH range (pH 6- pH 8) 
and weak voltage sensitivity. However, IKSper is activated by a lower voltage range than 
mSlo3 and displays distinct inward current which is absent from mSlo3 recordings. IKSper is 
the dominant hyperpolarizing conductance within the physiological range, and thus is 
believed to dictate the resting membrane potential of the spermatozoan. IKSper current was 
found to be inhibited by the general motility and volume regulatory K+ channel (TASK2 and 
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Kv1.5) inhibitors; quinine (1.4.2), clofilium (1.4.3) and mibefradil (1.4.4) (Navarro et al., 
2007). The original study was unable to confirm if mSlo3 channel is the IKSper current 
mediator in mouse CatSper1 KO mature spermatozoa as the only commercially available 
anti-mSlo3 antibody is raised in mouse (NeuromAB) (Navarro et al., 2007). In the original 
study the IKSper current was found not to be modulated by the presence of membrane 
permeant cAMP analogs (Navarro et al., 2007). This characteristic of IKSper seems to 
contradict the subsequent reported mSlo3 characteristics (Martínez-López et al., 2009). This 
subsequent study also found that the spermatocyte currents isolated after inhibition of the 
endogenous KATP and ENaC channels, were activated by high [pH]i and 8Br-cAMP. This 
discrepancy was explained to be due to the [pH]i used in the experiments, the original study 
used a [pH]i of 7, under which condition 8BR-cAMP is unable to activate the isolated 
spermatocyte currents. Activation with 8BR-cAMP was only seen when the [pH]i was 7.4 or 
higher (Martínez-López et al., 2009). Like mSlo3, the alkalinisation activated sperm K+ 
current is increased by the presence of DiC8-PIP2. This increase was on average 3.2 fold and 
reversible by application of epidermal growth factor (EGF), which in turn activates EGF 
receptors and hydrolyses the endogenous PIP2 (Tang et al., 2010a). 
 
Recently two studies describe the generation of mSlo3 KO mice and the isolation of 
spermatozoa. As expected in both of these studies KO spermatozoa lacked or had a reduced 
alkalinisation activated K+ current (Santi et al., 2010; Zeng et al., 2011). The discrepancy is 
due to the voltages used in the current recording protocols. In the initial study where no 
alkalinisation activated K+ current was observed in the KO spermatozoa voltage steps were 
limited to the -80 mV to +60 mV range (Santi et al., 2010). The second study used a voltage 
ramp from -100 mV to +100 mV to record currents from their KO spermatozoa and thus 
observed a second alkalinisation activated K+ current, which they termed Kres, which is 
activated by potentials greater than +60 mV (Zeng et al., 2011). The second study also found 
that they could distinguish Kres currents due to the reversibility of clofilium block (Zeng et 
al., 2011). Both studies found that mSlo3 KO spermatozoa were unable to undergo the 
alkalinisation-activated hyperpolarisation required for capactiation (discussed in 1.3.4.2) and 
in fact depolarised under these conditions. The studies concluded that mSlo3 KO 
spermatozoa have reduced progressive motility (Santi et al., 2010; Zeng et al., 2011). The 
second study, interestingly, also found that mSlo3 KO spermatozoa were unable to maintain 
normal volume regulation under osmotic stress (Zeng et al., 2011). Due to these 
characteristics of mSlo3 KO spermatozoa, both studies found that even with normal mating 
indictors (vaginal plugs) male mSlo3 KO mice were infertile and unable to produce 
offspring (Santi et al., 2010; Zeng et al., 2011). Neither of these studies has addressed the 
discrepancies observed between IKSper and heterologously expressed mSlo3 in ooctytes. In 
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particular, that although the pH range (pH 6- pH 8) and weak voltage sensitivity of 
activation are similar in the two systems, both of these characteristics are shifted leftwards 
for IKSper compared to mSlo3, suggesting that there is a yet unknown accessory or 
modulatory protein to mSlo3. 
 
1.3.4.2 Capacitation and Acrosome Reaction  
Capacitation is defined as the penultimate step in the maturation of spermatozoa in the 
female reproductive tract; this process was first reported in 1951 by two independent groups 
(Austin, 1951; Chang, 1951). During the process of capacitation, the spermatozoa acquire 
hyperactivated motility, chemotaxis and are readied for the acrosome reaction prior to 
fertilisation. Capacitation occurs after several hours in the female reproductive tract, in the 
fallopian tubes. From in vitro analysis capacitation requires the oviductal fluid to contain; 
albumin, bicarbonate and extracellular Ca2+ (Visconti et al., 2002). The initiation of 
capacitation is currently unknown, but may be due to two effects of albumin on 
spermatozoa. Firstly removal of cholesterol from the membrane, modifying the membrane 
properties and secondly by directly stimulating the alkalinisation activated CatSper channels 
(Xia & Ren, 2009). In humans there is a third possible initiator of capacitation, progesterone, 
which has been shown to activate hCatSper but not mCatSper channels (Lishko et al., 2011). 
The initial rise in [Ca2+]i and [HCO3-]i activates soluble adenylyl cyclase (SACY), which in 
turn increases [cAMP]i levels and activation of PKA causing phosphorylation of a range of 
target proteins (Visconti et al., 2002; Harrison & Gadella, 2005). The cAMP rise also causes 
a rise in pHi by activation of HV1 channels in humans, and the Na+-dependent Cl-–HCO3- 
exchanger in mouse (Zeng et al., 1996; Lishko et al., 2010). The increase in intracellular pH 
is thought to activate IKSper current and drives the membrane potential to negative potentials. 
This sequentially increases the driving force of Ca2+ entry via CatSper channels which are 
also activated by high pHi (Kirichok et al., 2006; Navarro et al., 2007, 2008). The high pHi 
and [Ca2+]i levels cause the characteristic high amplitude, asymmetrical flagellar beating of 
hyperactivation by affecting the axoneme (Ho et al., 2002). 
 
Currently the chemoattractant for spermatozoa is unknown, it has been suggested that in 
humans the progesterone secreted by the cumulus cells can activate the hCatSper channels 
and cause chemotaxis by induced asymmetrical tail beating (Lishko et al., 2011). However, 
other chemoattractants have been suggested and the importance of chemotaxis in 
mammalian systems is contentious (reviewed in (Eisenbach & Giojalas, 2006)). Once the 
capacitated spermatozoa reach the egg, hyperactivation of the spermatozoan flagella is 
essential to allow the spermatozoan to penetrate the protective outer layers of the egg 
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(Suarez, 2008). The protective outer layers of the egg consist of; the outermost layer, the 
cumulus oophorus, and the inner zona pellucida layer (Suarez, 2008). Hyperactivation of the 
spermatozoan flagella is enough to drive the spermatozoan through the cumulus oophorus; 
however, the zona pellucida matrix is too dense. To penetrate the zona pellucida the 
spermatozoan must undergo the acrosome reaction caused by exocytic fusion of the 
acrosomal vesicle with the spermatozoan’s plasma membrane; this process allows fusion of 
the spermatocyte with the egg (Clark et al., 1993; Dean, 2007).   
 
1.3.4.3 K+ channels in spermatozoan volume regulation 
The finding that mSlo3 KO spermatozoa were unable to maintain normal volume regulation 
under osmotic stress suggests that mSlo3 channels play a role in the volume regulation of the 
spermatocyte (Zeng et al., 2011). Spermatozoa undergo regulatory volume decrease (RVD) 
when they move from the vas deferens (≈350 mOsm) to the vaginal tract (≈280 mOsm). 
Defects in RVD result in angulations and coiling of the spermatozoan flagella, which is 
associated with infertility in domestic animals and mice. mSlo3 channels have been 
previously discounted for a role in RVD due to reported TEA sensitivity, leading to Kv1.5 
and TASK2 channels being the primary channels theorised to mediate volume regulation 
and motility (Yeung & Cooper, 2001; Barfield et al., 2005a, 2005b). However, their study 
used up to 10 mM TEA without seeing significant effects, which is below the mSlo3 IC50 of 
49 mM at +60 mV (Barfield et al., 2005b). The K+ current that regulates volume and 
motility is also sensitive to as little as 200 μM quinine when applied for 5 minutes (Yeung & 
Cooper, 2001; Barfield et al., 2005b). The volume regulatory K+ current has also been 
shown to be to be sensitive to clofilium (10 μM) when applied for 75 minutes. The volume 
regulatory K+ current is also sensitive to 4-AP, a K+ channel inhibitor shown to have effects 
on spermatozoan volume regulation (Barfield et al., 2005a). However, this compound was 
found to enhance rather than inhibit IKSper, possibly in consequence of indirect alkalinisation 
of cells (Navarro et al., 2007).  
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1.4 IKSper K+ current inhibitors  
 
1.4.1 Barium  
Barium ions (Ba2+) are one of the earliest reported non-specific blockers of K+ channels, 
Ba2+ block of a K+ conductance was first observed in grasshopper and lobster mucle fibres, 
where Ba2+ application resulted in an “all or none” firing activity (Werman & Grundfest, 
1961; Werman et al., 1961). Further studies have since shown that Ba2+ blockade is non 
specific for K+ channels as the binding site is within the highly conserved K+ selectivity 
filter present in all K+ channels (1.1.2.1). Ba2+ is able to enter the selectivity filter as it has a 
crystal radius of 1.34 Å which is almost undistinguishable from the K+ crystal radius of 1.33 
Å (Armstrong & Taylor, 1980). Early studies of the Ba2+ block of K+ channels in squid giant 
axons and Slo1 channels in reconstituted bilayers led to a permeation pathway model with 
four distinct sites for K+ binding, with Ba2+ able to occupy one of the sites with a slowed off 
rate (Figure 1.4.A) (Armstrong & Taylor, 1980; Neyton & Miller, 1988). Their model 
suggested that Ba2+ is able to access and cross the K+ selective pore region. However in the 
presence of K+ on both sides of the membrane, the high affinities of the “lock in” sites at 
either end of the filter are occupied by K+. This means that the Ba2+ ion becomes “locked” 
within the pore, stopping K+ ions from transversing. In high extracellular [K+] (50 mM) 
there is a second extracellular site termed the “enhancement site”, this is only occupied at 
high [K+]e as it is very close to the Ba2+ binding site. Thus when the enhancement site is 
filled both ions will be subject to strong ionic repulsion “enhancing” the dissociation of Ba2+ 
to the internal solution. This finding also suggests that in the conducting K+ channel (as 
crystallised later by Y. Zhou et al. (2001)) occupancy of all the sites in the pore results in 
mutual destabilisation of the ions in the pore, this allows an increased rate of escape of the 
pore and thus rapid conduction. This model also explains the voltage dependence of Ba2+ 
blockade whereby Ba2+ inhibition is relieved by membrane depolarisations. As, under 
physiological conditions, depolarisation of the membrane will unblock the external “lock-in” 
site and allow the Ba2+ to follow the electrogenic driving force and exit through the 
extracellular side of the pore (Neyton & Miller, 1988). This permeation pathway model was 
confirmed by the solving of the crystal structure of the KcsA pore bound with Ba2+ (Figure 
1.4.B) (Jiang & MacKinnon, 2000).  
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Figure 1.4 Localisation of the Ba2+ binding site within the K+ selective filter. The 
original model of Ba2+ block of the K+ pore (A), suggested by Neyton & Miller (1988), 
showing the location of the four K+ binding sites and their respective distances through the 
membrane. This model also shows the suggested Ba2+ binding site (green) within the pore as 
well as the extracellular and intracellular lock in sites and enhancement site occupied with 
K+ (red), which is only occupied at high [K+]e. The crystal structure (B) of the KcsA pore 
bound with Ba2+ and Rubidium (red), acting as a K+ substitute, confirmed the original 
model. Modified from Neyton & Miller (1988) (A) and Y. Jiang & R. MacKinnon (2000) 
(B). 
  
A
B
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1.4.2 Quinine and Quinidine 
Quinine (Figure 1.5.A) and quinidine (Figure 1.5.B) are steroisomers of the same chemical 
formulae, with similar inhibitory properties at K+ channels. It has been suggested by 
previous studies that voltage dependent inhibition of K+ channels by these compounds 
occurs due to the protonated form of the drug binding to the intracellular side of the channel 
(Zhang et al., 1998; Sănchez-Chapula et al., 2003; Tang et al., 2010b). The reported 
differences in affinity such as for the human ether-a-go-go-related gene (hERG) K+ channel 
that is more strongly inhibited by quinidine than quinine, may be partly due to the differing 
pKa values of these two compounds (Sănchez-Chapula et al., 2003). As at pH ≈ 7.5, roughly 
physiological pH, 92.6% of quinidine (pKa, 8.6) is protonated in comparison to 90% of 
quinine (pKa, 8.5).  
 
The S6 domain of the K+ channel has been shown to be a major determinant of the 
characteristics of quinidine and quinine inhibition. Study of mutations in the S6 domain of 
the HERG K+ channel have been shown to affect the characteristics of inhibition by 
quinidine and quinine. In HERG channels block is thought to be due to the aromatic groups 
of the quinoline π- stacking between the Y652 and F656 residues (Sănchez-Chapula et al., 
2003). S6 domain mutations in the rKv1.4 K+ channel have also been shown to affect the 
characteristics of quinidine inhibition. Mutation of T529 in the S6 domain to a more 
hydrophobic residue results in slowing of the rate of deactivation and a negative shift in the 
voltage dependence of activation of currents. This effect is theorised to be due to the residue 
at 529, during the open state, faces away from the lumen and faces the other TM α-helices. 
Thus increasing the hydrophobicity of the residue at 529 stabilises this condition. These 
mutations in rKv1.4 channels also result in increased quinidine potency, due to quinidine 
binding by intercalation of the hydrophobic moiety of the compound into the protein interior 
during the open state (Zhang et al., 1998). The importance of the S6 domain in quinidine 
potency has also been observed in Kv4.2 channels. In Kv4.2 channels it has been shown that 
the voltage dependence of quinidine inhibition can be disrupted by minor mutations in the 
S6 domain. (Caballero et al., 2003).   
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Figure 1.5 Structures of the non-specific K+ channel inhibitors. Chemical structures of 
the non- specific K+ channel inhibitors; quinine (A), quinidine (B), clofilium (C) and 
mibefradil (D). Chemical structures were drawn using MarvinSketch and coloured with the 
standard CPK colours (Chemaxon, 2011).  
A B
C
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1.4.3 Clofilium 
Clofilium (Figure 1.5.C) is a quaternary ammonium compound, which was first described as 
an antifibrillatory agent that selectively prolonged the cardiac action potential duration and 
the effective refractory period in canine Purkinje fibers (Steinberg & Molloy, 1979). It is 
currently thought that clofilium causes open channel block of K+ channels in a use 
dependent manner via an “activation trap” mechanism by binding from the intracellular side 
of the K+ channel and interacting with the selectivity filter (Steidl & Yool, 2001; Gessner & 
Heinemann, 2003). However, it has been shown that differing K+ channels have slightly 
differing properties with regards to clofilium inhibition. Clofilium has a ≈ 100 fold lower 
potency for Kv1.5 channels over HERG and hEAG channels, also the onset and recovery of 
block is faster at Kv1.5 than at HERG/hEAG channels (Steidl & Yool, 2001; Gessner & 
Heinemann, 2003). This suggests that whilst the binding site for clofilium is conserved, the 
affinity of the binding site differs from channel to channel possibly due to interactions with 
the hydrophobic walls of the intracellular entry pathway.   
 
1.4.4 Mibefradil 
Mibefradil, originally called Ro 40-5967, (Figure 1.5.D) was originally developed by Roche 
as a Ca2+ channel inhibitor for treatment of hypertension (Osterrieder & Holck, 1989). 
However, less than ten years after the initial report mibefradil was withdrawn due to the 
potential for serious drug interactions. Since mibefradil was withdrawn from the market it 
has been shown to affect a range of voltage gated K+ channels. KATP currents from adrenal 
cells were the first found to be inhibited by mibefradil, at a concentration lower than that 
required for T-type Ca2+ channels. Inhibition of this current is thought to arise through 
stabilisation of the closed state of the channel in a voltage independent manner (Gomora et 
al., 1999). However, block of hKv1.5 channels expressed in CHO cells, was found to be 
voltage dependent and the study suggested that mibefradil blocks the open state of the 
channel in a use dependent manner (Perchenet & Clément-Chomienne, 2000). Interestingly, 
intermediate conductance calcium-activated channel (IKCa1) channel currents were affected 
biphasically by mibefradil application; currents were voltage dependently inhibited by 
concentrations higher than 5 μM but showed increased current amplitudes if mibefradil 
concentrations were less than 2 μM. It was suggested that this may be due to low 
concentrations of mibefradil increasing the sensitivity of the IKCa1 channel for Ca2+ (Yoo et 
al., 2008). These differing effects of mibefradil suggest that whilst mibefradil is able to 
block a range of K+ channels the binding site and mechanism of action may not be 
conserved. 
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1.5 Slo2.χ channels 
 
1.5.1 Introduction to Slo2.χ channels 
The Slo2.χ sub-family of channels were first identified in Caenorhabditis elegans from 
sequence homology with Slo1 and Slo3 channels. Expression of the encoded C.elegans Slo2 
(cSlo2) protein displayed a channel with synergistic activation by Ca2+ and Cl- with weak 
voltage dependence, due to the lack of positive charges in the S4 domain, and a single-
channel conductance of 110 pS in symmetrical K+ (Yuan et al., 2000). Soon after the 
identification of cSlo2, mammalian orthologues were identified in both mouse (mSlo2) and 
rat (rSlo2), originally called Slack - Sequence like a Ca2+ activated K+ channel. These 
channels differed from the cSlo2 in that rather than synergistic activation by Ca2+ and Cl- 
they were instead activated by Na+ and Cl- with a unitary conductance of 165 pS, and 
irreversibly inhibited by Ca2+ (Joiner et al., 1998; Yuan et al., 2003). The rSlo2.2 channel 
had been previously identified as a member of the Slo family of channels when originally 
cloned, but activation of the channel by Na+ or Cl- had not been recognized.  
 
1.5.2 Slo2.χ α-subunit variants 
1.5.2.1 Slo2.2b 
The rSlo2.2b α-subunit is the archetype of the Slo2.χ family, as this was the initially cloned 
subunit originally called Slack - Sequence like a Ca2+ activated K+ channel (Joiner et al., 
1998). Slo2.2b α-subunits are the “classical” Slo2.2 channels, which have a long N-terminal 
domain that has little sequence identity to any of the other Slo2.χ family α-subunits. 
Hydrophilicity plots of the rSlo2.2 indicate that unlike mSlo1, the rSlo2.2 structure has only 
six TM domains, S1 through S6 (Figure 1.2.D). The lack of an S0 domain means that these 
α-subunits are unable to interact with Sloβ subunits. Sequence analysis of rSlo2.2 found that 
this α-subunit also lacks a positively charged S4 domain, believed to act as a component of 
the voltage sensor in voltage sensitive K+ channels (1.1.2.2) (Joiner et al., 1998). 
Surprisingly, it appears that rSlo2.2 mediated currents have weak voltage dependence of 
activation and outward rectification when expressed in Chinese hamster ovary (CHO) cells 
(Joiner et al., 1998; Yuan et al., 2000, 2003). Synergistic activation of the rSlo2.2 subunit by 
chloride is thought to occur through the “chloride bowl”, a region of positively charged 
amino acids in a homologous position to the negatively charged residues in the rSlo1 
“Calcium Bowl” (Yuan et al., 2000, 2003). The synergistic activation by sodium of the 
rSlo2.2 subunit is thought to occur partly through a motif that is similar to those found in 
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Na+ sensitive Kir subunits (Kir3.2 and Kir3.4). The Na+ sensing domain consists of the region 
between D818 and H823 in the RCK2 domain of the rSlo2.2 α-subunit. Mutations of these 
residues in the Na+ sensing domain reduced but did not abolish Na+ sensitivity and reduced 
the ability of Cl- to activate the channel (Zhang et al., 2010). Slo2.2b channels activate in a 
biphasic manner, with an instantaneous component followed by a slow time dependent 
component that takes several hundred milliseconds to reach a level of steady state current 
(Brown et al., 2008). At the single channel level rSlo2.2b currents have large openings with 
a single sub-conductance state (Joiner et al., 1998; Bhattacharjee et al., 2003; Brown et al., 
2008). rSlo2.2b α-subunits are unique within the Slo2.χ family as these subunits have been 
shown to form heteromeric channels with other members of the Slo channel family. rSlo2.2b 
α-subunits have been observed to be able to form functional tetramers with the hSlo1 subunit 
with distinctive pharmacology and an intermediate conductance (Joiner et al., 1998). In 
oocytes, rSlo2.2b α-subunits have also been shown to form intermediate conductance 
channels with rSlo2.1 subunits (Chen et al., 2009). 
 
1.5.2.2 Slo2.2a 
The presence of Slo2.2 splice variants was first indicated by the discrepancy between the 
expression profiles from in-situ hybridisation (ISH) and immunohistochemical (IHC) results 
(1.5.4.1) (Bhattacharjee et al., 2002, 2005). From PCR analysis exon 1a was found 
approximately 14 kb upstream of the exon previously described to form the amino terminus 
(exon 1b). Exon 1a encodes a novel N-terminus regulated by a differing promoter, the α-
subunit with this sequence was termed, Slo2.2a. A second variant of both rSlo2.2a and 
rSlo2.2b was also found that was missing exon 2 from the sequence (Slo2.2ax and 
Slo2.2bx). Compared to the rSlo2.2b α-subunit the rSlo2.2a α-subunits have a shorter N-
terminal domain which has a high level of sequence identity (78.1%) to the Slo2.1 N-
terminal sequence. The rest of the α-subunit sequence is identical between the two variants. 
rSlo2.2a channels have distinct electrophysiological characteristics from rSlo2.2b currents. 
rSlo2.2a whole cell currents activate rapidly in response to a voltage step, in a manner 
similar to rSlo2.1 channels. However, introduction of the rSlo2.2b N-terminal sequence to 
Slo2.1α-subunit failed to slow the rate of activation, suggesting that potentially there is N-C 
terminus communication that mediates this property. At the single channel level rSlo2.2a 
channels have multiple sub-conductance states whereas rSlo2.2b channels have one main 
sub-conductance state. rSlo2.2a single channel recordings have a mean open time six-fold 
shorter than rSlo2.2b due to shorter openings to the fully open state (Brown et al., 2008). 
The rSlo2.2a and rSlo2.2b α-subunit also differ in their ability to form heteromeric channels 
with the rSlo2.1 subunit (Chen et al., 2009). 
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1.5.2.3 Slo2.2m 
The last of the Slo2.2 isoforms, Slo2.2m, was discovered at the same time as the Slo2.2a 
isoform. rSlo2.2m has a unique 1.2 kb 5’ sequence directly upstream of exon 3, this is a third 
unique N-terminal sequence as the S1 domain encoding begins at exon 4. As with rSlo2.2a 
the rest of the subunit sequence is identical to rSlo2.2b. The electrophysiological properties 
and the expression profile of rSlo2.2m channels have not been defined (Brown et al., 2008).  
 
1.5.2.4 Slo2.1  
The last distinct Slo channel sub family member is rSlo2.1, this sister channel was named 
Slick - Sequence like an intermediate conductance K+ channel. The rSlo2.1 α-subunit was 
discovered as a protein with 74% identity to the rSlo2.2 α-subunit sequence. Like rSlo2.2, 
the S0 domain and charges in the S4 domain are absent from the rSlo2.1 sequence. The 
Slo2.1 currents are activated by Na+/Cl- but the channel is inhibited by intracellular ATP. As 
the rSlo2.1 sequence has an ATP binding site motif (GXXXXGKT) subsequent to the RCK2 
domain. The sensitivity to the endogenous activators was shown to differ with rSlo2.1 being 
less sensitive to Na+ and more sensitive to Cl- in comparison with rSlo2.2. The rSlo2.1 
currents show weak voltage dependence of activation, however, whole cell recordings 
displayed a faster activation rate compared to rSlo2.2b currents. rSlo2.1 currents were first 
described as being a functional hybrid between KNa and ATP-sensitive (KATP) K+ channels 
(Bhattacharjee et al., 2003). As discussed later (1.5.4.2) Slo2.1 α-subunits are differentially 
controlled by endogenous modulators compared to rSlo2.2 subunits (Santi et al., 2006). As 
mentioned earlier (1.5.2.1) rSlo2.1 α-subunits can form heteromeric channels with the 
rSlo2.2b, but not the rSlo2.2a, α-subunit. These heteromeric channels have been shown to 
form intermediate conductance channels in oocytes. From results of co-immunopreciptation 
techniques performed on rat brain tissue it appears that these heteromeric Slo2.1/Slo2.2b 
channels are able to be formed in vivo (Chen et al., 2009). 
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1.5.3 Pharmacology of Slo2.χ channels  
The class I and IV anti-arrhythmic drugs, quinidine and bepridil (respectively), were 
originally shown to inhibit KNa currents in cardiac tissue (Mori et al., 1998). Further 
investigation of the affects of these compounds has determined their full profile against 
rSlo2.2b channels. Quinidine inhibition of rSlo2.2b appears to be voltage independent. In 
rSlo2.2b transfected human embryonic kidney (HEK) cells quinidine has an IC50 of 89.6 
μM. Examination of channel kinetics indicated that quinidine produced a marked and 
reversible decrease in channel activity. This was due to a decrease in the mean open time of 
the channel. Bepridil inhibition of rSlo2.2b appears similar to quinidine in that it is also 
voltage independent and reversible. In transfected HEK cells bepridil was shown to be more 
potent with an estimated IC50 of 1.0 μM. Examination of channel kinetics displayed that 
bepridil also decreased the mean open time of the channel. These results signify that 
quinidine and bepridil inhibition has a direct effect on rSlo2.2b, rather than an effect on 
intracellular Na+ levels (Yang et al., 2006). rSlo2.2b channels, like some of the voltage gated 
K+ channels, have also been shown to be inhibited by forskolin in a cAMP independent 
manner (Nuwer et al., 2009). 
 
Currently only one non-endogenous activator of rSlo2.2b has been observed; bithionol (1.6), 
a bis-phenol anti-parasitic compound. Activation by bithionol (EC50 = 0.77 μM) showed an 
interesting characteristic, the weak voltage dependence of the Slo2.2 currents was modified. 
In the presence of bithionol the activation voltage is shifted to more negative potentials, 
allowing more channels to be open for a given voltage (Yang et al., 2006). In vivo bithionol 
has also been shown to increase the speed of decay of AMPA induced excitatory 
postsynaptic current in lamprey spinal neurons by enhancement of a KNA current, resulting in 
a decreased synaptic response (Nanou et al., 2008). Application of bithionol to MNTB 
neurons has been shown to enhance the accuracy of timing of action potentials during high 
frequency firing of the neuron and thus increasing the fidelity of the information encoded 
(Yang et al., 2007). These studies were either performed solely on rSlo2.2b channels or in 
native cells, without examination of the possible effects on either rSlo2.2a or rSlo2.1 
channels, thus it is unknown if the pharmacology described is distinctive. hSlo2.1 channels 
have been shown to be activated by niflumic acid (NFA) with an EC50 of 2.08 ± 0.04 mM. 
Whilst the molecular basis of NFA activation of K+ channels is unknown, the rapidity of 
activation of hSlo2.1 from extracellular application suggests that the binding site is readily 
accessible from the extracellular solution (Dai et al., 2010). As with previous 
pharmacological studies this activator was not tested on any of the other Slo2.χ subunits. 
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1.5.4 Physiological Relevance of Slo2.χ  
1.5.4.1 Expression profile of Slo2.χ channels  
It has been difficult to determine separate physiological functions for Slo2.1 and Slo2.2 with 
regards to mediating the KNa current. This is partially due to the overlap between 
endogenous activators and the tissue expression pattern of rSlo2.1 and rSlo2.2. KNa currents 
have been shown to be present in cardiomyocytes (Kameyama et al., 1984; Choisy et al., 
2004) and a range of neurons (Dryer, 1994; Bischoff et al., 1998; Yang et al., 2007; Gao et 
al., 2008). In the rat brain, the expression profile of Slo2.1 and Slo2.2 α-subunits, have been 
further explored utilizing in-situ hybridization (ISH) and immunohistochemical (IHC) 
methods (Bhattacharjee et al., 2002, 2005). These methods showed wide-spread and 
overlapping expression of the Slo2.χ channels throughout the brain (Table 1). IHC staining 
of the Slo2.2 channel showed relatively high protein levels in the olfactory bulb, midbrain 
and brainstem. IHC staining conflicted with the ISH results in regions such as the piriform 
cortex, ventral cochlear nucleus, CA3 of the hippocampus, and cerebellar nuclei 
(Bhattacharjee et al., 2002). However, this discrepancy was due to the epitope chosen for the 
original anti-Slo2.2 antibody, the first 15 amino acids of the N-terminus. This region of the 
protein is now known to be a site of variation due to splice variants (1.5.2.1) (Brown et al., 
2008).  
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Brain region 
Slo2.1 Slo2.2 
In situ 
hybridization 
Immunocytochemisty 
In situ 
hybridization 
Immunocytochemisty 
Olfactory bulb ++++ ++++ N/A ++ 
Cerebral cortex +++ +++ ++ + 
Frontal cortex ++ ++ ++ ++ 
Piriform cortex +++ +++ ++ - 
Hypothalamus ++ +++ N/A N/A 
Hippocampus     
CA1 ++++ ++++ - - 
CA2 ++++ +++ - - 
CA3 ++++ +++ ++++ + 
Dentate gyrus ++++ +++ + + 
Habenula ++++ ++ ++ + 
Thalamus  ++ ++ ++ +++ 
Substantia nigra  ++ +++ +++ +++ 
Red nucleus +++ +++ +++ ++++ 
Oculomotor nucleus  +++ +++ +++ ++++ 
Trapezoid nucleus +++ +++ ++++ ++++ 
Cerebellar nuclei  +++ +++ +++ +/- 
Motor trigeminal  ++ ++ +++ +++ 
Facial nucleus  +++ +++ N/A +++ 
Ventral cochlear 
nucleus 
++ +++ +++ +/- 
 
Table 1.1: Slo2.χ expression patterns in the rat brain. The number of (+) indicates the 
relative level of expression, (-) indicates no expression and N/A indicates region was not 
interrogated. Modified from (Bhattacharjee et al., 2002, 2005). 
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1.5.4.2 Physiological modulators of Slo2.χ channels  
Neurons, in vivo, do not express Slo2.χ channels in isolation. Slo2.χ channels have been 
shown to be targets of modulation by Gαq-protein coupled receptors (GqPCR). Slo2.1 has 
been shown to be inhibited in cardiac myocytes by activation of α1A adrenoceptors. This 
modulation was shown to be a PLC independent pathway, as the addition of PLC inhibitors 
failed to change the effect of phenylephrine on these cells (Choisy et al., 2004). Similar 
inhibition has also been shown in rat striatal cholinergic neurons, with activation of 
mGluR1/5 providing the inhibitory stimulus. Inhibition of Slo2.1 was not the main target for 
modulation in these cells, except under heavy firing conditions (when Na+ was sufficient) or 
during ischaemia (Berg et al., 2007). Interestingly it was shown by Santi et al., (2006) that 
whilst Slo2.1 is inhibited by GqPCR activation, Slo2.2 mediated currents were enhanced. 
This inverse modulation was dependent on protein kinase C (PKC) activation. Application 
of 60 nM phorbol 12-myristate 13-acetate (PMA), a PKC activator, caused a reduction of 
approximately 90% in the Slo2.1 mediated currents. 160 nM PMA was found to increase 
Slo2.2 mediated currents by approximately five fold. Further investigation of PKC 
regulation demonstrated that Slo2.1 had an IC50 of 20 nM, whereas Slo2.2 had an EC50 of 50 
nM for PMA. This differential regulation was found to be dependent on the C-terminal tails, 
as Slo2.1 has several unique PKC phosphorylation sites. The physiological significance of 
this contrary effect of PKC activation by GqPCRs on Slo2.χ has yet to be determined (Santi 
et al., 2006).  
 
Unlike PKC, protein kinase A (PKA) does not directly modulate Slo2.2 currents; as neither 
application of 8Br-cAMP nor PKA catalytic subunit had effects on the electrophysiological 
characteristics of the heterologously expressed rSlo2.2 channels (Nuwer et al., 2009). 
However, it has been shown that PKA activation in dorsal root ganglion (DRG) neurons 
causes a reduction in the KNa component of the K+ current. This reduction in KNa component 
has been shown to be, at least in part, to internalisation of Slo2.2 subunits in a PKA 
dependent manner (Nuwer et al., 2010). The rSlo2.2b channel has been determined to be 
activated by the Fragile X mental retardation protein (FMRP) in a reversible manner. FRMP 
increases the number of channels openings, but reduce the openings to subconductance 
states. The interaction of FRMP is thought to be through the C-terminal domain of rSlo2.2b 
between amino acids 804-1237. These findings suggest that some of the neuronal 
abnormalities observed in Fragile X syndrome may be due to the effects on KNa currents 
resulting in altered firing patterns (Brown et al., 2010). 
 
31 
 
Slo2.2 has been shown to be activated directly by 17β-estradiol (E2). It was shown that 10 
μM E2 increased the Po of Slo2.2 from 0.035 to 0.32. This effect was theorized to be 
possibly due to enhanced phosphorylation, concurrent with GqPCR activation of the 
channel. Whilst 10 μM exceeds the observed plasma concentration, localized tissue 
concentrations may surpass global concentrations (Zhang et al., 2005). The effect of high 
levels of E2 suggests Slo2.χ may contribute neuroprotection in response to estradiol during 
ischemic conditions (reviewed in (Amantea et al., 2005)). Slo2.2 has also been shown to be 
modulated by other factors that are characteristic of ischaemia and hypoxia, namely pH and 
intracellular CO2. Reduction of pH was observed to reduce the number of openings (NPo) in 
a dose-dependent manner. This inhibition was partially reversible on return to pH 7.3, and 
was attenuated by high intracellular Na+. An increase in intracellular CO2 was also shown to 
have a similar inhibitory affect, although this is probably due to a concurrent drop in pH. 
Thus under ischemic/hypoxic conditions Slo2.2 activity is modulated by conflicting factors, 
increased Na+ and decreased pH (Ruffin et al., 2008). 
 
1.5.4.3 Known physiological functions of Slo2.χ channels in neurons 
Slo2.χ channels appear to have a variety of physiological functions depending on cell type 
and differing [Na]i levels in subcellular localisations. Three major functional roles of Slo2.χ 
channels in neurons have been reported, in the depolarizing after-potential, spike frequency 
timing and establishment of the RMP. There was initially disagreement in the literature as to 
involvement of KNa currents in mediating the depolarizing after-potential. This was due to 
initial studies finding the EC50’s for Na+ of ≈40 mM (rSlo2.2) and ≈80 mM (rSlo2.1), both 
of which are greater than the reported resting [Na+]i in neurons (4-15 mM). However, further 
studies have found that in the presence of NAD+ the EC50 is shifted to ≈20 mM [Na+]i, near 
the physiological range (Tamsett et al., 2009). Secondly Slo2.χ channels are assumed to co-
localise with Na+ channels (Dryer, 1994), and have been shown to co-localise with AMPA 
receptors (Nanou et al., 2008), thus localised [Na+]i may be higher than in the whole cell. 
This co-localisation is probably due to both Slo2 and GluR1 subunits containing PDZ 
binding domains. PDZ binding domains allow these channels to bind to the scaffolding 
protein postsynaptic density-95 (PSD-95), which have three PDZ domains, and scaffolds 
proteins at excitatory postsynaptic membranes (Hayashi et al., 2000; Uchino et al., 2003). In 
rat medium-diameter (25-35 µm) DRG neurons and CA1 pyramidal cells, Slo2.χ channels 
have been shown to be able to mediate the depolarizing after-potential of single action 
potentials (Gao et al., 2008). In cells isolated from the olfactory bulb and striatum, it has 
been shown that Slo2.2 channels mediate a large delayed outward current. This current was 
found to be controlled by a TTX sensitive persistent inward Na+ current (Budelli et al., 
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2009). It has been shown that in Kv1.3 KO mice, the KNa current is up-regulated in olfactory 
neurons; this is thought to be a compensatory mechanism to allow some control of spike 
timing (Lu et al., 2010).  
 
Interestingly whereas in rat it appears both Slo2.1 and Slo2.2 contribute to spinal cord KNa, it 
has been shown in lamprey spinal cord to be mediated solely by Slo2.2. In lamprey spinal 
cord neurons, the role is slightly different; Slo2.2 mediates part of the slow 
afterhyperpolarisation (sAHP). The contribution of this channel is increased under high 
frequency firing of the neuron. This is theorised to be a safety mechanism to ensure 
frequency regulation (Wallén et al., 2007). This physiological function has also been 
determined for Slo2.χ in the medial nucleus of the trapezoid body (MNTB) in the auditory 
brainstem. In the MNTB increasing KNa augments the accuracy of timing of action potentials 
at high frequency firing of the neuron. This in turn increases the fidelity of the information 
encoded (Yang et al., 2007). Bischoff et al., (1998) concluded that the KNa current, mediated 
by Slo2.χ channels, contribute to the establishment of RMP in physiological conditions and 
have a secondary role of stabilizing the neuron under pathophysiolgical conditions such as 
hypoxia. This conclusion may have been due to the cell type observed in the study, rat 
small-diameter (20-25 µm) DRG neurons. Small DRG neurons have an action potential 
frequency of 0.5-2 Hz, under physiological conditions, approximately 15-fold too low to 
cause a high localised Na+ concentration to activate KNa currents. Secondly small DRG 
neurons lack the anatomical architecture to facilitate Na+ accumulation such as the node of 
Ranvier or an axon hillock with a high density of Na+ channels (Bischoff et al., 1998). It has 
been suggested that KNa have a role in the mediation of inflammatory pain by DRG neurons. 
PKA activation has shown to be critical to mediation of inflammatory pain (Malmberg et al., 
1997). Thus the PKA dependent internalization of Slo2.2 is thought to play a part in causing 
the hyper-excitability characteristic of nociceptive firing (Nuwer et al., 2010). 
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1.6 Bithionol 
 
Bithionol is a bis-phenol anti-parasitic compound, originally used in antibacterial soaps 
(Hopper & Wood, 1958). At the molecular level bithionol has been shown to inhibit the 
glutamate dehydrogenase enzyme (GDH). GDH, with NAD+ or NADP+ as a cofactor, 
catalyzes the deamination of L-glutamate to 2-oxogluterate which is then fed into the Krebs 
cycle. Bithionol molecules bind as a pair to the GDH protein in the cleft between the 
neighbouring subunit dimers of the hexamer preventing the expansion and contraction of the 
enzymatic cleft and thus stopping the reaction (Li et al., 2009). The only K+ channel shown 
to be affected by bithionol application is the KNa current mediating channel, rSlo2.2b (1.4.2) 
(Yang et al., 2006).  
 
1.7 Primary aims of the Thesis  
 
This thesis has three main aims; firstly in Chapter III to investigate if mSlo3 currents in 
oocytes share pharmacological properties with the IKSper current in spermatocytes described 
by Navarro et al. (2007). We hypothesise that mSlo3 channels may underlie a component of 
IKSper, due to similar electrophysiological properties and range of pH sensitivity. IKSper is a 
critical component of the capacitation reaction (1.3.4.2), causing hyperpolarisation of the 
membrane in turn increasing the driving force of Ca2+ entry via CatSper channels. Recent 
Slo3 KO mice studies were found to have a reduced IKSper current in spermatozoa, resulting 
in infertile spermatozoa (Santi et al., 2010; Zeng et al., 2011). However, KO models often 
result in down-regulation of unintended targets or up-regulation of compensatory 
mechanisms. Confirmation of the effects of the IKSper inhibitors on mSlo3 channel will 
strengthen the case that the mSlo3 channel mediates part of the IKSper current. A recent 
chimaera of mSlo3/Slo1 (MC13) has been shown to share some of the IKSper pharmacological 
profile but this has not been tested on the WT mSlo3 channel (Tang et al., 2010b). Due to 
the overlap in pharmacology, sensitivity of mSlo3 channels to the IKSper inhibitors will also 
suggest that mSlo3 currents are a component of the K+ current involved in motility and 
volume regulation.  
 
The second aim of this thesis, described in Chapter IV, is to determine if a range of 
expressed sequence tags (EST’s) encode a novel isoform of the mSlo3 α-subunit. A range of 
EST’s have been identified in a range of tissues, particularly neuronal tissue, which 
correspond to the mSlo3 sequence. This is potentially an exciting find as previous studies 
have shown mSlo3 α-subunit expression is limited to the testis and spermatozoa, which is 
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contrasted by the ubiquitous expression of the related mSlo1 α-subunit (Schreiber et al., 
1998).  
 
The third aim of the thesis is to characterise hSlo2.2a currents with respect to their 
sensitivity to intracellular NaCl and I/V relationships, from heterologous expression in HEK 
cells (Chapter V). The majority of studies of the Slo2 sub-family have been performed using 
the rat homologues of these channels. However no study has examined the human Slo2.2a 
and Slo2.1 of these channels. The human homologues have the more K+ selective GYG 
selectivity filter sequence in the pore domain rather than the GFG sequence found in rat. 
This chapter also aims to determine if bithionol, which is known to activate rSlo2.2b 
channels, also activates the hSlo2.2 and hSlo2.1 channels. The specificity of bithionol 
activation will be tested by application to the endogenous Kv K+ channels of HEK cells and 
the pancreatic type KATP channels of 832/13 INS cells. Lastly, the thesis aims to examine the 
effects of bithionol activation of endogenous KNa currents from ex vivo rat DRG cells. 
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Chapter II: Methods  
 
2.1 General molecular biology 
 
The methods that are described in this section were used for the construction and subcloning 
of constructs. Further details of the general molecular biology methods can be found in 
Molecular Cloning: A Laboratory Manual (3rd Edition) (Sambrook & Russell, 2000).    
 
2.1.1 Materials  
A) Chemicals and reagents 
All chemicals were purchased from Sigma Chemical Company and VWR (BDH) unless 
stated otherwise. Bacterial growth media were purchased from BD Biosciences (Difco) and 
Oxoid. Distilled water was used for preparation of growth media. Sterile nuclease free water 
(Sigma) was used for DNA/RNA application solutions. Oligonucleotide primers were 
purchased from Invitrogen. Pfu Turbo DNA polymerase was purchased from Stratagene; 
Phusion DNA polymerase was from Finnzymes; all other DNA modifying enzymes were 
purchased from New England Biolabs.   
 
B) Plasmids (source/donor) 
 
For cRNA production: 
pBF-KCNMA3: a 6.3 kb plasmid, which contains a sequence that confers ampicillin 
resistance in E. coli. A cDNA encoding the full length α-subunit of mSlo3 was cloned 
downstream of the SP6 promoter (Lippiat). 
pBF-KCNMA1: 6.5 kb plasmid, containing an gene that confers ampicillin resistance in E. 
coli. A cDNA encoding a the full length α-subunit of hSlo1 was cloned downstream of the 
SP6 promoter (Lippiat). 
pYX-Asc-CV562866: 2.4 kb plasmid, containing an gene that confers ampicillin resistance 
in E. coli. A cDNA encoding the CV562866 fragment was cloned downstream of the T7 
promoter (Genbank).  
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For mammalian expression: 
pcDNA6-hSlo2.2-EGFP: 9.5 kb plasmid, which contains a gene that confers ampicillin 
resistance in E. coli. The cDNA encodes the full length α-subunit of hSlo2.2a, which is 
tagged at the C-terminus with GFP to allow verification of transfection efficiency and 
subcellular localisation (Lippiat). 
pcDNA6-hSlo2.1: 9.4 kb plasmid, which contains a gene that confers ampicillin resistance 
in E. coli. The cDNA encodes the full length α-subunit of hSlo2.1 (Lippiat). 
pEGFP: 4.7 kb plasmid, which contains a gene that confers kanmycin resistance in E. coli. 
The cDNA encodes EGFP to allow verification of transfection efficiency (Lippiat). 
pcDNA6-hSlo2.1-RFP: 9.4 kb plasmid, which contains a gene that confers ampicillin 
resistance in E. coli. The cDNA encodes the full length α-subunit of hSlo2.1, tagged at the 
C-terminus with RFP to allow verification of transfection efficiency and subcellular 
localisation (Newson/Lippiat). 
 
C) Bacterial growth media 
SOB Medium: 2 % (w/v) bactotryptone, 0.5 % (w/v) yeast extract, 10 mM NaCl, 2.5 mM 
KCl, adjusted to pH 7.0 with NaOH. The after cooling the medium was supplemented with 
sterile 10 mM MgCl2 
LB: Lysogeny broth 1X (Sigma) 
LB agar: Lysogeny broth agar 1X (Sigma) 
(All media was autoclaved) 
 
D) Antibiotics and media supplements 
Ampicillin (1000x): 100 mg/ml ampicillin salt in H2O. 
Kanamycin (1000x): 30 mg/ml kanamycin sulphate in H2O. 
(All aqueous solutions were filter sterilised using a 0.22 µm filter) 
    
E) Solutions required for preparation of DNA 
TE buffer (100x): 1 M Tris.Cl (tris(hydroxymethyl)aminomethane hydrochloride), pH 8.0, 
0.1 M EDTA (ethylenediaminetetraacetic acid) 
TAE (50x): 2 M Tris.Cl pH 8.5, 50 mM EDTA, 1.2 % acetic acid  
EtBr: 10 mg/ml ethidium bromide in H2O. 
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F) Solutions for PCR 
dNTPs: 2 mM dATP, 2 mM dCTP, 2 mM dGTP, 2 mM dTTP, in sterile H2O. 
Pfu buffer (10x): 100 mM KCl, 100 mM (NH4)2SO4, 200 mM Tris.Cl pH 8.8, 20 mM 
MgSO4, 1 % Triton X-100, 1 mg/ml nuclease-free bovine serum albumin (Stratagene) 
 
2.1.2 Site-directed mutagenesis 
Site-directed mutagenesis is a non-exponential PCR based method that is a useful tool for 
introduction/reversion of point mutations, and deletion or insertion of small nucleotide 
sequences (up to approximately 20 nucleotides). The primers were designed for the 
Stratagene Quikchange site-directed mutagenesis kit. Complementary forward and reverse 
primers were designed to contain the desired sequence and flanking sequence; with Tm 
values of ~75 ºC. The primers were diluted to 2 pmole/μl and added to a PCR reaction 
mixture containing 1x Pfu buffer, 0.2 mM dNTPs, 5 % glycerol, 50 ng template plasmid 
DNA, 1 U Pfu Turbo DNA polymerase, in H2O, to a final reaction volume of 50 μl. The 
PCR protocol required an initial denaturing step at 95 ºC for 30 seconds, followed by 
repeating cycles (x 16) of 95 ºC for 30 s, 55 ºC for 1 min, 68 ºC for ~1 min per 500 bp, with 
a final extension step of 68  ºC for 7 min. The reaction mixture was then incubated with 20 
U of DpnI endonuclease for 1 hr at 37 ºC to specifically remove the methylated template 
plasmid DNA, prior to transformation of the PCR product into cells. The presence of the 
mutation was determined by transforming sequences into E.coli (2.1.8) and DNA 
sequencing of plasmid DNA isolated from the transformants (2.1.9). 
 
2.1.3 Rapid Amplification of cDNA Ends (RACE) 
RACE PCR is a technique that allows cloning of full length RNA transcripts, converted to 
cDNA, found within a cell from short sequences, such as expressed sequence tags (EST). 
Primers were designed using NCBI primer blast design software (www.ncbi.nlm.nih.gov) 
utilising the mSlo3 WT related EST sequence identified in a cDNA library from mouse 
head, GenBank Acc: CV562866, (2.1.1b). All 50 μl PCR reactions had the following 
composition (μl) ; H2O 35.5, Buffer HF 10, dNTP 1, cDNA template 1, forward primer 1, 
reverse primer 1, Phusion polymerase (Finnzymes) 0.5. Marathon RACE PCR was 
performed using mouse brain Marathon-readyTM cDNA (Clontech) to isolate the potential 
neuronal isoform. Marathon-readyTM cDNA is double stranded cDNA made from mRNA 
isolated from male/female mice brains, aged 8-12 weeks. The cDNA is supplied ligated to 
the marathon adaptor at both the 5’ and 3’ end. First round PCR was performed under 
conditions described in Table 2.1, with CVstart/CVend run against Adaptor Primer (AP) 1. 
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The APs are targeted to the adapter ligated to all the ds-cDNA sequences in the sample. The 
products of these reactions were used as template for second round (nested) PCR, the EST 
specific internal CVF*/CVR* against AP2, targeted to the inner adapter. Second round 
products were then cleaned (2.1.6) and then ligated (2.1.4) for amplification. 
  
 
  
First Round PCR Second Round PCR 
Phase 
Temperature 
(OC) 
Time 
(s) 
Number 
of cycles 
Temperature 
(OC) 
Time 
(s) 
Number 
of cycles 
Initial 
Denaturation 
98 30 1 98 30 1 
Denaturation 98 7 
35 
98 7 
35 Annealing 68 20 62±6 20 
Extension 72 45 72 30 
Final Extension 72 300 1 72 300 1 
Table 2.1: Marathon RACE PCR Conditions 
 
2.1.4 Blunt End Ligation of DNA 
The ligation of DNA requires a specific enzyme, DNA ligase, which is capable of covalently 
joining DNA ends by catalysis of ATP dependent formation of phosphodiester bonds 
between the 3’ hydroxyl and 5’phosphate termini. The StrataClone Blunt PCR Cloning Kit 
(Stratagene) for ligation of RACE PCR products (2.1.3) into plasmids to allow 
transformation and sequencing (2.1.8-10) was used. Products were ligated into the kit 
plasmid, pSC-B-amp/kan, as specified by the manufacturer. The kit vector mix contains two 
blunt ended DNA strands; these have toperisomerase I charged arms, either side of the insert 
site. After the 5 minute ligation reaction the DNA-enzyme intermediate can be transformed 
into the supplied competent cells (2.1.8). The intermediate is then circularised by the Cre-
recombinase enzyme in the supplied competent cells, which recognises the lox-P site at the 
opposing end of the vector.     
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2.1.5 Endonuclease digestion of DNA 
Restriction-endonuclease enzymes bind specific DNA sequence motifs and catalyse 
hydrolysis of a specific phosphodiester bond resulting in fragmentation of DNA molecules. 
Enzymatic digest of samples was used for restriction analysis of plasmid DNA. Digestion of 
DNA was typically accomplished by ≈10 U of endonuclease per reaction and in the presence 
of the recommended buffer, diluted to the required concentration with H2O. Reactions were 
incubated at the optimal temperature (normally 37 oC) for 1 to 16 hrs, depending on DNA 
concentration and enzyme activity. 
 
2.1.6 Purification of DNA fragments from reaction mixtures 
The purification of DNA from reaction mixtures such as PCR or restriction-endonuclease 
digests that contain unwanted DNA, enzymes and chemical contaminants is necessary in 
preparation for subsequent cloning steps. Extraction of DNA from a heterogeneous mixture 
of different sized fragments required size separation by agarose gel electrophoresis. 
Homogeneous mixtures, where only one DNA fragment was present, were purified directly 
from the reaction mixture. Purification was performed using a QIAEX II Gel Extraction Kit 
(Qiagen) following the kit instructions. 
  
The reaction mixture was separated by agarose gel electrophoresis, using either 1 % or 2% 
agarose gels. Electrophoresis was conducted in fresh 1x TAE buffer to prevent 
contamination, at 60 V for 90 min (dependent on fragment size and agarose percentage). The 
DNA band of interest was excised using a cleaned/fresh scalpel, from the gel under low-
level UV transillumination. Approximately 600 µl QX1 buffer, 3 volumes to 1 volume of 
gel, was added to the gel section containing the DNA band of interest. The reaction mixture 
was supplemented with 20 µl QIAEX II, which was resuspended by vortexing before 
addition. This mixture was then incubated at 50 oC for 10 mins, with agitation by vortexing 
every two minutes. Once the agarose was solubilised, the sample was centrifuged, and the 
supernatant removed. The pellet was then washed first with QX1 then twice with buffer PE. 
The pellet was then air-dried by centrifugation at 2000 rpm for ≈12 minutes. DNA was then 
eluted from the QIAEX II glass milk pellet, by resuspension in 20 µl RNA-free water; this 
mixture was then incubated for 5 minutes and centrifuged. The supernatant was then 
pipetted into a fresh microcentifuge tube and stored at -20 oC for later use.   
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2.1.7 Agarose gel electrophoresis 
Agarose gel electrophoresis was used to differentiate DNA samples by molecular weight. 
DNA was detected by staining with ethidium bromide (EtBr) and visualised under UV light. 
Usually, agarose gels consisted of 1 or 2 % agarose in 1x TAE buffer, supplemented with 
0.5 µg/ml EtBr. The gel was placed in a horizontal electrophoresis tank and submerged in 1x 
TAE buffer. The DNA sample was mixed with either 5x/6x loading buffer and loaded into a 
well on the gel. Into a parallel well DNA ladder, HyperladderTM I (Bioline), was loaded for 
size and concentration estimation of fragments in the sample DNA. The electrophorisis 
protocols typically consisted: 90 V for 30 min for standard 1 % gels; and 60-70 V for 1-1.5 
hrs for 2% gels. 
 
2.1.8 Transformation of competent E. coli 
Competent E. coli (20-50 µl of cell suspension) were gently mixed with the DNA to be 
transformed (typically 2-5 µl). Following incubation for 30 min on ice, the cell mixture was 
heat-shocked at 42 ºC for 45 s and returned to ice. The cell mixture was diluted in LB-broth 
(500 μl) and for kanamycin selective samples, incubated at 37 ºC in a shaking incubator (200 
rpm.) for 1 hour. A portion of the diluted cell mixture (75-100 μl) was spread on a LB agar 
plate supplemented with a selective antibiotic and incubated overnight at 37 ºC.   
 
2.1.9 Purification of plasmid DNA from E. coli 
Plasmid DNA was purified from E. coli using the alkali-lysis method with a MiniPrep Spin 
Kit (Qiagen). This involved lysis of the cells with NaOH/SDS, precipitation of SDS coated 
cell components including chromosomal DNA. This renders the super-coiled plasmid DNA 
soluble. The super-coiled DNA is then immobilised, de-salted by alcohol precipitation and 
eluted in sterile water. Colonies picked from LB Agar plates were used to inoculate 2-5 ml 
of LB broth (supplemented with the selective antibiotic corresponding to plasmid) and 
incubated for 9 hours/overnight at 37 ºC in a shaking incubator (200 rpm). Cells were 
harvested in 1.5 ml microcentrifuge tubes and the MiniPrep Spin Kit (Qiagen) instructions 
were followed. 
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2.1.10 DNA sequencing 
Automated dye-terminated DNA sequencing services were provided by either FBS 
sequencing services or GATC (GATC Biotech AG). Sequencing primers were either 
supplied as part of the sequencing service or custom designed (Tm 60-65 ºC). The 
sequencing window was typically +20 nucleotides downstream of the primer site, up to 
+500-600 nucleotides, prior to degeneration of the sequencing reaction. 
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2.2 General protein methods  
 
2.2.1 Materials and reagents 
Chemicals and solutions as used in previous sections, unless stated otherwise. 
2.2.2 Preparation of Protein Samples 
A) Solutions 
Homogenisation Buffer: 50 mM Tris-HCl pH 8.0, 100 mM KCl, 1 mM EDTA 
Lysis Buffer: 50 mM Tris-HCl pH 8.0, 100 mM KCl, 1 mM EDTA, 1% Triton X-100 
Sample Buffer: 0.5 M Tris, 2% Glycerol, 4% 10% SDS, 0.05% Bromophenol blue, 1% H2O 
 
B) Homogenisation 
Homogenisation buffer was aliquoted to 10 mls and supplemented with protease inhibitors 
(Roche). Tissue samples were retrieved from adult rats post mortem (all procedures were 
carried out in accordance with current UK Home Office requirements), samples were frozen 
at the point of retrieval with liquid nitrogen. Samples were then placed on ice, following 
which they were diced using a clean scalpel blade. After dicing, samples were placed in 5 
mls of homogenisation buffer and mechanically homogenised using a glass homogeniser. 
Samples were centrifuged to remove cell debris for 13000 rpm at 4 OC for 15 mins.      
 
C) Separation of Membrane Fractions 
After centrifugation the cell lysate was recovered into an ultracentrifuge tube; tubes were 
then balanced. Ultracentrifugation was performed using a Beckman TLA120.2 rotor and 
ultracentrifuged at 55 krpm at 4 OC for 1 hour. Ultracentrifuged supernatant was isolated and 
stored. The membrane pellet was resuspended in lysis buffer and transferred to a clean 
microcentrifuge tube for storage. Before running on gels (2.2.4) samples were diluted with 
2x sample buffer supplemented with 2% β-mercaptoethanol  
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2.2.3 The BCA assay 
A) Solutions 
Reagent mix: 1 volume of 4% (w/v) CuSO4, 50 volumes of Bicinchoninic acid (BCA) 
solution  
BSA standards: 0.2, 0.4, 0.6, 0.8 or 1.0 mg/ml bovine serum albumin (BSA) made up in 
identical buffer as relevant protein sample 
 
B) The assay 
The reduction of Cu2+ by peptide bonds in an alkaline environment results in the generation 
of Cu1+ ions. Cu1+ ions are chelated by BCA in a 1:2 ratio; this reaction results in production 
of a purple coloured product. Protein concentration of the sample was measured by mixing a 
10 µl with 200 µl of reagent mix in a flat bottomed 96-well plate. The plate was incubated 
for 30 mins at 37 OC, and then absorbance at λ 570 nm was measured on an automated plate-
reader. Protein concentration was determined from the OD570nm using a BSA protein 
standard concentration curve. 
 
2.2.4 SDS-PAGE 
A) Solutions 
Resolving Gel: 3 mls 30% Acrylamide/bisacrylamide, 2.5 mls 1.5M Tris.Cl pH8.8, 0.1 mls 
10% SDS, 0.1 mls 20% Ammonium persulphate (APS), 0.005 mls 
Tetramethylethylenediamine (TEMED), 4 mls H2O 
Stacking Gel: 0.85 mls 30% Acrylamide/bisacrylamide, 0.625 mls 1.5 M Tris.Cl pH6.8, 
0.05 mls 10% SDS, 0.05 mls 20% Ammonium persulphate (APS), 0.005 mls TEMED, 3.4 
mls H2O 
 
B) Production of Polyacrylamide gels 
10% resolving gels were formulated as described above. TEMED component was added 
lastly before pouring the gel. After pouring, the exposed gel surface was covered with 
butanol to avoid oxygen inhibition of acrylamide crosslinking. After ~30mins the butanol 
layer was poured off and stacking gel made up as described in 2.2.4.A and added to the gel, 
and a lane comb inserted to form the wells. After ~30 minutes either the lane comb was 
removed and the gel used immediately, or the gel was stored at 4 OC overnight in a moist 
environment.  
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C) Electrophoresis 
Proteins were separated by electrophoresis in 25 mM Tris, 192 mM glycine, 0.1 % (w/v) 
SDS, pH~ 8.3 (running buffer). Protein size was estimated using the PageRulerTM plus 
prestained protein ladder that covers the kDa 11-250 molecular weight (Mw) range. 
Electrophoresis was carried out in a Bio-Rad Protean III tank, which were assembled 
according to manufactures instructions. The electrophoresis control box (Bio-Rad 
PowerPac) was programmed for 180 mV, for 50 min, until the dye front nearly reached the 
bottom of the gel.      
2.2.5 Western blotting  
A) Solutions and antibodies  
Transfer Buffer: 25 mM Tris, 192 mM glycine, 20 % (v/v) MeOH, 0.1 % (w/v) SDS 
PBS-T: PBS pH 8.0, 20 % Tween-20 
Blocking buffer: PBS-T, 5 % low-fat skimmed milk powder 
Antibody incubation buffer: PBS-T, 0.5 % low-fat skimmed milk powder 
Rat anti-Slo3 high-affinity primary antibody (Neuro-Mab): 1:1000 dilution 
Goat anti-mouse HRP-conjugated secondary antibody (Bio-Rad): 1:50000 dilution  
 
B) Western transfer of proteins onto nitrocellulose membrane 
After SDS-PAGE, gels to be western blotted were incubated in ice cold transfer buffer for 
approximately 5 min. The gel was then placed in good contact with a pre-soaked HybondTM 
nitrocellulose membrane (GE healthcare), sandwiched between blotting paper and thin card 
(soaked in transfer buffer), and placed in the semi-dry transfer apparatus (Bio-Rad). A 
current of 0.3-0.6 mA was applied for an hour to transfer the proteins from the gel onto the 
nitrocellulose membrane. 
 
C) Immunoblotting of nitrocellulose membrane 
Post transfer, the nitrocellulose membrane was first washed three times with PBS-T for an 
hour to remove any residual methanol. After washing, the membrane was incubated in 
blocking buffer for an hour with agitation at room temperature. The membrane was washed 
in PBS-T for an hour. The membrane was then incubated in the Slo3 antibody incubation 
buffer with gentle agitation overnight at 4 °C. The primary antibody was discarded and the 
membrane was washed three times in PBS-T for a total of an hour, and incubated in HRP-
conjugated secondary antibody, at room temperature for an hour with agitation. Finally, the 
membrane was washed three times for a total of an hour, prior to chemiluminescence. 
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D) Visualisation of immunoblotted protein bands by enhanced chemiluminescence (ECL)  
The membranes were transferred from PBS-T to a glass plate and excess PBS-T wiped 
away. The surface of the membrane was evenly covered with 0.6 ml SuperSignal West 
Femto Chemiluminescence (Thermo). These substrates consist of two components: luminol 
and peroxide buffer. The components were mixed in equal volumes (0.3 ml of each), and the 
membrane incubated in the solution for approximately 1 min in the dark at RT. The 
membrane was then drained of excess fluid, excess SuperSignal wiped away, and wrapped 
in cling film. Under dark room conditions, the membrane was exposed to Biomax XAR film 
(Kodak) for between 10 s and 10 min. The film was then developed, fixed (Kodak), rinsed in 
water, and allowed to dry. 
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2.3 Heterologous expression in X. laevis oocytes  
2.3.1 Materials and reagents 
As in previous sections, except for the following: 
 
A) General solutions 
Anaesthetic: 0.2 % (w/v) Tricaine mesylate (MS222), pH 7.5 by addition of Tris Base 
powder 
OR-Mg: NaCl 82 mM, KCl 2 mM, MgCl2 20 mM, HEPES 5 mM, pH 7.5 
ND-96: NaCl 96 mM, KCl 2 mM, MgCl2 1 mM, HEPES 5 mM, CaCl2 1.8 mM, pH 7.5, 50 
μg/ml G418 
Barths (modified): NaCl 84 mM, KCl 1 mM, NaHCO3 2.4 mM, MgSO4 0.82 mM, CaCl2 
0.41 mM, Ca(NO3)2 0.33 mM, HEPES 5 mM, pH 7.4. Supplemented with 100 IU/ml 
penicillin/streptomycin, 2 mM pyruvate and 50 mg/ml genatmycin  
F304Y Barths (modified): NaCl 84 mM, KCl 23 mM, NaHCO3 2.4 mM, MgCl2 0.82 mM, 
CaCl2 0.41 mM, Ca(NO3)2 0.33 mM , HEPES 5 mM and pH 7.4. Supplemented with 100 
IU/ml penicillin/streptomycin, 2 mM pyruvate and 50 mg/ml genatmycin 
Ringer’s solution: NaCl 115 mM, KCl 2.5 mM, CaCl2 1.8 mM, HEPES 10 mM, pH 7.2 
High K+ solution: NaCl 17.5 mM, KCl 100 mM, CaCl2 1.8 mM, HEPES 10 mM, pH 7.2 
 
B) Inhibitor Stock Solutions 
 Quinine: 500 mM in DMSO 
 Clofilium: 9.8 mM in Ringer’s Solution (10mg in 2ml) 
 Mibefradil: 8.79 mM in Ringer’s Solution (5mg in 1ml) 
 Quinidine: 250 mM in DMSO 
 Barium: 1 M in Ringer’s or High K+ Solution   
 
2.3.2 Synthesis of cRNA  
The in vitro synthesis of complimentary-RNA (cRNA) was required for cRNA 
microinjection into X. laevis oocytes, in order to enable expression of channel constructs (as 
described in section 2.3.3). The plasmid pBF, containing channel constructs downstream of 
a SP6 promoter was linearised by MluI endonuclease. The linearised plasmid DNA was 
purified directly from the reaction mixture (as described in section 2.1.6). The purified DNA 
(1 μg) was used as a template for SP6 RNA polymerase directed cRNA production, which 
was supplied as an RNase free kit, mMessage machine synthesis kit (Ambion) (utilising a 2 
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hr incubation for maximal yield). The cRNA was analysed for homogenicity by agarose gel 
electrophoresis and quantified by UV spectrometry at A260 nm (A 1.0 = 40 μg/ml RNA). 
 
2.3.3 X. laevis oocyte preparation and microinjection 
Female X. laevis frogs were anaesthetised and handled in accordance with Home-Office 
schedule 1 guidelines by registered personnel. The level of anaesthesia was tested by 
reaction of the withdrawal involuntary response. The frogs were killed by spinal bisection 
and pithing, and the ovarian lobes were removed from the torso by a midline incision. The 
ovarian lobes were used on the day of sacrifice or stored in OR-Mg buffer at 4 °C for up-to 
3-4 days. The ovarian lobes were transferred to fresh OR-Mg buffer. The lobes were initially 
physically disrupted into small clumps. The follicular membranes of the X. laevis oocytes 
were removed by transfer to OR-Mg containing 1 mg/ml collagenase type 1A (Sigma-
Aldrich, UK) for 45 min at RT, with gentle mixing. The defolliculated X. laevis oocytes 
were washed four times in OR-Mg buffer, and then incubated for a second time in the 
presence of 1 mg/ml collagenase for 30 min at RT. Collagenased X. laevis oocytes were 
washed thoroughly in 1x OR-Mg (5-6 washes), before being washed twice and stored in 
ND-96 at 18 °C. X. laevis oocytes in the late stages of mitosis (stages V and VI) were 
visually selected and transferred to a separate dish for later microinjection. The selected X. 
laevis oocytes were approximately 1 mm in diameter, which had clearly defined vegetal 
(light side) and animal poles (dark side). The X. laevis oocytes were typically injected either 
on the day or the day after preparation.     
 
Baked glass capillaries were pulled to make injection pipettes using an automatic pipette 
puller. The tips were pulled using a two stage program designed to give a fine tip and long 
shank, then trimmed to the correct diameter using a pair of forceps. Pre-prepared samples of 
cRNA were injected into each X. laevis oocyte using a Pneumatic PicoPump pressure 
injection system (World Precision Instruments; following the manufacturer’s instructions). 
The injection volume was set to ≈50 nl by adjusting either the diameter of the pipette tip or 
by altering the length of the pneumatic pulse. The loaded injection pipette was aligned with 
a X. laevis oocyte by micromanipulation; the injection pipette was jabbed in to the vegetal 
pole near the border with the animal side, followed by a pneumatic pulse, and withdrawal of 
the pipette tip from with in the X. laevis oocyte. The injected X. laevis oocytes were 
incubated individually in a 96-well plate containing 1x Barth’s solution at 18 OC, for 1-3 
days, prior to experimentation to allow for expression. mSlo3-F304Y injected oocytes were 
stored in F304Y Barth’s solution, designed using the Goldman-Hodgkin-Katz voltage 
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(GHK) equation (Hille, 2001) to set the resting membrane potential (RMP) to ≈ -30 mV 
(3.2.2). 
 
2.3.4 Electrophysiology – Two electrode voltage clamp 
A) Current recordings 
The X. laevis oocyte currents were recorded at room temperature (≈ 25 ± 20 OC) in Ringer’s 
solution perfused at a rate of 2 ml/min. The microelectrodes were made from thin-walled 
borosilicate glass (GC100F-15, Harvard apparatus LTD) using a PMP-100D electrode puller 
(Microdata Instrument, Inc.) filled with 3 M KCl, connected to the headstage by silver wires 
electroplated with chloride. The resistance of the voltage electrode was between 1 and 5 
MΩ, and the resistance of the current electrode was between 0.3 and 2.5 MΩ. A silver/silver 
chloride pellet electrode was used as the bath reference. 
 
After insertion of the microelectrodes, the X. laevis oocyte was left for up to 5 min to allow 
the membrane to reseal around the electrodes. Membrane potential was controlled using a 
GeneClamp 500 amplifier (Axon), monitored by a TekTronix 2205 Oscilliscope, digitised 
using a NI USB-6211 (National Instruments) and recorded using WinWCP (V 4.0.5). 
Recordings were filtered at 5 kHz and sampled at 4 kHz. Typically for I/V protocols, X. 
laevis oocytes were voltage-clamped at a holding potential of -80 mV, and the voltage was 
stepped up in +10 mV increments (with a 3 s interpulse period), up to 140 mV for 400 ms. 
During inhibition protocols oocytes were held voltage-clamped at a potential of -80 mV, 
then stepped for 200 ms to +100 mV. After a 1s interval during which the oocyte was 
clamped at -80 mV, a voltage ramp from -80 mV to +100 mV over 1.5 s duration was 
applied. The interpulse period for the inhibition protocols was 1 s. Sample traces for the I/V 
and inhibitor protocols are provided in the relevant figure legends. Inhibitors were applied 
until steady state inhibition of the +100 mV recording pulse occurred. 
 
B) Analysis of Electrophysiological Recordings 
Raw data were analysed using Clampfit 9.2 (Molecular Devices) and then compiled using 
Excel 2003 (Microsoft Ltd) and OriginPro 7.5 (Originlab) software packages. I/V curves and 
RMP values were collated and averaged (±S.E.M) before plotting. Activation time constants 
(τ) were fitted in WinWCP software with equation 1. 
 
Equation 1:   ݕሺݔሻ ൌ ܣ. ቆ1 െ ܧܺܲ ቀെ ௫
த౗ౙ౪
ቁቇ
௉
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Where A is the peak current amplitude and τact is the activation time constant. Individual I/V 
relationships were converted to conductance-voltage (G/V) relationships. G/V plots were 
plotted over the -50 to +140 mV range to minimise intrinsic error due to erroneous points 
around the reversal potential, created by the conversion from current to conductance. Plots 
were fitted with unconstrained Boltzmann function (equation 2) to determine the predicted 
maximal conductance (Gmax). 
 
Equation 2:    ܩ ൌ ீ೘ೌೣିீబ
ଵା௘
൭ೇషೇభ
మ
൱
ೖ
൅ ܩ଴ 
Where G0 is the initial conductance, V1/2 is the half-activation voltage and k is a measure of 
the voltage dependence. Conductance values were normalised to the predicted Gmax, and 
plotted fitting with a Boltzmann function asymptoted to Gmax of 1 to gain individual 
measurements of the V1/2 and k values (slope). Average G/V plots were generated from the 
average (± SEM) of the individual data and plotted.  
 
Percentage current remaining (I%) of current was calculated by normalisation of inhibition 
induced current (I) to vehicle (either 0.5% DMSO or Ringer’s) induced current (I[B]0): 
 
Equation 3:    ܫ%  ൌ  ቀ
ூ  
ூሾ஻ሿబ
ቁ כ 100 
Inhibition curves were fitted individually to the normalised data for each oocyte with 
maxima asymptoted to 100% with equation 4. 
 
Equation 4:    ܫ ൌ   ூሾBሿబ
൬ଵ ା ቀ ሾBሿ
಺಴ఱబ
ቁ
H
൰
 
Where H is the Hill coefficient, [B] is inhibitor concentration and I[B]0 is the current in the 
absence of inhibitor. IC50 values were collated and averaged (±S.E) to determine final IC50 
values for each construct. The voltage dependence of quinine, quinidine and barium block of 
mSlo3 currents were determined by calculating values of zδ, the fraction of the electric field 
that the blocker experiences and the valency of the blocker, from the estimates of IC50 values 
obtained at +20, +40, +60, +80 and +100 mV (K0.5(V))according to the Woodhull equation 
(Woodhull, 1973) for individual oocytes. The apparent δ and K0.5(0), the apparent affinity at 
0 mV, for each oocyte were calculated according to the transformed Woodhull (equation 5). 
 
Equation 5:   ݈݊ܭ଴.ହሺܸሻ  ൌ  ݈݊ܭ଴.ହሺ0ሻ ൅  ቀ
ఋ௭௏ி
ோ்
ቁ 
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Where V is membrane potential, R is the gas constant, T is absolute temperature and F is 
Faraday's constant. Data were then collated and analysed to give average apparent δ and 
K0.5(0) values. All data are presented as mean ± SEM and all results are n ≥ 3. Statistical 
tests and significance were performed using GraphPad Prism 4 (GraphPad Software Inc) as 
described in section 2.5. 
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2.4 Heterologous expression in HEK293 cells 
2.4.1 Materials and reagents 
As in previous sections, except for the following: 
 
A) Tissue culture solutions  
HEK293 media: Dulbecco's Modified Eagle Medium - GlutaMAX™-I (GIBCO ®), 10% 
Fetal bovine Serum, 50 units Penicillin and 5µg/ml Streptomycin 
DPBS: Dulbecco's Phosphate-Buffered Saline (GIBCO ®) 
Opti-MEM: Opti-MEM® I Reduced Serum Media (GIBCO ®) 
Serum free media (SFM): Dulbecco's Modified Eagle Medium - GlutaMAX™-I (GIBCO 
®), 50 units/ml Penicillin and 5µg/ml Streptomycin 
Trypsin: Trypsin, 0.05% with EDTA 4Na (GIBCO ®)  
 
B) Electrophysiological solutions 
Extracellular Solution: NaCl 140 mM, KCl 5 mM, CaCl2 1 mM, Glucose 29 mM, HEPES 
25 mM, pH 7.4, ≈330 mOsm 
Intracellular solution (0 mM Na+): KCl 130 mM, EGTA 5 mM, HEPES 10 mM, pH 7.4, 
≈294 mOsm 
Low Cl- Intracellular solution (0 mM Na+ 1 mM Cl-): KCl 1 mM, K-gluconate 129 mM 
EGTA 5 mM, HEPES 10 mM, pH 7.4, ≈294 mOsm 
 
B) Activator stock solutions 
 Bithionol: 10 mM in DMSO 
 Bithionol Sulfoxide: 10 mM in DMSO 
 
2.4.2 Transfection of HEK293 Cells  
In vitro synthesis of plasmids was required before plasmid transfection into HEK293 cells 
(as described in section 2.1.9). The transfection mixture was produced with the composition 
(per 35 mm well of a six well plate): 100 µL pre warmed (37oC) SFM or Optimem, 3 µL 
Fugene® 6 (Roche), 1-1.5 µg of cDNA. The mixture was incubated for 20-30 mins at RT 
before being added to ~50% confluent cells. Cells were incubated for 24-48 hrs and then 
replated into a 35 mm dish at lower density for electrophysiological study 3-24 hours later. 
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2.4.3 Electrophysiology - Whole cell patch clamp 
A) Setup 
The microelectrode pipettes were made from thin-walled filimented borosilicate glass 
(GC150TF-15, Harvard Apparatus Ltd) using a PP-830 (Narishige) electrode puller. Pipettes 
were fire-polished after pulling with a MF830 (Narishige) micro-forge. HEK293 medium in 
35mm dishes was gently exchanged with approximately 2 mls of extracellular solution, 5 
mins prior to patching. The 35 mm dish was then placed on a modified stage of a Nikon 
TE2000 Microscope (Nikon), and connected to the ground (silver/silver chloride pellet) 
electrode with an agar bridge. Agar bridges were produced, before patching, by dissolving 
0.5% agar in extracellular solution and using this solution to fill reshaped thin walled glass. 
Transfected cells were identified by fluorescence; pipettes were first backfilled with 
intracellular solution (making sure of the absence of air bubbles). For variable [Na+]i 
experiments intracellular (and low Cl- intracellular) solutions were modified with the 
addition of NaCl (or Na-gluconate) to the required concentration before the pipette was 
filled. Once filled the pipette was mounted on the EPC10 headstage (HEKA) ensuring good 
contact between the intracellular solution and the silver chloride wire. Slight positive 
pressure was applied to the pipette before the pipette was manoeuvred so that it was in 
contact with the extracellular solution. The resistance of the voltage electrode was between 1 
and 3.5 MΩ, pipettes with higher resistance were discarded. The pipette voltage offset was 
zeroed; taking into account the Liquid Junction Potential (LJP) of the solutions calculated 
using Clampex 9.2 (Molecular Devices). The pipette was then manoeuvred so that it was 
gently touching the membrane of the cell. Suction was applied until a seal of ~ 100 
MΩ formed and then the suction was released, until a GΩ seal was formed. The pipette was 
then voltage clamped at -80 mV, and the fast capacitance (C-fast) of the pipette was 
cancelled. Gentle suction was then applied to break through the membrane, ceasing on the 
appearance of slow capacitance (C-Slow) spikes. C-slow was then cancelled, however if the 
series resistance of the breakthrough was more than twice the pipette resistance, more 
suction was applied until this situation had occurred. Exceptions occurred when using low 
Cl- intracellular solution, when thrice the pipette resistance was deemed usable. 
 
B) Current Recording 
Pipette potential was controlled using the Patchmaster software through an EPC10 amplifier 
(HEKA). After membrane breakthrough (2.4.3A) the HEK293 cell was clamped at -80 mV, 
and a voltage ramp was applied. From a -70 mV holding voltage, command voltage was 
stepped down to -100 mV for 100 ms then ramped to +100 mV over 500 ms before stepping 
back to -70 mV. The interpulse period for the ramp protocol was 5 s and the sample rate was 
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1 kHz. Throughout the recording the reversal potential and conductance was monitored 
through the online analysis function of the Patchmaster software. Typically for I/V 
protocols, cells were voltage-clamped at a holding potential of -80 mV and the voltage was 
stepped up in +10 mV increments (with a 3 s interpulse period), up to 100 mV for 200 ms. 
The sample rate for the I/V protocol was 10 kHz. Sample traces for I/V and ramp protocols 
are provided in the relevant figure legends.  
 
For dose response and single dose protocols a voltage ramp (as previously described) was 
applied for ~250 s to allow not only the intracellular solution to dialyse the cell but also to 
allow currents to stabilise. Then compounds were applied by perfusion until the conductance 
reached a steady state of at least 10 sweeps of the ramp protocol. For single dosage 
applications perfusion of vehicle (extracellular solution) was executed until currents reached 
steady state. For dose response experiments wash steps of vehicle (extracellular solution) 
were performed after 1, 10, 30 µM dosages to ensure that there was an accurate baseline and 
that observed current was not due to leak currents between the pipette and cell. 
 
C) Analysis of Electrophysiological Recordings 
Raw data were analysed using the online analysis function of the Patchmaster software and 
then compiled using Excel 2003 (Microsoft Ltd) and OriginPro 7.5 (Originlab) software 
packages. Conductance and current were first internally normalised to the calculated 
capacitance of each cell. Values were collated and averaged (±SEM) before plotting. To 
generate dose response curves for pharmacologically active compounds, which resulted in a 
change in conductance, firstly steady state conductance density was averaged. Once 
averaged the conductance density for each concentration, G[A]χ, was normalised to the 
average vehicle conductance density, G[A]0, using equation 6. 
 
Equation 6:   ܩ௡௢௥௠  ൌ  ൫ܩሾܣሿఞ / ܩሾܣሿ଴൯ כ 100 
Activation curves were fitted individually to the normalised data for each cell with a logistic 
dose response curve: 
Equation 7:   ݕ ൌ  ܩ’ሾܣሿ଴ ൅  ቀ
ீ’ሾ஺ሿಟିீ’ሾ஺ሿబ
ଵାଵ଴ሺౢ౥ౝሺECఱబషಟሻH
ቁ 
Where H is the Hill coefficient, G’[A]χ is the maximal conductance density in the presence 
of the activator and G’[A]0 is the average conductance density in the absence of activator. 
EC50 values were collated and averaged (±SEM) to determine final EC50 values for each 
compound. All data are presented as mean ± SEM and all results are n ≥ 3. Statistical tests 
and significance were performed using GraphPad Prism 4 (GraphPad Software Inc) as 
described in section 2.5. 
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2.5 General bioinformatics and statistical analysis methods 
 
2.5.1 Bioinformatics 
The RCK domains of the Mouse Slo1 (NP_034740) protein as described by (Yusifov et al., 
2008) were aligned with the homologous regions in mSlo3 WT (NP_032458) using 
ClustalW2 (EBI). The DomPred Protein Domain Prediction Server (Marsden et al., 2002) 
was used to predict the secondary protein structure of the RCK homologous regions of 
mSlo3 WT (NP_032458). The online modelling server, SWISS MODEL, was used in the 
first approach mode for homology modelling and alignment of protein sequences (Peitsch, 
1995; Arnold et al., 2006; Kiefer et al., 2009). The first approach mode requires sequence 
homology throughout the protein of interest and the template sequence. Therefore, deletion 
of non-homologous regions in the protein of interest was required for complete homology 
modelling and alignment. The model building process is carried out in three stages:  
 
   1) Sequence identity check (>25 % threshold)         
   2) Generation of models with ProModII 
   3) Energy minimisation of models with Grosmos96 
 
2.5.2 Statistical analysis 
Data are expressed as mean ± standard error of the mean (SEM). Parametric data were tested 
for significance using Student’s t-test (Student, 1908) with Welch’s correction for unequal 
variance when comparing two groups or when multiple comparisons were required analysis 
of variance (ANOVA) tests were performed with the correct post-hoc tests. For non-
parametric data a Kruskal–Wallis one-way analysis of variance test was performed. Post-hoc 
tests were performed in order to observe internal significance between the multiple groups 
compared. Bonferroni post-hoc tests were preferred for internal comparison between all 
groups. Nonparametric analysis required Dunn’s multiple comparison post hoc tests to 
compare the groups. Significance was determined as a p value of less than 0.05. 
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Chapter III: Pharmacology of mSlo3  
 
3.1 Chapter 3 Introduction 
 
3.1.1 Characteristics of the mSlo3 channel 
The large-conductance Ca2+-activated K+ channels (Slo1, BKCa) are highly characterised for 
their gating by voltage and intracellular Ca2+ (Butler et al., 1993). Slo1 is distinctive due to 
the large unitary conductance but also has distinctive “regulator of K+ conductance” (RCK) 
domain architecture in the large C-terminus tail that provides most of the physiological 
modulatory sites. The closest relative mSlo3 was identified via an expressed sequence tag 
(EST) with homology to the C-terminal region of mSlo1 and PCR analysis of a variety of 
tissues (Schreiber et al., 1998). The Slo3-encoded channel was found to be expressed solely 
in spermatozoa and testis (Schreiber et al., 1998). The mSlo1 and mSlo3 channels have 
highest homology in the core domain which contains the six TM domains and RCK1. The 
mSlo1 S0 through to S8 shares 56% identity to the mSlo3, S0 through to S8 regions. The S9 
and S10 regions are more divergent and there is only 39% identity between mSlo3 and 
mSlo1. The mSlo3 channel was found to be modulated by internal pH and voltage whereas 
mSlo1 also displays voltage dependent activation but it is modulated by Ca2+ rather than 
intracellular alkalisation (Schreiber et al., 1998). When expressed in Xenopus oocytes mSlo3 
displayed a lower unitary conductance of 106 pS in 160 mM symmetrical K+ (Schreiber et 
al., 1998). The pharmacology of mSlo3 differs in comparision to Slo1; mSlo3 is largely 
insensitive to extracellular tetraethylammonium (TEA) with an IC50 of 49 mM in 
comparison to block of Slo1 which has an IC50 of 0.14 mM (Schreiber et al., 1998). This 
difference in TEA sensitivity is due to the lack of a tyrosine (Y294), when mutated in Slo1 
results in mSlo3 levels of inhibition (Tang et al., 2010b). mSlo3 channels are also insensitive 
to the scorpion toxins, iberiotoxin and charybdotoxin, the “classical” Slo1 inhibitors (Tang 
et al., 2010b). The channel properties of mSlo3 have been difficult to discern due to two 
reasons. Firstly successful expression in mammalian cells has proved elusive for unknown 
reasons. Secondly to attain detectable expression in Xenopus oocytes a level of 40 ng of 
cRNA is required for injection; oocytes also have to be kept for three to fourteen days in 
order to observe significant currents. This is an exceptionally high amount of RNA in 
comparison to Slo1, which requires 20-fold less cRNA and an incubation time of only 1-3 
days to attain significant channel expression. The original study also noted that the mSlo3 
channel had a short mean open time and a low open probability (Po) at physiological 
voltages (Schreiber et al., 1998). 
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mSlo3 is activated in alkaline buffers in the range of pH 7.0 - pH 9. pH 9 is not a defined 
physiological limit to channel activation, as at a pH higher than 9 patch stability cannot be 
maintained. Analysis of the effects of pH on Po of the channel suggested that multiple 
protonation sites exist on the mSlo3 C-terminus domain (Zhang et al., 2006a). Interestingly, 
analysis of the activation and deactivation time courses of macroscopic currents exposed fast 
and slow exponential components. Their work suggested that there are two distinct inter-
converting channel populations. Increasing pH was found to affect the amplitude of 
activation; whilst the time course of activation remained constant. This finding suggested a 
shift between populations was dependent on the level of protonation of the mSlo3 channel 
(Zhang et al., 2006a). This theory is reliant on the distinct populations each having a discrete 
steady state Po, however this was not observed in analysis of single channel traces (Zhang et 
al., 2006b). One curious aspect of the fast component of channel deactivation is the minimal 
dependence on pH. However single channel traces exhibited a rapid opening and closing that 
prevented simple definition of a unitary current level. Thus it was concluded that there is 
insufficient evidence to determine the effects of pH on the gating steps controlling mSlo3 
activation time course (Zhang et al., 2006b). 
 
3.1.2 Physiological relevance of mSlo3 
The function of the mSlo3 channel in native tissues, testis and spermatozoa, has yet to be 
fully elucidated. Using mouse CatSper1 KO mature spermatozoa the IKSper current was 
identified, the properties of which are similar to the mSlo3 channel mediated current, 
including the shape of the I/V curve, the potentiation of the current over a similar pH range 
(pH 6 - pH 8) and weak voltage sensitivity. The original study was unable to confirm if 
mSlo3 channel is the IKSper current mediator in mouse CatSper1 KO mature spermatozoa due 
to the only commercially available anti-mSlo3 antibody having been raised in mouse 
(NeuromAB) (Navarro et al., 2007). IKSper is the dominant hyperpolarising conductance 
within the physiological range, and thus is believed to dictate the resting membrane potential 
of the spermatozoan. During the process of capacitation, the spermatozoa acquire chemotatic 
behaviour, hyperactivated motility and are readied for the acrosome reaction prior to 
fertilisation. The spermatozoan cytoplasm undergoes alkalinisation in the female 
reproductive tract due to activation of HV1 channels in humans, and the Na+-dependent Cl-–
HCO3- exchanger in mouse (Zeng et al., 1996; Lishko et al., 2010). The increase in 
intracellular pH is thought to activate IKSper and drive the membrane potential to negative 
potentials. This sequentially increases the driving force of Ca2+ entry via the alkalinisation 
activated CatSper channels, in turn increasing level of hyperactivated motility (Kirichok et 
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al., 2006; Navarro et al., 2007, 2008). IKSper current is sensitive to the general motility and 
volume regulatory K+ channel (TASK2 and Kv1.5) inhibitors; quinine, clofilium and 
mibefradil (Navarro et al., 2007). Quinine and clofilium have been shown to exert their 
effects on spermatozoan volume regulation and motility by inhibiting a TEA-insensitive K+ 
current (Yeung & Cooper, 2001; Barfield et al., 2005a, 2005b). A recent study showed a 
chimaeric mSlo3 (MC13), with residues 1-181 substituted with Slo1 was blocked by the 
stereoisomer of quinine, quinidine. Quinidine block was proposed to be due to the 
protonated form binding to the intracellular side of the MC13 channel with a higher affinity 
for the closed state (Tang et al., 2010b).  
 
3.1.3 Chapter Aims 
3.1.3.1 Can we modify the channel properties to increase channel activity?  
There is difficulty in getting detectable mSlo3 currents from injected Xenopus oocytes due to 
the low intrinsic Po of mSlo3. Thus to increase the activity of the channel we tested an S6 
domain (F304Y) mutation. This mutation is homologous to the F380Y mutation in the S6 
domain of hSlo1, which stabilises the open state of the channel by reducing the closing rate 
and shifting the voltage dependence of the opening rate (Lippiat et al., 2000). Therefore if 
the F304Y mutation has similar effects we should be able to get more consistent detectable 
currents allowing for easier measurement of channel properties. 
 
3.1.3.2 What effect does our mutation have on intracellular pore blockers?  
We aim to test the effect of our mutation on the relative potency of quinine, a compound that 
has been used extensively to test volume regulation and mobility in spermatozoa. Defined 
properties for the potency of inhibition may allow easier identification of mSlo3 currents as 
a component of IKSper current. We aim to also test the optical isomer quinidine, a compound 
that has been suggested to bind to the intracellular side of the channel in the close state. Thus 
we hypothesise quinidine inhibition will be reduced in the F304Y injected oocytes as this 
mutation should reduce the amount of channels in the closed state. 
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3.1.3.3 What effect does our mutation have on extracellular pore blockers? 
Ba2+ ions inhibit K+ currents, in a voltage dependent manner, by blocking the selectivity 
filter in the K+ channel. Ba2+ inhibition can be relieved by increased concentration of K+ ions 
resulting in increased competition for occupancy of the selectivity filter (Armstrong & 
Taylor, 1980; Neyton & Miller, 1988; Jiang & MacKinnon, 2000). We theorise that our 
F304Y mutation should not affect the potency of Ba2+ inhibition. As the mutation should 
only increase the open probability of the mSlo3 channel, thus the selectivity filter should be 
unaffected.  
 
3.1.3.4 Do mSlo3 currents share pharmacological properties with IKSper? 
We hypothesise that mSlo3 channels may underlie a component of IKSper, due to similar 
electrophysiological properties and range of pH sensitivity. We aim to trial the 
pharmacological profile described for the IKSper current on mSlo3 expressed in Xenopus 
oocytes (Navarro et al., 2007). Confirmation of the effects of these inhibitors will strengthen 
the case that the mSlo3 channel mediates at least part of the IKSper current. Also, because of 
the overlap in pharmacological properties, sensitivity of mSlo3 channels to the inhibitor 
range will also suggest that mSlo3 currents are a component of the K+ current involved in 
motility and volume regulation. 
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3.2 Chapter 3 Results 
 
3.2.1 Effects of mutation of F304 on electrophysiological properties 
Currents from oocytes were measured using two-electrode voltage clamp during a 100 ms 
voltage step of -100 to +140 mV in 10 mV increments, from a -80 mV holding potential. 
mSlo3-injected ooctyes (Figure 3.1) displayed currents similar to those previously described 
by Schreiber et al. (1998), a voltage dependent delayed rectifier current with no inactivation, 
properties that are distinct from the endogenous current (Figure 3.1). The sample traces of 
the mSlo3 (Figure 3.1.A), F304Y (Figure 3.1.B) and endogenous channels (Figure 3.1.C) 
show that this pulse is of sufficient duration for currents to reach steady state activation. The 
average plots of I/V relationship show the distinction of the experimental currents from the 
contaminating endogenous currents, which display activation above +100 mV. F304Y 
currents (Figure 3.1.B) show similar properties to mSlo3 currents, a voltage dependent 
delayed rectifier current with no inactivation, but display activation from lower voltage 
potentials. Analysis of the F304Y current traces display significantly (P<0.05, Student’s t-
test) faster activation kinetics τ+100mV (3.31 ± 0.07 ms, n=26) compared to mSlo3 τ+100mV 
(5.69 ± 0.09 ms, n=29). Traces were sampled to generate average current-voltage (I/V) 
relationships (± SEM) (Figure 3.1.D).  
 
The average I/V curves show a leftward shift of ≈40 mV in voltage activation caused by the 
mutant F304Y, in comparison with the mSlo3 currents. Thus individual I/V relationships 
were converted to conductance-voltage (G/V) relationships, averaged (± SEM) and plotted 
as described in 2.3.4.B. Whilst in the plots of the average G/V relationships, shown in Figure 
3.2, F304Y currents display a leftward shift in the voltage activation in comparison to mSlo3 
currents. However, the Boltzmann function fits of the individual G/V data sets found that the 
average F304Y V1/2 (30.83 ± 38.17 mV, n=26) was not significantly (P>0.05, Student’s t-
test) shifted from the mSlo3 V1/2 (55.79 ± 63.33 mV, n=29). The voltage dependence, as 
quantified by the slope, of the conductance relationship, was not significantly (P>0.05, 
Student’s t-test) changed by the F304Y mutation (50.57 ± 10.78 mV, n=26) compared to 
mSlo3 (67.49 ± 24.90 mV, n=29). 
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Figure 3.1 Electrophysiological properties of oocytes expressing wildtype and mutant 
mSlo3 channels. Sample traces of (A) mSlo3, (B) F304Y and (C) uninjected oocytes are 
shown in response to the voltage step protocol, -100 mV to 100 mV in 10 mV intervals. 
Traces were complied to generate I/V curves (D), which show the leftward shift in voltage 
activation caused by the mutant F304Y. Also shown is the distinction of the experimental 
currents from the control endogenous uninjected currents. 
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Figure 3.2 Effects on the conductance-voltage relationship due to F304Y mutation. 
Individual I/V relationships were converted to conductance-voltage relationships before 
collating and plotting. Plots were fitted with Boltzmann function asymptoted to maxima of 
1. The average F304Y V1/2 (30.83 ± 38.17 mV) was found to be not significantly (P>0.05, T-
test) shifted from the mSlo3 V1/2 (55.79 ± 63.33 mV). The voltage dependence (as quantified 
by the slope) of the conductance relationship, was also not significantly (P>0.05, T-test) 
changed by the F304Y mutation (50.57 ± 10.78 mV) compared to mSlo3 (67.49 ± 24.90 
mV). 
 
  
62 
 
3.2.2 Effects of F304Y on oocyte resting membrane potential 
mSlo3 currents are not a major determinant of RMP, unlike IKSper (Navarro et al., 2007), as 
no significant difference between mSlo3 RMP (-38.4 ± 2.68 mV, n=32) and uninjected RMP 
(-24.1 ± 3.23 mV, n=12) (Figure 3.3) was observed. However, oocytes have endogenous 
channels that contribute to RMP, as can be seen in Figure 3.1C and D. If the significance 
threshold was relaxed to P<0.1 the mSlo3 RMP was found to be significantly lower than the 
uninjected RMP. The F304Y mutant channels, that are open across a wider voltage range 
(Figure 3.1D), were a major determinant of RMP (-68 ± 4.93 mV, n=26) and displayed a 
significant difference (P<0.05, Kruskal–Wallis, Dunn’s post hoc test) in comparison with 
mSlo3 and uninjected RMP.  
 
The effects of F304Y expression on oocyte RMP’s were so pronounced, storage in modified 
Barth’s solution (2.3.1.A), appeared to be ootoxic. Surviving oocytes had a more negative 
RMP, near EK, of ≈-79 mV in comparison to an uninjected oocyte (≈-30 mV). Modified 
Barth’s solution (2.3.1.A) was adapted using the Goldman-Hodgkin-Katz voltage (GHK) 
equation (Hille, 2001) (equation 8) to adjust the RMP to ≈-30 mV to compensate for the 
hyperpolarised RMP of F304Y injected oocytes.   
 
Equation 8:   ௠ܸ ൌ
ோ்
ி
ln ൬
௉ಿೌశሾே௔
శሿ೚ೠ೟ ା ௉಼శሾ௄
శሿ೚ೠ೟ ା ௉಴೗షሾ஼௟షሿ೔೙ 
௉ಿೌశሾே௔
శሿ೔೙ ା ௉಼శሾ௄
శሿ೔೙ ା ௉಴೗షሾ஼௟షሿ೚ೠ೟ 
൰ 
Where Vm is membrane potential, R is the gas constant, T is absolute temperature, F is 
Faraday's constant, Pion is the permeability coefficient of the ion across the membrane and 
[ion]χ is the concentration of the ion where χ is the orientation of the membrane. Intracellular 
ion concentrations and ion permeability of collagenased Xenopus oocytes were measured in 
an earlier study (Costa et al., 1989). Using the values for our standard modified Barth’s 
solution gave a calculated Vm of -27.83 mV for uninjected oocytes. Rearranging the equation 
we calculated ܲ௄శ for our F304Y injected oocytes, twelve-fold higher than for uninjected 
oocytes. Using these calculated values (ܲ௄శ , ܲே௔శand ஼ܲ௟ష), the extracellular KCl 
concentration was varied until a calculated Vm of -36 mV was achieved. This composition of 
extracellular solution was termed F304Y Barth’s solution; F304Y injected oocytes were 
stored in this solution during the 1-3 day incubation. This method increased oocyte viability 
with a survival rate of ≈ 90%.   
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Figure 3.3 Effects of wild-type and mutant mSlo3 channels expression on the 
membrane potential of oocytes. The RMP of oocytes was recorded before voltage clamp 
was applied, then collated and averaged. Analysis of the RMP showed a significant 
difference in F304Y injected oocytes (P<0.05, Kruskal–Wallis, Dunn’s post hoc test). 
However the RMP of mSlo3 injected oocytes was not significantly different in comparison 
to uninjected oocyte’s RMP.  
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3.2.3 Quinine sensitivity of mSlo3 currents 
Inhibition curves were generated by application of increasing concentrations of quinine 
ranging from 0.5 μM to 1 mM and recording current amplitude in response to a +100 mV 
pulse from -80 mV, as can be seen in the sample traces (Figure 3.4.A and 3.4.B). Inhibition 
curves were normalised to vehicle control (0.5% DMSO), plotted as Figure 3.4.C and fitted 
using a logistic dose response curve with maxima asymptoted to 100%. Block of the F304Y 
mutant channel (IC50 = 15.9 ± 3.31 μM, n=16) was significantly more sensitive (P<0.05, 
one-way ANOVA; Bonferroni post hoc test) in comparison to mSlo3 channels (IC50 = 169.4 
± 40.1 μM, n=12). The F304Y mutation alters the Hill slope value, (0.69 ± 0.02) compared 
to mSlo3 (1.00 ± 0.21), however this affect is not significant (P>0.05, Student’s t-test). The 
inhibition curve for currents in uninjected oocytes shows that the inhibition observed in the 
injected oocytes is not due to inhibition of endogenous channels. This is firstly due to the 
low level of current at this voltage (Figure 3.1.D) and the currents in uninjected oocytes have 
an increased quinine IC50 = 253.7 ± 69.3 μM (n=4) (Figure 3.4.C).  
 
The voltage dependence of quinine block of mSlo3 and F304Y currents were determined 
from calculated individual oocyte IC50 values obtained at +20,+40, +60, +80 and +100 mV 
from currents evoked by a -80 to +100 mV voltage ramp. IC50 values were then averaged (± 
SEM) and plotted against the respective voltage (Figure 3.5). Straight line fits were fitted to 
individual data sets and used to calculate values of zδ, the product of the fraction of the 
electric field that the blocker experiences (δ) and the valence of the blocker (z) and the 
potency of block at 0 mV (K0mV) according to the transformed Woodhull equation 
(Woodhull, 1973) (2.3.4.B). Quinine inhibition of mSlo3 was calculated to have a zδ = -0.12 
± 0.07 (n=12) with the F304Y mutation significantly (P<0.05, Two-way ANOVA; 
Bonferroni post hoc test) increasing this value (zδ = -0.49 ± 0.06, n=12). The negative value 
for zδ suggests that quinine block is incompatible with the classical Woodhull model of a 
positively charged molecule binding from the extracellular side to a site within the 
membrane. However, a negative value for zδ for a positively charged molecule suggests that 
the molecule is binding from the intracellular side of the channel. These findings also 
suggest that the binding site of quinine to the F304Y channel is four-fold deeper in the 
electric field than in the mSlo3 channel. The F304Y mutation (K0mV = 48.78 ± 11.91 μM, 
n=12) also significantly (P<0.05, Two-way ANOVA; Bonferroni post hoc test) increases the 
sensitivity of the channel at 0 mV to quinine in comparison to mSlo3 channels (214.45 ± 
45.03 μM, n=12).  
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Figure 3.4 Concentration response of quinine inhibition on mSlo3 and F304Y. Sample 
traces of (A) mSlo3 and (B) F304Y are shown in response to a +100mV pulse with sample 
range of increasing quinine concentrations. The difference in sensitivity of mSlo3, F304Y 
and uninjected currents in response to quinine block is shown in C. Inhibition curves were 
fitted with a dose response curves with maxima asymptoted to 100% current. Block the of 
F304Y mutant (IC50=15.94 ± 3.31 μM, n=16) was significantly more sensitive (P<0.05, one-
way ANOVA; ; Bonferroni post hoc test) in comparison to mSlo3 (IC50=169.35 ± 40.08 μM, 
n=12). It appears that the F304Y mutation affects the Hill slope, (0.69 ± 0.02) compared to 
mSlo3 (1.00 ± 0.21), however this effect is not significant (P>0.05, T-test). 
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Figure 3.5 Voltage dependence of quinine inhibition. The voltage dependence of quinine 
block of mSlo3 and F304Y currents were determined by estimates of IC50 values obtained 
from ramp traces at +20, +40, +60, +80 and +100 mV and plotted to the transformed 
Woodhull equation. Straight line fits of individual oocytes were used to calculate values of 
zδ, and the potency of block at 0 mV (K0mV). Quinine inhibition of mSlo3 was calculated to 
have a zδ = -0.12 ± 0.07 (n=12) with the F304Y mutation significantly (P<0.05, Two-way 
ANOVA; Bonferroni post hoc test) increasing this value (zδ = -0.49 ± 0.06, n=12). The 
F304Y mutation (K0mV = 48.78 ± 11.91 μM, n=12) also significantly (P<0.05, Two-way 
ANOVA; Bonferroni post hoc test) increased the sensitivity of the channel at 0 mV to 
quinine in comparison to mSlo3 channels (K0mV = 214.45 ± 45.03 μM, n=12) 
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3.2.4 Quinidine sensitivity of mSlo3 currents 
Currents were recorded during application of increasing concentrations of quinidine ranging 
from 0.1 μM to 400 µM in response to +100 mV pulse from -80 mV, as can be seen in the 
sample traces (Figure 3.6.A and 3.6.B). Data were normalised to the maximal current 
response and plotted and fitted using a logistic dose response curve with maxima asymptoted 
to 100% (Figure 3.6.C). Quinidine block the of F304Y channels (IC50 = 2.42 ± 0.60 μM, 
n=9) was significantly more sensitive (P<0.05, Student’s t-test) in comparison to mSlo3 
channels (IC50 = 19.89 ± 1.42 μM, n=7). It appears that the F304Y mutation significantly 
(P<0.05, Student’s t-test) effects the Hill slope value, (0.76 ± 0.06) compared to mSlo3 (1.15 
± 0.15). The current traces (Figure 3.6.B) show characteristics mimicking inactivation of the 
channel, in particular the 1 μM quinidine concentration trace. The inhibition curve for 
currents in uninjected oocytes (Figure 3.6.C) shows that the inhibition observed in the 
injected oocytes is not due to inhibition of endogenous channels.  
 
The voltage dependence of quinidine block of mSlo3 and F304Y currents were determined 
by estimates of individual oocyte IC50 values obtained at +20,+40, +60, +80 and +100 mV 
from currents evoked by a -80 to +100 mV voltage ramp and the average (±SEM) plotted in 
Figure 3.7. Straight line fits were fitted to individual data sets and used to calculate values of 
zδ, and K0mV according to the transformed Woodhull equation (Woodhull, 1973) (2.3.4.B). 
Quinidine inhibition of mSlo3 was calculated to have a zδ = -0.12 ± 0.15, (n=7) with the 
F304Y mutation significantly (P<0.05, Two-way ANOVA; Bonferroni post hoc test) 
increasing this value (zδ = -0.46 ± 0.05, n=7). These findings suggest that, like quinine, the 
binding site of quinidine in the F304Y channel is four-fold deeper within the electric field 
than in the mSlo3 channel. The negative value for zδ suggests that quinidine block, like 
quinine block, is caused by a positively charged molecule binding from the intracellular side 
of the channel. Interestingly when comparing quinine and quinidine block, it appears that for 
neither mSlo3 channels nor F304Y channels there is no significant difference (P>0.05, Two-
way ANOVA; Bonferroni post hoc test) in the zδ values dependent on drug. The F304Y 
mutation (K0mV = 6.23 ± 1.27 μM, n=7) also significantly (P<0.05, Two-way ANOVA; 
Bonferroni post hoc test) increases the sensitivity of the channel at 0 mV to quinidine in 
comparison to mSlo3 channels (19.98 ± 4.17 μM, n=7).  
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Figure 3.6 Concentration response of quinidine inhibition on mSlo3 and F304Y. Sample 
traces of (A) mSlo3 and (B) F304Y are shown in response to a +100mV pulse with sample 
range of increasing quinidine concentrations. The difference in sensitivity of mSlo3, F304Y 
and uninjected currents in response to quinidine block is shown in C. Inhibition curves were 
fitted with a dose response curves with maxima asymptoted to 100% current. Block the of 
F304Y mutant (IC50=2.42 ± 0.60 μM, n=9) was significantly more sensitive (P<0.05, T-test) 
in comparison to mSlo3 (IC50=19.89 ± 1.42 μM, n=7). Interestingly the F304Y mutation also 
significantly affects (P<0.05, T-test) the Hill slope for quinidine inhibition, (0.76 ± 0.06) in 
comparison to mSlo3 (1.15 ± 0.15).  
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Figure 3.7 Voltage dependence of quinidine inhibition. The voltage dependence of 
quinidine block of mSlo3 and F304Y currents were determined by estimates of IC50 values 
obtained from ramp traces at +20, +40, +60, +80 and +100 mV and plotted according to the 
transformed Woodhull equation. Straight line fits of individual oocytes were used to 
calculate values of zδ, and K0mV. Quinidine inhibition of mSlo3 was calculated to have a zδ 
= -0.12 ± 0.15, (n=7) and K0mV = 19.98 ± 4.17 μM. F304Y channels gave significantly 
different calculated values (P<0.05, Two-way ANOVA; Bonferroni post hoc test), zδ = -0.46 
± 0.05, (n=7) and K0mV = 6.23 ± 1.27 μM. 
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3.2.5 Ba2+ sensitivity of mSlo3 currents  
Inhibition curves were generated by application of increasing concentrations of Ba2+ ranging 
from 20 μM to 10 mM and recording current amplitude in response to a +100 mV pulse 
from -80 mV, as can be seen in the sample traces (Figure 3.8.A and 3.8.B). Inhibition curves 
were normalised to the maximal current response and plotted as Figure 3.8.C and fitted 
using a logistic dose response curve with maxima asymptoted to 100%. Block the of F304Y 
mutant (IC50 = 524.55 ± 96.99 μM, n=5) was not significantly more sensitive (P>0.05, 
Student’s t-test) in comparison to wild type mSlo3 (IC50 = 646.28 ± 100.27 μM, n=6). The 
F304Y mutation does not effect (P>0.05, Student’s t-test) the Hill slope values, (1.05 ± 0.12) 
compared to mSlo3 (0.883 ± 0.11). Approximately twenty percent of current in both the 
F304Y and mSlo3 recordings remain at the highest Ba2+ concentration. This can be largely 
attributed to the endogenous currents in uninjected oocytes, which were unaffected by 
addition of 10mM Ba2+. Ba2+ inhibition was observed in the sample traces, Figure 3.8.A and 
3.8.B, to visibly slow the rate of activation. Individual currents were fitted with activation 
curves (Figure 3.9.A and 3.9.B) to gain τ+100mV values, τ+100mV was found to increase for both 
F304Y and mSlo3 currents in a linear concentration dependent fashion (Figure 3.9.C). 
Interestingly, the Ba2+ dependence of τ+100mV of the F304Y mutant currents (0.28 ± 0.05 
ms/µM, n=5) was significantly slowed (P<0.05, Student’s t-test) in comparison to mSlo3 
currents (0.09 ± 0.01 ms/µM, n=6). 
 
The voltage dependence of Ba2+ block of mSlo3 and F304Y currents were determined by 
estimates of individual oocyte IC50 values obtained at +20,+40, +60, +80 and +100 mV from 
currents evoked by a -80 to +100 mV voltage ramp and the average (±SEM) plotted in 
Figure 3.10. Straight line fits were fitted to individual data sets and used to calculate values 
of zδ, and K0mV according to the transformed Woodhull equation (Woodhull, 1973) 
(2.3.4.B). Ba2+ inhibition of mSlo3 was calculated to have a δ = 0.66 ± 0.46, (n=5) with the 
F304Y mutation not significantly (P>0.05, Student’s t-test) changing this value (δ = 0.12 ± 
0.05, n=5). However if one of the mSlo3 fits is excluded as it has an unfeasible calculated δ 
of ≈ 2, the δ value changes to 0.20 ± 0.09 (n=4), suggesting that in both mSlo3 and F304Y 
block by Ba2+ is quite shallow in the electric field. The positive value for δ suggests Ba2+ 
inhibition is caused by the positively charged ion entering the channel from the extracellular 
side. Ba2+ inhibition of mSlo3 was calculated to have K0mV = 293.57 ± 74.48 μM (n=5). 
Inhibition of F304Y gave a significantly different (P<0.05, Student’s t-test) calculated K0mV 
= 521.08 ± 39.00 μM (n=5). Exclusion of the same data set for mSlo3 as before, shifts the 
K0mV value to 339.80 ± 75.38 μM, and removes the significance difference in K0mV (P>0.05, 
Student’s t-test).  
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Figure 3.8 Concentration response of Ba2+ inhibition on mSlo3 and F304Y. Sample 
traces of (A) mSlo3 and (B) F304Y are shown in response to a +100mV pulse with sample 
range of increasing Ba2+ concentrations. The difference in sensitivity of mSlo3 and F304Y 
currents in response to Ba2+ block is shown in C. Inhibition curves were fitted with a dose 
response curves with maxima asymptoted to 100% current. Block the of F304Y mutant 
(IC50=524.55 ± 96.99 μM, n=5) was not significantly more sensitive (P>0.05, T-test) in 
comparison to mSlo3 (IC50=646.28 ± 100.27 μM, n=6).The F304Y mutation also does not 
significantly affect (P>0.05, T-test) the Hill slope, (1.05 ± 0.12) compared to mSlo3 (0.88 ± 
0.11). 
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Figure 3.9 Ba2+ dependent slowing of τ. Individual oocyte currents for mSlo3 (A) and 
F304Y (B) were fitted with activation curves (red line) to gain τ+100mV values, before plotting 
against the respective Ba2+ concentration (C). τ+100mV was found to increase for both F304Y 
and mSlo3 currents in a linear concentration dependent fashion. The concentration 
dependence of τ+100mV of the F304Y mutant currents (0.28 ± 0.05 ms/µM, n=5) was 
significantly slowed (P<0.05, T-test) in comparison to mSlo3 currents (0.09 ± 0.01 ms/µM, 
n=6). 
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Figure 3.10 Voltage dependence of Ba2+ inhibition. The voltage dependence of Ba2+ block 
of mSlo3 and F304Y currents were determined by estimates of IC50 values obtained from 
ramp traces at +20, +40, +60, +80 and +100 mV and plotted to the transformed Woodhull 
equation. Straight line fits were used to calculate values of δ, the fraction of the electric field 
that the blocking ion experiences and the potency of block at 0 mV (K0mV). Ba2+ inhibition of 
mSlo3 was calculated to have K0mV = 293.57 ± 74.48 μM (n=5), however inhibition of 
F304Y gave a significantly different (P<0.05, T-test) calculated K0mV = 521.08 ± 39.00 μM 
(n=5). δ was found not to be significant (P>0.05, T-test) between mSlo3 (0.66 ± 0.46) and 
F304Y (0.12 ± 0.05) 
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3.2.6 Pharmacological profile of mSlo3 
The profile of the pharmacology of the mSlo3 channel was determined by application of 
inhibitors, dissolved either directly into either DMSO or Ringers to generate stock solutions, 
and then diluted to the required concentrations in standard Ringers solution. Inhibitors were 
then applied until steady state inhibition of a +100 mV recording pulse occurred, then 
washed with Ringers solution to relieve the inhibition as can be seen in Figure 3.11.A. 
Inhibition levels were measured and averaged and compared to the IKSper values calculated 
by (Navarro et al., 2007). Inhibition by 500 μM quinine (73.3 ± 4.87 %, n=11) was found to 
be not largely different from the reported IKSper data (88 %, n=9). Mibefradil 5 μM (18 ± 
3.27%, n=4) and clofilium 50 μM (59 ± 9.5 %, n=4) were sizeably different from the 
reported IKSper data, 69 % (n=4) and 92 % (n=6) inhibition, respectively. As a control 20 mM 
TEA was applied and resulted in inhibition of 20.2 ± 0.74 % (n=6). 2 mM Ba2+ was also 
applied, the same concentration used by Navarro et al (2007), inhibited 70.04 ± 3.73 % 
(n=3) of the current in normal K+ levels. When High K+ solution (2.3.1) was perfused with 
2mM Ba2+ inhibition was significantly (P>0.05, Student’s t-test) reduced to 10.65 ± 2.32 % 
(n=3). This is consistent with the findings of Navarro et al (2007) who found IKSper currents 
were Ba2+ insensitive in equipotent K+ (160 mM), but were sensitive to Ba2+ when Na+ was 
the dominant extracellular ion. As can be seen in the sample traces (Figure 3.11.A) the 
quinine (500 μM), clofilium (50 μM) and TEA (20 mM) inhibition is reversible. Ba2+ was 
partially reversible at 2.5 mM extracellular K+ and completely reversible at 100 mM 
extracellular K+. Interestingly the mibefradil (5 μM) sample trace (Figure 3.11.A), indicates 
that relief of inhibition results in an increased current, as shown by the light grey trace.  
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Figure 3.11 Pharmacological profile of mSlo3. The profile of the pharmacology of the 
mSlo3 channel was determined by application of inhibitors until steady state inhibition (light 
gray trace) of the -80 to +100 mV recording pulse occurred, then washed with Ringers to 
relieve the inhibition (dark gray trace). The mibefradil sample trace appears to indicate that 
relief of inhibition increases the current. The bar chart (B) shows the comparison of the 
average inhibition of the current in response to a range of compounds.  
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3.3 Chapter 3 Discussion 
 
3.3.1 Electrophysiological effects of the F304Y mutation 
The current understanding of the function and structure of the mSlo3 channel is limited; 
predominately due to the lack of recordable expression in mammalian cell lines. Functional 
mSlo3 expression has only been detected by injection of cRNA into oocytes. Although 
oocytes need to be injected with a near maximal level of ≈50 nl of the mSlo3 cRNA (≈1 
μg/μl) to gain currents that are distinct from endogenous channels. In comparison hSlo1 
cRNA can be diluted 20-400 fold and distinct recordable currents attained. mSlo3 current 
recordings in poorly expressing oocytes are contaminated by the endogenous currents at 
positive potentials (> +100 mV). Previous studies in hSlo1 revealed mutation of 
phenylalanine in position 380 in the S6 domain to tyrosine (F380Y) stabilises the open state 
of the channel by reducing the closing rate and shifting the voltage dependence of the 
opening rate (Lippiat et al., 2000). The mSlo3 channel has a homologous phenylalanine in 
position 304. Thus we introduced the homologous mutation F304Y to attempt to solve the 
difficulties with channel activation and reduce the requirement for high cRNA levels by 
stabilising the open state of the channel. 
 
Thus the F304Y mutation in mSlo3 should cause a leftward shift in the voltage dependence 
of the current and increase the conductance allowing a lower cRNA level to be injected. Our 
results show this mutation in mSlo3 causes a leftward shift in the current-voltage 
relationship and an increase in the τ+100 mV. However the V1/2 and voltage dependence values 
for F304Y calculated from the G/V curves showed no significant difference from the mSlo3 
values. This lack of difference in the G-V relationship may be due to the fact that neither 
channel reaches a quantifiable plateau of GMax at +140 mV. Thus, calculated GMax values 
with intrinsic error, had to be utilised to normalise the data. To achieve a measurable GMax 
value for the channels would require voltages greater than +140 mV. This would introduce 
two new problems, a larger proportion of contaminating endogenous current and increasing 
problems with voltage drop and capacitance. This requirement for a non-physiological range 
of positive voltages to reach GMax is consistent with previous studies of mSlo3 when the 
currents failed to reach a measurable GMax plateau in macroscopic patches pulled from 
oocytes at voltages up to +300 mV (Zhang et al., 2006a; Tang et al., 2010b).  
 
The effects of the F304Y mutation on the voltage range of activation were very clear from 
the assessment of the change in oocyte RMP. F304Y expressing oocytes required a modified 
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Barth’s solution that shifted the EK value to ≈-36 mV, as calculated by the GHK equation, 
for successful incubation. This demonstrates that the major determinant of the RMP of the 
F304Y injected oocytes is a K+ current, with a 12 fold higher ܲ௄శ. Our analysis of the RMPs 
found that unlike IKSper, mSlo3 expression does not significantly affect the RMP of 
expressing oocytes. However this is likely to be dependent on the ≈-44 mV shift in RMP due 
to F304Y expression which statistically masks the ≈-14 mV difference between the mSlo3 
induced RMP and uninjected RMP. However, if the significance value is relaxed to P<0.1 
the mSlo3 RMP was found to be significantly lower than in uninjected oocytes. Therefore 
our findings show that effect of the F304Y mutation on mSlo3 is parallel to the effects of the 
F380Y mutation on hSlo1 (Lippiat et al., 2000). This suggests that like hSlo1 this residue 
may have a critical function in the gating mechanism. Mutation from a nonpolar to polar 
amino acid potentially alters the sensitivity to a range of activators. Our current study does 
not encompass changes in the sensitivity of pH or pharmacological activators of mSlo3. This 
is predominantly because mSlo3 has no known agonists and past attempts to acidify/alkalise 
the intracellular oocyte solution using varied extracellular solutions in the absence of the 
chloride current blocker DIDS was observed to have opposing effects on endogenous 
currents (Schreiber et al., 1998). Supplementing our solutions with 1 mM DIDS would 
inhibit the endogenous currents; however the amounts required for our pharmacology studies 
would be prohibitively expensive. 
 
3.3.2 Method of Inhibition by Quinine and Quinidine of mSlo3  
Quinine and, the stereoisomer quinidine, are non specific K+ channel inhibitors, for which 
the full mechanism of block has not been defined. Quinine block of rSlo1 has been shown to 
display the characteristics of open-channel block, primarily inducing “flickery” block and 
reducing current amplitude (Franciolini et al., 2001). Quinidine inhibition of mSlo1 shows a 
weak voltage dependence of block and can be fitted with an open channel block scheme 
(Tang et al., 2010b). This theory of the mechanism of quinine and quinidine inhibition offers 
an explanation as to why F304Y channels are more sensitive compared to mSlo3, as these 
channels are open across more of the voltage range, thus have a higher Po resulting in an 
increased apparent affinity. Observations of the inhibition trace (Figure 3.6.B) in particular 
the 1 μM concentration trace, displays characteristics mimicking inactivation of the channel. 
However, fitting a voltage dependent activation and inactivation equation to the data gave 
poor fits and inconsistent values. This is most probably due to a combination of high 
variability in the levels of starting current and problems with control of the voltage clamp of 
ooctyes over-expressing F304Y with currents greater than 30 nA at +100 mV. This theory, 
however, appears to be contrary to a previous study’s findings using an mSlo1/mSlo3 
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chimaera (MC13), which has the residues 1-181 substituted with Slo1, had a higher affinity 
for the closed state. However this study admits that for cytosolic application of quinidine, no 
model of block fits the data any better than the other (Tang et al., 2010b). These findings 
support our suggestion that the F304Y mutation appears to have similar effects to the F380Y 
mutation in hSlo1 and stabilises the open state of the channel. 
 
3.3.3 Site of Inhibition by Quinine and Quinidine of mSlo3  
Quinidine inhibition is thought to result from binding of the protonated form to the 
intracellular side of the channel. This has been proposed by earlier studies that found that 
application of cytosolic quinidine on Slo1 channels and the MC13 chimaera was ≈ 5 fold 
more potent than extracellular application. Their study also found that variance of the pH, 
which in turn varies the percentage of protonated quinidine, proportionally varied the block 
of mSlo1 channels (Tang et al., 2010b). Our studies fit with these previous findings as 
negative values for zδ suggest that quinine and quinidine block is incompatible with the 
classical Woodhull model of a positively charged molecule binding from the extracellular 
side to a site within the membrane. However, negative values for zδ for a positively charged 
molecule suggest that the molecule is binding from the intracellular side of the channel. 
Comparison of quinine and quinidine block, shows for both F304Y and mSlo3 channels 
there is no significant difference (P>0.05, Two-way ANOVA; Bonferroni post hoc test) of 
the zδ values dependent on isomer applied. This suggests that quinine and quinidine bind to 
the same site within the channel but with different affinities. However, the differing pKa 
values of quinine and quinidine, due to the differing spatial orientation, may also contribute 
to the differing IC50 values observed. 
 
Previous studies have suggested that block occurs due to the protonated form of the drug 
binding the channel (Zhang et al., 1998; Sănchez-Chapula et al., 2003; Tang et al., 2010b). 
At the resting oocyte pH ≈ 7.5, 92.6% of quinidine (pKa, 8.6) is protonated in comparison to 
90% of quinine (pKa, 8.5) (Schreiber et al., 1998). Therefore the rightwards shift in IC50, 
may be partly due to the higher intracellular levels of a protonated compound. Full 
protonation of both compounds would occur at pH ≈ 6.5, below the required pH range for 
activation of the mSlo3 (Zhang et al., 2006a). Our finding that quinidine is more potent than 
quinine in inhibiting the mSlo3 channel agree with the observation that the Human ether-a-
go-go-related gene (HERG) K+ channel is also more strongly inhibited by quinidine than 
quinine (Sănchez-Chapula et al., 2003). This is to be anticipated as the compounds have 
distinct three-dimensional orientations, therefore it is to be expected that the binding 
properties may be different at the same site. 
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Secondly the S6 domain of the K+ channel has been shown to be a major determinant of the 
characterisitics of quinidine inhibition. Study of mutations in the S6 domain of the HERG 
K+ channel have been shown to affect the characteristics of inhibition by quinidine and 
quinine (Sănchez-Chapula et al., 2003). Also S6 domain mutations in the rKv1.4 K+ channel 
affect the characteristics of inhibition by quinidine (Zhang et al., 1998). Although not 
significant, the shift in the Hill slope for F304Y channels compared to mSlo3, suggests that 
the explanation for the apparent increased open channel block may not be as simple as an 
increased Po. There is a second explanation for the increase in the apparent affinities of the 
F304Y channels to these compounds. It has been shown that the equivalent residue to F304 
in the HERG K+ channel, Y652 in the S6 domain, affects the characteristics of inhibition by 
quinine and quinidine. Interestingly comparing our F304Y K0mV values to the WT HERG 
IC50 recorded at 0 mV found no difference for either quinine or quinidine. However mutation 
of Y652 to F (Y652F) in HERG channels, the inverse of our mutation in mSlo3, does not 
affect the potency of block but decreases the voltage dependence of inhibition by these 
compounds (Sănchez-Chapula et al., 2003) this is in contrast to our mSlo3 K0mV values 
which show a ≈ 4 fold reduction in potency compared to F304Y channels. Interestingly, 
chloroquine inhibition, (a related quinoline with two protonation sites) of HERG channels 
shows a ten fold reduction in potency at 0 mV dependent on the mutation of Y652F 
(Sánchez-Chapula et al., 2002). We see a similar change in our finding that F304Y currents 
were ≈ 10- fold more potently inhibited by quinine or quinidine compared to mSlo3 at +100 
mV. In HERG channels block is thought to be due to the aromatic groups of the quinoline π- 
stacking between the Y652 and F656 residues (Sănchez-Chapula et al., 2003). The mSlo3 
channel, however, has an isoleucine (I308) in the homologous position to F656 and thus π- 
stacking to this residue is not possible.  
 
Dependence on the F304 position in mSlo3 is probably increased for binding of quinine or 
quinidine. In rKv1.4 channels mutation of T529, equivalent to L303 in mSlo3, to a more 
hydrophobic residue results in slowing of deactivation and a negative shift in the voltage 
dependence of activation (Zhang et al., 1998). This effect is theorised to be due to the 
residue at 529, during the open state, faces away from the lumen and face the other TM α-
helices, thus increasing the hydrophobicity of the residue at 529 stabilises this condition 
(Zhang et al., 1998). These mutations in rKv1.4 channels also result in increased quinidine 
potency, which is proposed to be due to quinidine binding by intercalation of the 
hydrophobic moiety of the compound into the protein interior during the open state (Zhang 
et al., 1998). Mutation of the T529 residue to T529Y, however, abolished rKv1.4 current 
expression, this was proposed to be due to tyrosine being too bulky to intercalate into the 
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protein interior (Zhang et al., 1998). This is in contrast with our F304Y mutation; however 
our mutation is 1 residue further down the α-helix. Thus it is likely that this residue is 
already partly intercalated with the other TM α-helices and requires less energy to fully 
intercalate and stabilise the open state. These findings explain why we observed significant 
increases in F304Y zδ values for both quinine and quinidine, compared to mSlo3. zδ values, 
a measure of the fraction of the electric field that the blocker experiences, are also a measure 
of the voltage dependence of block. Thus the observed IC50 shift dependent on the F304Y 
mutation is probably due to a combination of the mutation revealing/increasing the binding 
site and increasing the Po. Although the quinine/quinidine binding site is a conserved 
architectural feature of voltage gated K+ channels, the potency of inhibition is dependent on 
the surrounding residues. Thus these compounds may be difficult to use in channel 
identification as cells rarely express a single type of K+ channel. This theory has been 
supported by a study performed on mSlo3 knock out (KO) spermatozoa where quinidine 
IC50 values were not significantly different for K+ currents in the WT and KO spermatozoan 
(Zeng et al., 2011). 
 
3.3.4 Ba2+ Inhibition 
Ba2+ is a voltage-dependent pore blocker of K+ channels, with well-known binding site 
mechanisms (Armstrong & Taylor, 1980; Neyton & Miller, 1988; Jiang & MacKinnon, 
2000). Extracellular Ba2+ binds to the pore without channel activation but is relieved by 
depolarisation (Armstrong & Taylor, 1980; Neyton & Miller, 1988). This can be seen in our 
finding that the τ+100mV values are increased in a linear concentration dependent relationship. 
This characteristic of Ba2+ block also explains why we see no significant difference in the 
IC50 values between F304Y and mSlo3 channels. Therefore the F304Y mutation effects are 
due to effects on gating mechanism rather than the selectivity of the channel pore. We used 
straight line fits plotted to individual oocyte values using the transformed Woodhull 
equation to calculate values of δ, and K0mV for Ba2+ for both the F304Y and WT mSlo3 
channel (Woodhull, 1973) (2.3.4.B). Ba2+ inhibition of mSlo3 was calculated to have a δ = 
0.66 ± 0.46, (n=5) with the F304Y mutation not significantly (P>0.05, Student’s t-test) 
changing this value (δ = 0.12 ± 0.05, n=5). However if we excluded one of the mSlo3 fits, 
which has a calculated δ of ≈ 2, which is impossible as δ > 1 for an extracellular positive ion 
would mean the Ba2+ ion would bind further through the pore than the intracellular side of 
the electric field. Rejecting this value, the δ value for Ba2+ ion in mSlo3 channels changes to 
a more realistic 0.20 ± 0.09 (n=4). These findings suggest that in both mSlo3 and F304Y 
channel block by extracellular Ba2+ is quite shallow in the electric field. Our finding that 
Ba2+ block is shallow is inconsistent with previous studies and the model of Ba2+ block in the 
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KcsA crystal structure which found the Ba2+ site is between the enhancement site (δ = 0.5) 
and internal lock-in site (δ = 0.7) (Armstrong & Taylor, 1980; Neyton & Miller, 1988; Jiang 
& MacKinnon, 2000). However our finding of δ ≈ 0.16 for Ba2+ suggests that Ba2+ is binding 
to the external lock-in site (δ = 0.15) in the pore. This is probably due to our experimental 
technique of using a ramp protocol rather than discrete voltage steps as Ba2+ blockade of K+ 
channels is reduced by depolarisation (Armstrong & Taylor, 1980). This is exemplified if we 
compare the IC50 values at +100 mV pulse from -80 mV to the +100 mV IC50 from the ramp 
traces there is a significant (P<0.05, paired-Student’s t-test) increase of nearly double the 
IC50 value that is independent of the F304Y mutation. Thus it is possible that in our ramp 
experiments the Ba2+ ion cannot reach the “classical” binding site due to the constant flow of 
ions through the pore and thus is only able to block the pore through binding to the external 
lock-in site. 
 
3.3.5 Pharmacological Profiling of mSlo3 currents 
In this study we attempt to elucidate the function of mSlo3 by defining the pharmacological 
profile and comparing with the described profile of the IKSper current. The pharmacological 
profile of our mSlo3 channels does not align perfectly with the reported profile of IKSper, the 
pH dependent current observed in spermatozoa (Navarro et al., 2007), though all compounds 
caused some degree of inhibition. Clofilium, a quaternary ammonium compound, was the 
most divergent from the observed IKSper inhibition as it not only showed a reduction in the 
level of inhibition but also a reversibility of the inhibition that was not observed with the 
IKSper current. This difference in binding properties may be due to the mechanism of clofilum 
block. It has been suggested that clofilium may cause channel block via an “activation trap” 
mechanism (Steidl & Yool, 2001). This has been suggested by the findings that Kv1.5 
channel recovery from block was slower at hyperpolarised potentials, however increased 
extracellular [K+] accelerated recovery (Steidl & Yool, 2001). This may explain why IKSper 
displayed an irreversible inhibition, as the membrane potential was only depolarised to -20 
mV (Navarro et al., 2007), whereas in our protocol the membrane potential was depolarised 
to +100 mV with each pulse, thus hastening the relief of inhibition. Clofilium has also been 
used to distinguish between K+ currents in spermatozoa, with apparent IKSper specificity 
(Zeng et al., 2011). Although currents were pulsed to +200 mV, most of the current at +100 
mV remained inhibited (Zeng et al., 2011). This difference is probably due to the timescale 
of application as we found that reversal of clofilium inhibition took 10 minutes or more 
whereas their study only washed for ≈ 3 minutes. The increase of the current during wash 
post mibefradil inhibition (5 μM) may be due to low mibefradil concentrations still present 
in the solutions. IKCa1 channel currents were decreased by concentrations of mibefradil 
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higher than 5 μM but showed increased current amplitudes with mibefradil concentrations 
≤2 μM (Yoo et al., 2008). The variation in IC50 values of mibefradil and clofilium may well 
be due to the difference in expression system as IKSper was recorded from intact Catsper KO 
spermatozoan, whereas, our system utilised expression in Xenopus oocytes. This system 
potentially lacks accessory proteins that may interact or modulate channel function; these 
may affect the Po and thus cause the observed differences in the apparent affinities. In 
addition IKSper is a current; thus it may be dependent on more than one type of channel. 
Lastly with use of patch clamp intracellular conditions can be controlled, whereas TEVC 
lacks this facility. Using cut open oocyte or macropatch techniques to record would allow 
control of these conditions. 
 
3.3.6 A potential role for mSlo3 channels in spermatozoa volume regulation. 
The pharmacological profile we have described also suggests additional roles for mSlo3 
channels in spermatozoa in volume regulation and motility. mSlo3 channels have been 
previously discounted for these roles due to reported TEA sensitivity (IC50 of 49 mM at +60 
mV), leading to Kv1.5 and TASK2 channels being the channels theorised to mediate volume 
regulation and motility (Yeung & Cooper, 2001; Barfield et al., 2005a, 2005b). However 
their study only used up to 10 mM TEA without seeing significant effects (Barfield et al., 
2005b). Our study shows that even at concentrations of 20 mM TEA is only able to inhibit 
20% of the current, therefore the exclusion of the mSlo3 channel as a potential component of 
volume regulation seems premature. The K+ current that regulates volume and motility is 
sensitive to as little as 200 μM quinine when applied for 5 minutes (Yeung & Cooper, 2001; 
Barfield et al., 2005b). Although this concentration is double the IC50 for the mSlo3 channel, 
the timescale of inhibition is similar to our findings. This study also shows that the mSlo3 
channels are sensitive to clofilium (50 μM); however clofilium application takes ≈10 
minutes to reach steady state (personal observation). The volume regulatory K+ current has 
also been shown to be to be sensitive to clofilium (10 μM) when applied for 75 minutes but 
not 5 minutes; this timescale correlates with our observations. The regulatory K+ current is 
also sensitive to 4-AP, a K+ channel inhibitor shown to have effects on spermatozoan 
volume regulation (Barfield et al., 2005a). However, this compound was found to enhance 
rather than inhibit IKSper, possibly in consequence of indirect alkalinisation of cells (Navarro 
et al., 2007), thus this compound was excluded from our study. Whilst our study cannot 
define mSlo3 as the sole channel mediating volume regulation and motility in the 
spermatozoan, we suggest that it has been prematurely discounted as a component of this K+ 
current. This theory is supported by recent studies on mSlo3 KO spermatozoa from 
transgenic mice that have shown reduced mobility, the second of the studies also showed 
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that mSlo3 KO spermatozoa were unable to maintain normal volume regulation under 
osmotic stress (Santi et al., 2010; Zeng et al., 2011).  
 
3.3.7 Challenges for the future  
Challenges for the future will be to examine: (a) if the effects of the F304Y mutation are 
concurrent for the other IKSper inhibitors; (b) utilising macro-patches of oocyte membranes 
the effects of the F304Y mutation can be investigated further; (c) the pharmacological 
characteristics of the compounds using oocyte macro-patches; (d) screening for a specific 
reversible pharmacological antagonist using a high throughput oocyte recording system; (e) 
if there are any accessory proteins that modify expression levels (partly addressed in Chapter 
4) with a view to gaining expression in mammalian systems. 
 
3.3.8 Chapter Summary 
This data reveals that the mutation of the conserved phenylalanine in the S6 domain (Slo3- 
F304/Slo1- F380) to tyrosine has conserved effects on Slo channel properties, namely a 
negative shift in voltage dependence of activation and increase the channel conductance. 
This mutation is in the conserved quinoline binding site and thus affects the potency of these 
compounds; however, extracellular pore blockers like Ba2+ are unaffected. Lastly the 
pharmacological properties we have found of mSlo3 match fairly well with the reported 
IKSper profile and suggest a role in volume regulation of spermatozoa.  
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Chapter IV: Self Regulation of mSlo3  
 
4.1 Chapter 4 Introduction 
 
4.1.1 Structural features of the Sloα family 
The Slo channel family is a family of ligand gated K+ channels that are homologous to Kv 
channels. These channels consist of six TM domains (like the voltage gated K+ (Kv) 
channels). Slo and Kv subunits share an archetypal topology consisting of six TM helices 
(S1-S6), these subunits are arranged as a tetramer to form a single ion conducting pore 
(Hille, 2001). However, unlike the Kv channel family, Slo1 and Slo3 channels possess an 
additional N-terminal helix (S0), creating an extracellular N-termini. More importantly, the 
Slo channel family possess large C-terminal cytoplamic domains. This domain is composed 
of a tandem arrangement of non-identical regulators of K+ conductance (RCK) domains, and 
it is these domains that confer ligand gating properties upon channel activation. Structural 
studies show that the RCK domain forms an octomeric gating ring in close proximity to the 
TM ion conduction pore, and potentially forming a cytoplasmic ion conduction pathway for 
ions moving through the channel (Yuan et al., 2010; Wu et al., 2010). The RCK domains are 
thought to undergo ligand dependent conformational change that alters the kinetics of the 
transition between the open/closed states of the channel activation gate. The Slo family of 
channels are exemplified by the Slo1 (also referred to as BKCa or MaxiK in the literature) 
have been extensively investigated due to the wide expression profile and high unitary 
conductance (260 pS) in symmetrical K+ (160 mM) (Butler et al., 1993). Previous studies 
have demonstrated that the Slo1 channel is gated by voltage (via the voltage sensor) and 
Ca2+ via the cytoplasmic RCK domains. RCK1 contains three residues (D362, D367 and 
M513) that are critical for high-affinity Ca2+ sensitivity. RCK2, however, has a “calcium 
bowl” formed from five consecutive negatively charged aspartates (D894–D898) (Yusifov et 
al., 2008). 
 
The mouse Slo3 (mSlo3) channel was first detected via an expressed sequence tag (EST), 
from the mouse promyelocytic WEHI-3 lymphocyte cell line, with homology to the C-
terminal “tail” of mSlo1. The cDNA’s from WEHI-3 were found to be either truncated or 
improperly spliced, suggesting that the full length channel was not expressed in this cell line. 
Using PCR analysis of a variety of tissues, the KCNU1 gene encoded channel (mSlo3) was 
found to be expressed solely in spermatozoa and testis. However, the study did admit that 
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the techniques used could not exclude restricted expression within tissues or low expression 
levels (Schreiber et al., 1998). Topology modeling from hydrophilicity profiling of the 
mSlo3 sequence indicated that like mSlo1 there are 11 hydrophobic domains, S0 through 
S10. The mSlo1 and mSlo3 sequences have highest similarity in the core domain containing 
the six TM domains and RCK1. The mSlo1 core, S0 through to S8, shares 56% sequence 
identity to the mSlo3 core region. The orthologs mSlo1 and dSlo1 share 62% identity 
through this core region. The S9 and S10 regions are more divergent and have only 39% 
identity between mSlo3 and mSlo1. The Slo3 channel, when expressed in Xenopus oocytes, 
was found to be modulated by internal pH, with channel activation at low [H+], and voltage 
rather than by Ca2+ and voltage like the Slo1 channel and the channel had a lower unitary 
conductance (106 pS) in symmetrical K+ (160 mM) (Schreiber et al., 1998). 
 
Interestingly, despite the complexity of the RCK domain structure and ligand interaction 
properties, this domain is conserved in prokaryotic K+ channels. These channels are 
exemplified by the MthK Ca2+-gated K+ channel from the bacteria Methanobacterium 
thermoautotrophicum. However, rather than a tandem RCK domain, these channels possess 
only a single RCK subunit (RCK1) that is tethered to the TM domains. These channels 
compensate for this loss by expression of an identical, separate RCK subunit (RCK2). The 
soluble RCK2 domain is encoded within the MthK gene itself, due to the presence of an 
internal start codon (M107) and assembles with RCK1 to form the octameric gating ring 
(Jiang et al., 2002b). The binding of Ca2+ to the RCK domains alters the conformation of the 
gating ring, thereby opening the gate (Li et al., 2007). This hypothesis has been proved 
correct by the two crystal structures of the isolated RCK domains which show a tetramer 
with each subunit containing two RCK domains. In these structures RCK1 acts like the inner 
RCK domain and RCK2 contributing the role of the soluble MthK RCK domain (Yuan et 
al., 2010; Wu et al., 2010). The MthK octomer, however, differs in the response to 
decreased pH in comparison with the Slo1 octamer. Below a pH of 7.5, MthK becomes 
insensitive to Ca2+ activation, because the RCK octamer tends to disassemble as it is 
structurally unstable at this pH. Alkaline pH (>7.5) increases the open probability (Po) for a 
given [Ca2+] and can activate the channel in the absence of Ca2+ (Lingle, 2007). This 
activation in response to pH (>7.5) is similar to the Slo3 channel characteristics (Schreiber et 
al., 1998). However, Slo1 is activated by low intracellular pH due to D367, one of the three 
residues that forms the RCK1 Ca2+ binding site, interaction with H365 and H394 (Yusifov et 
al., 2008; Hou et al., 2008). Interestingly mutation of both these histidine residues affected 
the Ca2+ sensitivity, suggesting that they also contribute to the RCK1 Ca2+ binding site (Hou 
et al., 2008).  
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4.1.2 Regulation of mSlo3 channel expression by accessory subunits  
Slo1 channels in vivo are not only formed solely from Slo1 α-subunits; there are four known 
Sloβ subunits, which have a range of effects on the functional properties of the channel. Sloβ 
have a conserved structure, consisting of two TM helices linked by a large extracellular 
loop. Sloβ subunits are thought to physically interact through the S0 and S1/2 domains of the 
Slo1 α-subunit, which is the region that mSlo1 and mSlo3 have the highest homology (Wu et 
al., 2009).  
 
A previous study of the interactions between mSlo3 and Sloβ subunits found that all of the 
Sloβ subunits appear to be able to interact with mSlo3. Sloβ2 was found to functionally 
interact with mSlo3 and displayed trypsin-sensitive inactivation (Yang et al., 2009). 
However of the four Sloβ subunits, only Sloβ4 has a gain of function effect on mSlo3 
currents. Sloβ4 injection with mSlo3 α-subunit results in an eight-fold increase in the 
conductance recorded from macropatches and increased surface expression. Expression of 
mSlo3 with Sloβ4 did not modify the voltage dependence, single channel conductance or the 
Po of currents. This suggests that Sloβ4 only affects expression level of the channels rather 
than the electrophysiological properties. Interestingly, for such an increase in expression, 
Sloβ4 KO mice had no change in the reproductive capacity, as quantified by litter size (Yang 
et al., 2009). This evidence suggests that there are other regulatory subunits that effect 
mSlo3 expression in vivo.  
 
4.1.3 Chapter aims 
4.1.3.1 To determine if neuronal EST’s encode an isoform of mSlo3 
Expression of mSlo3 α-subunit is restricted to the testis and spermatozoa, unlike the mSlo1 
α-subunit (Schreiber et al., 1998). However a range of expressed sequence tags (EST’s) have 
been identified in a range of tissues, particularly neuronal tissue, that correspond to the 
mSlo3 sequence. We aim to use RACE PCR (2.1.3) to examine if these EST’s encode a 
novel splice variant of the α-subunit of mSlo3. If the RACE PCR of the EST’s finds a 
sequence with an ORF, the amino acid sequence will be determined and compared to the 
known mSlo3 sequence. Secondly if the variant contains the mSlo3 epitope recognised by 
the NeuroMab mouse anti-mSlo3 antibody we will be able to probe an assortment of tissue 
homogenates to see if this unique isoform is expressed outside the restricted profile for 
mSlo3. 
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4.1.3.2 What architectural features of mSlo3 are also present in the isoform 
The C-terminal domain of the α-subunit of mSlo3 is believed to contain two RCK domains, 
homologous to the mSlo1α structure. Thus as most of the EST sequences appear to be 
analogous to large parts of the mSlo3 C-terminal domain, we aim to align the sequences 
with the previously reported RCK sequences (Yusifov et al., 2008) and determine the 
secondary structure to establish if any of the architectural features of mSlo1 are preserved in 
the mSlo3/isoform sequence. 
 
4.1.3.3 What effect does the isoform have on Sloα-subunit expression 
Alpha subunits of the mSlo1 channel have been previously shown to hetromultimerise with 
other α-subunits (Joiner et al., 1998). However, mSlo1/Slo3 hetromultimeric currents have 
been impossible to distinguish from mSlo1 currents primarily due to the difficulty in mslo3 
expression and the size of the mSlo1 currents. Thus we aim to co-inject our isoform in 
oocytes to see if we can observe any effects on mSlo1 and mSlo3 mediated currents. 
Secondly we aim to see if the isoform has any effect on the previously reported increase of 
mSlo3 currents dependent on the co-injection of the hSloβ4 (Yang et al., 2009). 
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4.2 Chapter 4 Results 
 
4.2.1 Sequence alignment of EST’s 
Mouse EST’s with homology to the mSlo3 cDNA sequence were identified using the 
UniGene database (Pubmed). Of most interest were the EST’s that were expressed outside 
the testis/spermatozoa, in a variety of neuronal tissues. Three were expressed in the adult 
male hippocampus (AK083174, BB428821 and BB653287), one from the subfornical organ 
and postrema (BQ175543), one in the upper head (CV562866) and one from the lateral wall 
of lateral ventricle (CX213584). EST’s were aligned to the mSlo3 cDNA sequence using 
ClustalW2 in figure 4.1. EST sequences that were homologous to the mSlo3 sequence were 
highlighted in grey to emphasise the high level of homology, bar a few SNP’s. The EST 
sequences were divergent from the mSlo3 sequence at the 5’ end; however there was 
internal consistency between the four EST sequences over this region. 
 
4.2.2 Probing for neuronal isoforms of mSlo3 
RACE PCR is a technique that allows cloning of full length RNA transcripts found within a 
cell from short sequences such as EST’s. Primers were designed using NCBI primer blast 
design software (Rozen & Skaletsky, 2000) utilising the mSlo3 WT related EST CV562866 
(CV) as a template, this EST was chosen as it had a divergent 5’ and an unknown 3’ 
sequence. Marathon RACE PCR was performed using mouse brain Marathon-readyTM 
cDNA (Clontech) to isolate any potential neuronal isoforms. First round PCR was performed 
under conditions described in 2.1.3, with CVstart/CVend run against Adaptor Primer (AP) 1. 
The result of the first round of Marathon RACE PCR, of the two CV specific primers against 
the outer adaptor primer (AP1) can be seen in figure 4.2.A. When visualised on ethidium 
bromide agarose gels the first round PCR products displayed smears with faint bands at 
1000-1500 bp. The products of these reactions were used as a template for second round 
PCR, the EST specific internal CVF*/CVR* against AP2, targeted to the inner adapter. 
Products were visualised, figure 4.2.B, forward EST internal primers produced high 
molecular weight bands of ≈1.5 kb. The reverse EST internal primer reactions produced only 
low molecular weight bands, between 200-600 bp. Second round products were then cleaned 
and then blunt end ligated, 2.1.4 before sequencing. 
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mSlo3 G A G A A C A G C C T A G T T T G A T C A C C A T T A C A A C C A A C A G A C C A A C G A C A A A C G A C A C A 2043
AK083174 - - - - A G T A A A C A T C C A C G G A G C A G A A G C C A G A C G T G T T T T C A A C A G A G A G C A G G T T 52
BB428821 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
BB653287 - - - - A G T A A A C A T C C A C G G A G C A G A A G C C A G A C G T G T T T T C A A C A G A G A G C A G G T T 52
BQ17543 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
CV562866 - - - - - - - - - - - - - - - - C G G A G C A G A A G C C A G A C G T G T T T T C A A C A G A G A G C A G G T T 40
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - G C C A G A C G T G T T T T C A A C A G A G A G C - - - - - 25
mSlo3 G T G G A T G A T A C C G A C A T G C T G G A C A G C A G T G G C A T G T T T C A C T G G T G C A G A G C A A T 2099
AK083174 T T T A A G A A A A G C T G A G A - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 68
BB428821 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
BB653287 T T T A A G A A A A G C T G A G A - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 68
BQ17543 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
CV562866 T T T A A G A A A A G C T G A G A G G A A T G G A A T G C C C A G - A T G T T T A A A A A C T G G A C T T T G A 95
CX213584 - - - - - - - - - - - - - - - - A G G A A T G G A A T G C C C A G C A T G T T T A A A A A C T G G A C T T T G A 65
mSlo3 G C C C T T G G A C A A G G T G G T T C T G A A A C G A A G T G A G A A G G C A A A A C A C G A G T T T C A G A 2155
AK083174 - - - - - - - - - - - - - - - - - - - - - G A A A C G A A G T G A G A A G G C A A A A C A C G A G T T T C A G A 103
BB428821 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
BB653287 - - - - - - - - - - - - - - - - - - - - - G A A A C G A A G T G A G A A G G C A A A A C A C G A G T T T C A G A 103
BQ17543 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
CV562866 A C T T G G T T C T T C T T G T A C A A A G A A A C G A A G T G A G A A G G C A A A A C A C G A G T T T C A G A 151
CX213584 A C T T G G T T C T T C T T G T A C A A A G A A A C T A A G T G A G A A G G C A A A A C A C G A G T T T C A G A 121
mSlo3 A C C A C A T T G T A G T A T G C G T G T T T G G A G A T G C C C A A T G T A C C C T G G T G G G G C T T C G G 2211
AK083174 A C C A C A T T G T T G T A T G C G T G T T T G G A G A T G C C C A A T G T A C C C T G G T G G G G C T T C G G 159
BB428821 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
BB653287 A C C A C A T T G T T G T A T G C G T G T T T G G A G A T G C C C A A T G T A C C C T G G T G G G G C T T C G G 159
BQ17543 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
CV562866 A C C A C A T T G T A G T A T G C G T G T T T G G A G A T G C C C A A T G T A C C C T G G T G G G G C T T C G G 207
CX213584 A C C A C A T T G T A G T A T G C G T G T T T G G A - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 146
mSlo3 A A T T T C G T G A T G C C C C T G A G A G C C A G C A A C T A C A C C C G G C A G G A G C T G A A G G A C A T 2267
AK083174 A A T T T C G T G A T G C C C C T G A G A G C C A G C A A C T A C A C C C G G C A G G A G C T G A A G G A C A T 215
BB428821 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
BB653287 A A T T T C G T G A T G C C C C T G A G A G C C A G C A A C T A C A C C C G G C A G G A G C T G A A G G A C A T 215
BQ17543 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
CV562866 A A T T T C G T G A T G C C C C T G A G A G C C A G C A A C T A C A C C C G G C A G G A G C T G A A G G A C A T 263
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
mSlo3 T G T T T T T A T T G G G T C T C T G G A G T A C T T C C A G A G A G A A T G G C G A T T T C T C C G A A A C T 2323
AK083174 T G T T T T T A T T G G G T C T C T G G A G T A C T T C C A G A G A G A A T G G C G A T T T C T C C G A A A C T 271
BB428821 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
BB653287 T G T T T T T A T T G G G T C T C T G G A G T A C T T C C A G A G A G A A T G G C G A T T T C T C C G A A A C T 271
BQ17543 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
CV562866 T G T T T T T A T T G G G T C T C T G G A G T A C T T C C A G A G A G A A T G G C G A T T T C T C C G A A A C T 319
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
mSlo3 T T C C C A A G A T A C A C A T T A T G C C T G G A T C T G C A C T C T A C A T G G G A G A T C T G A T T G C A 2379
AK083174 T T C C C A A G A T A C A C A T T A T G C C T G G A T C T G C A C T C T A C A T G G G A G A T C T G A T T G C A 327
BB428821 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
BB653287 T T C C C A A G A T A C A C A T T A T G C C T G G A T C T G C A C T C T A C A T G G G A G A T C T G A T T G C A 327
BQ17543 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
CV562866 T T C C C A A G A T A C A C A T T A T G C C T G G A T C T G C A C T C T A C A T G G G A G A T C T G A T T G C A 375
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
mSlo3 G T C A A T G T A G A G C A G T G C T C T A T G T G C G T C A T C T T A G C C A C A C C C T A C A A G G C A C T 2435
AK083174 G T C A A T G T A G A G C A G T G C T C T A T G T G C G T C A T C T T A G C C A C A C C C T A C A A G G C A C T 383
BB428821 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
BB653287 G T C A A T G T A G A G C A G T G C T C T A T G T G C G T C A T C T T A G C C A C A C C C T A C A A G G C A C T 383
BQ17543 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
CV562866 G T C A A T G T A G A G C A G T G C T C T A T G T G C G T C A T C T T A G C C A C A C C C T A C A A G G C A C T 431
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
mSlo3 G A G C A G C C A G A T T C T G G T G G A C A C A G A G G C C A T C A T G G C C A C C C T C A A C A T C C A G T 2491
AK083174 G A G C A G C C A G A T T C T G G T G G A C A C A G A G G C C A T C A T G G C C A C C C T C A A C A T C C A G T 439
BB428821 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
BB653287 G A G C A G C C A G A T T C T G G T G G A C A C A G A G G C C A T C A T G G C C A C C C T C A A C A T C C A G T 439
BQ17543 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
CV562866 G A G C A G C C A G A T T C T G G T G G A C A C A G A G G C C A T C A T G G C C A C C C T C A A C A T C C A G T 487
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  
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mSlo3 C C C T G C G G A T C A C C A G T C C T A C T C C A G G G T C T T C A A A G T C A G A A G T A A A G C C A T C A 2547
AK083174 C C C T G C G G A T C A C C A G T C C T A C T C C A G G G T C T T C A A A G T C A G A A G T A A A G C C A T C A 495
BB428821 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
BB653287 C C C T G C G G A T C A C C A G T C C T A C T C C A G G G T C T T C A A A G T C A G A A G T A A A G C C A T C A 495
BQ17543 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
CV562866 C C C T G C G G A T C A C C A G T C C T A C T C C A G G G T C T T C A A A G T C A G A A G T A A A G C C A T C A 543
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
mSlo3 T C T G C C T T T G A T A G T A A A G A A A G G A A G C A A A G A T A C A A A C A G A T C C C C A T T C T C A C 2603
AK083174 T C T G C C T T T G A T A G T A A A G A A A G G A A G C A A A G A T A C A A A C A G A T C C C C A T T C T C A C 551
BB428821 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
BB653287 T C T G C C T T T G A T A G T A A A G A A A G G A A G C A A A G A T A C A A A C A G A T C C C C A T T C T C A C 551
BQ17543 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
CV562866 T C T G C C T T T G A T A G T A A A G A A A G G A A G C A A A G A T A C A A A C A G A T C C C C A T T C T C A C 599
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
mSlo3 T G A A C T G A A G A A T C C C T C C A A C A T C C A C T T T A T T G A G C A G A T G G G C G G A C T G G A T G 2659
AK083174 T G A A C T G A A G A A T C C C T C C A A C A T C C A C T T T A T T G A G C A G A T G G G C G G A C T G G A T G 607
BB428821 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
BB653287 T G A A C T G A A G A A T C C C T C C A A C A T C C A C T T T A T T G A G C A G A T G G G C G G A C T G G A T G 607
BQ17543 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
CV562866 T G A A C T G A A G A A T C C C T C C A A C A T C C A C T T T A T T G A G C A G A T G G G C G G A C T G G A T G 655
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
mSlo3 G A A T G C T C A A A G G G A C T A G C T T G C A T C T C A G C A C T T C T T T C T C C A C C G G T G C T G T C 2715
AK083174 G A A T G C T C A A A G G G A C T A G C T T G C A T C T C A G C A C T T C T T T C T C C A C C G G T G C T G T C 663
BB428821 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
BB653287 G A A T G C T C A A A G G - A C T A G C T T G C A T C T C A G C A C T T C T T T C T C C A C C G G T G C T G T C 662
BQ17543 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
CV562866 G A A T G C T C A A A G G G A C T A G C T T G C A T C T C A G C A C T T C T T T C T - - - - - - - - - - - - - - 697
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
mSlo3 T T T T C A G A C A C C T T C T T G G A T T C T C T C C T G G C C A C G T C C T T C T A C A A T T A C C A T G T 2771
AK083174 T T T T C A G A C A C C T T C T T G G A T T C T C T C C T G G C C A C G T C C T T C T A C A A T T A C C A T G T 719
BB428821 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
BB653287 T T T T - A - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 667
BQ17543 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0
CV562866 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
mSlo3 C G T G G A A T T A C T T C A G A T G C T A G T G A C T G G A G G C A T A A G C T C T G A G A T G G A A C A C T 2827
AK083174 C G T G G A A T T A C T T C A G A T G C T A G T G A C T G G A G G C A T A A G C T C T G A G A T G G A A C A C T 775
BB428821 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - T T G A G A T G G A A C A C T 15
BB653287 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
BQ17543 - - - - - - - - - - - - - - - - - - - - - A G T G A C T G G A G - C A T A A G C T C T G A G A T - G A A C A C T 33
CV562866 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
mSlo3 A T T T G G T T A A G G A G A A G C C C T A T A A G A C A A C T G A C G A C T A T G A G G C A A T C A A G T C T 2883
AK083174 A T T T G G T T A A G G A G A A G C C C T A T A A G A C A A C T G A C G A C T A T G A G G C A A T C A A G T C T 831
BB428821 A T T T G G T - A A G G A G A A G C C C T A T A A G A C A A C T G A C G A C T A T G A G G C A A T C A A G T C T 70
BB653287 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
BQ17543 A T T - - G T T A A G G A G A A G C C C T A T A A G A C A A C T G A C G A C T A T G A G G C A A T C A A G T C T 70
CV562866 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
mSlo3 G G G A G G A C G C G G T G T A A G C T G G G A C T C C T C T C T T T A G A C C A A A C C G T T C T A T C A G G 2939
AK083174 G G G A G G A C G C G G T G T A A G C T G G G A C T C C T C T C T T T A G A C C A A A C C G T T C T A T C A G G 887
BB428821 G G G A G N A C G C G G T G T A A G C T G G G A C T C C T C T C T T - A G A C C A A A C C G T T C T A T C A G G 126
BB653287 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
BQ17543 G G G A G G A C G C G G T G T A A G C T G G G A C T C C T C T C T T T A G A C C A A A C C G T T C T A T C A G G 126
CV562866 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
mSlo3 C A T T A A T C C A A G A A A A A C C T T T G G A C A G C T G T T C T G T G G C T C A T T G G A T A A T T T C G 2995
AK083174 C A T T A A T C C A A G A A A A A C C T T T G G A C A G C T G T T C T G T G G C T C A T T G G A T A A T T T C G 943
BB428821 C A T T A A T C C A A G A A A A A C C T T T G G A C A G C T G T T C T G T G G C T C A T T G G A T A A T T T C G 182
BB653287 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
BQ17543 C A T T A A T C C A A G A A A A A C C T T T G G A C A G C T G T T C T G T G G C T C A T T G G A T A A T T T C G 182
CV562866 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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mSlo3 G G A T C C T A T G T G T C G G C T T A T A C C G T A T G A T T G A T G A A G A G G A A C C C A G C C A A G A A 3051
AK083174 G G A T C C T A T G T G T C G G C T T A T A C C G T A T G A T T G A T G A A G A G G A A C C C A G C C A A G A A 999
BB428821 G G A T C C T A T G T G T C G G C T T A T A C C G T A T G A T T G A T G A A G A G G A A C C C A G C C A A G A A 238
BB653287 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
BQ17543 G G A T C C T A T G T G T C G G C T T A T A C C G T A T G A T T G A T G A A G A G G A A C C C A G C C A A G A A 238
CV562866 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
mSlo3 C A C A A A A G G T T T G T G A T C A C C A G G C C A T C C A A T G A G T G C C A C C T G C T G C C C T C A G A 3107
AK083174 C A C A A A A G G T T T G T G A T C A C C A G G C C A T C C A A T G A G T G C C A C C T G C T G C C C T C A G A 1055
BB428821 C A C A A A A G G T T T G T G A T C A C C A G G C C A T C C A A T G A G T G C C A C C T G C T G C C C T C A G A 294
BB653287 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
BQ17543 C A C A A A A G G T T T G T G A T C A C C A G G C C A T C C A A T G A G T G C C A C C T G C T G C C C T C A G A 294
CV562866 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
mSlo3 T C T C G T G T T T T G T G C C A T C C C T T T C A A C A C C A C C T G T G G C A A A T C A G A C A G C A G T C 3163
AK083174 T C T C G T G T T T T G T G C C A T C C C T T T C A A C A C C A C C T G T G G C A A A T C A G A C A G C A G T C 1111
BB428821 T C T C G T G T T T T G T G C C A T C C C T T T C A A C A C C A C C T G T G G C A A A T C A G A C A G C A G T C 350
BB653287 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
BQ17543 T C T C G T G T T T T G T G C C A T C C C T T T C A A C A C C A C C T G T G G C A A A T C A G A C A G C A G T C 350
CV562866 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
mSlo3 C T T C A A T T C A G G C T C A A A A C A A C T C T A C A A A C G C G A C G A C G C C A T T G G C C C A G G G G 3219
AK083174 C T T C A A T T C A G G C T C A A A A C A A C T C T A C A A A C G C G A C G A C G C C A T T G G C C C A G G G G 1167
BB428821 C T T C A A T T C A G G C T C A A A A C A A C T C T A C A A A C G C G A C G A C G C C A T T G G C C C A G G G G 406
BB653287 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
BQ17543 C T T C A A T T C A G G C T C A A A A C A A C T C T A C A A A C G C G A C G A C G C C A T T G G C C C A G G G G 406
CV562866 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
mSlo3 T C G A A T T T C T T C G A T T C G C A C C A T G C C G A C G A G T C C C A C G A T C T T T A C C C A G T C G A 3275
AK083174 T C G A A T T T C T T C G A T T C G C A C C A T G C C G A C G A G T C C C A C G A T C T T T A C C C A G T C G A 1223
BB428821 T C G A A T T T C T T C G A T T C G C A C C A T G C C G A C G A G T C C C A C G A T C T T T A C C C A G T C G A 462
BB653287 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
BQ17543 T C G A A T T T C T T C G A T T C G C A C C A T G C C G A C G A G T C C C A C G A T C T T T A C C C A G T C G A 462
CV562866 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
mSlo3 C G A C A C G G G A G A G A G G T G G T C T C A G C A C C A C C A C T C C C G A G T C T A T C C T T T G G A C A 3331
AK083174 C G A C A C G G G A G A G A G G T G G T C T C A G C A C C A C C A C T C C C G A G T C T A T C C T T T G G A C A 1279
BB428821 C G A C A C G G G A G A G A G G T G G T C T C A G C A C C A C C A C T C C C G A G T C T A T C C T T T G G A C A 518
BB653287 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
BQ17543 C G A C A C G G G A G A G A G G T G G T C T C A G C A C C A C C A C T C C C G A G T C T A T C C T T T G G A C A 518
CV562866 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
mSlo3 C G T T A G A T G C C A G T G A T A T T G T T C A A G A A A A A T A A A A A C A G A A A C A T G C T A T T T T T 3387
AK083174 C G T T A G A T G C C A G T G A T A T T G T T C A A G A A A A A T A A A A A C A G A A A C A T G C T A T T T T T 1335
BB428821 C G T T A G A T G C C A G T G A T A T T G T T C A A G A A A A A T A A A A A C A G A A A C A T G C T A T T T T T 574
BB653287 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
BQ17543 C G T T A G A T G C C A G T G A T A T T G T T C A A G A A A A A T A A A A A C A G A A A C A T G C T A T T T T T 574
CV562866 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
mSlo3 G T G C C A G T T G C T T A G T G G T C A G C G A G T T G G C A A G C C C A C G G T G C T G T G G A A G G G A C 3443
AK083174 G T G C C A G T T G C T T A G T G G T C A G C G A G T T G G C A A G C C C A C G G T G C T G T G G A A G G G A C 1391
BB428821 G T G C C A G T T G C T T A G T G G T C A G C G A G T T G G C A A G C C C A C G G T G C T G T G G A A G G G A C 630
BB653287 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
BQ17543 G T G C C A G T T G C T T A G T G G T C A G C G A G T T G G C A A G C C C A C G G T G C T G T G G A A G G G A C 630
CV562866 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
mSlo3 C A T C T T A T C C C A G T G A A T C T G G T G T A A T G A A T A A A G A T G C C C A T G A T A A A T G G T A A 3499
AK083174 C A T C T T A T C C C A G T G A A T C T G G T G T A A T G A A T A A A G A T G C C C A T G A T A A A T G G T - - 1445
BB428821 C A T C T T A T C C C A G T G A A T C T G G T G T A A T G A A T A A A G A T G C C C A T G A T A A A T G G T - - 684
BB653287 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
BQ17543 C A T C T T A T C C C A G T G A A T C T G G T G T A A T G A A T A A A G A T G C C C A T G A T A A A T G G T A A 686
CV562866 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
CX213584 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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mSlo3 A A A A A A A A A A A A A A A A 3515
AK083174 - - - - - - - - - - - - - - - -
BB428821 - - - - - - - - - - - - - - - -
BB653287 - - - - - - - - - - - - - - - -
BQ17543 A A A A A A A A A A A A A A A A 702
CV562866 - - - - - - - - - - - - - - - -
CX213584 - - - - - - - - - - - - - - - -
 
Figure 4.1 Alignment of EST’s with mSlo3. Non-spermatozoa EST’s were aligned to the 
mSlo3 cDNA sequence using ClustalW2. Conserved nucleotides of the EST sequences to 
the mSlo3 sequence are highlighted in grey. A high level of sequence identity was observed 
except around the 5’ end of the EST sequences where there was internal consistency but 
divergence from the mSlo3 sequence.  
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Figure 4.2 Visualisation of Marathon RACE PCR products. PCR products were 
separated on ethidium bromide agarose gels. The result of the first round of Marathon RACE 
PCR, of the two CV specific primers against the outer adaptor primer (AP1) can be seen in 
(A). The products displayed smears which show faint bands at 1000-1500 bp. The second 
round of Marathon RACE PCR (B) using the EST specific internal primers against the inner 
AP2 primer. As can be seen in (B) forward EST internal primers gave high molecular weight 
bands of ≈1.5 kb. The reverse EST internal primer reactions produced only low molecular 
weight bands, between 200-600 bp.  
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4.2.3 Expression of CV562866  
cDNA sequences from the Marathon RACE PCR reactions were sequenced and a full length 
CV562866 sequence constructed. This sequence was translated and found to contain an ORF 
starting at nucleotide 217 (Met740). The product of the ORF was aligned with the mSlo3 
protein sequence using SWISS MODEL, figure 4.3 (Peitsch, 1995; Arnold et al., 2006; 
Kiefer et al., 2009). Alignment of the ORF protein (CV) with the mSlo3 sequence 
demonstrated a hundred percent sequence identity to the C-terminus of the mSlo3 sequence. 
As the CV sequence contains the epitope sequence recognised by the NeuroMab Anti-Slo3 
antibody, we were able to investigate if ESTs are expressed at the protein level. Western 
blotting (4.4.A) was performed using CV562866 and full length mSlo3 (α3) expressed in 
HEK293 cells as control. Tissues were retrieved from adult Wistar rats, homogenised and 
then lysed and centrifuged to isolate the membrane fraction. Proteins from the tissue 
samples, membrane and supernatant, were separated on a 10% SDS gel (2.2.5) and later 
transferred to a nitrocellulose membrane. The membrane was probed with 1:1000 mouse 
anti-mSlo3 antibodies and visualised with 1:1000 anti-mouse-HRP secondary antibody. 
Transient transfection of HEK293 cells with pYX-Asc-CV562866 showed a band at 
between 36-55 kDa which was not present in the mSlo3 or control HEK cells and was 
consistent with the predicted molecular weight (Mw) of 47 kDa for CV. CV was also 
detected in blood, cytoplasmic fractions of liver and kidney and both the membrane and 
supernatant fractions from testis. Interestingly a high molecular weight band, of ≈100 kDa, 
was also observed in these tissues, the Mw of which is approximate to the lower band found 
in the mSlo3 control transfected cells. Localisation within the brain was defined using 
immunohistochemical techniques, brain slices were probed with 1:1000 anti-mSlo3 
antibodies and visualised with Alexa 555. However when looking at the sample section, 
4.4.B, a 60x image from the sub dentate gyrus region, shows widespread non-specific 
binding. 
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mSlo3 F Q N H I V V C V F G D A Q C T L V G L R N F V M P L R A S N Y T R Q E L K D I V F I G S L E Y F Q 766
CV562866 M P L R A S N Y T R Q E L K D I V F I G S L E Y F Q 26
mSlo3 R E W R F L R N F P K I H I M P G S A L Y M G D L I A V N V E Q C S M C V I L A T P Y K A L S S Q I 816
CV562866 R E W R F L R N F P K I H I M P G S A L Y M G D L I A V N V E Q C S M C V I L A T P Y K A L S S Q I 76
mSlo3 L V D T E A I M A T L N I Q S L R I T S P T P G S S K S E V K P S S A F D S K E R K Q R Y K Q I P I 866
CV562866 L V D T E A I M A T L N I Q S L R I T S P T P G S S K S E V K P S S A F D S K E R K Q R Y K Q I P I 126
mSlo3 L T E L K N P S N I H F I E Q M G G L D G M L K G T S L H L S T S F S T G A V F S D T F L D S L L A 916
CV562866 L T E L K N P S N I H F I E Q M G G L D G M L K G T S L H L S T S F S T G A V F S D T F L D S L L A 176
mSlo3 T S F Y N Y H V V E L L Q M L V T G G I S S E M E H Y L V K E K P Y K T T D D Y E A I K S G R T R C 966
CV562866 T S F Y N Y H V V E L L Q M L V T G G I S S E M E H Y L V K E K P Y K T T D D Y E A I K S G R T R C 226
mSlo3 K L G L L S L D Q T V L S G I N P R K T F G Q L F C G S L D N F G I L C V G L Y R M I D E E E P S Q 1016
CV562866 K L G L L S L D Q T V L S G I N P R K T F G Q L F C G S L D N F G I L C V G L Y R M I D E E E P S Q 276
mSlo3 E H K R F V I T R P S N E C H L L P S D L V F C A I P F N T T C G K S D S S P S I Q A Q N N S T N A 1066
CV562866 E H K R F V I T R P S N E C H L L P S D L V F C A I P F N T T C G K S D S S P S I Q A Q N N S T N A 326
mSlo3 T T P L A Q G S N F F D S H H A D E S H D L Y P V D D T G E R W S Q H H H S R V Y P L D T L D A S D 1116
CV562866 T T P L A Q G S N F F D S H H A D E S H D L Y P V D D T G E R W F Q H H H S R V Y P L D T L D A S D 376
mSlo3 I V Q E K 1166
CV562866 I V Q E K 426
 
Figure 4.3 Alignment of CV562866 ORF with mSlo3 sequence. CV562866, the EST used for primer design, when sequenced was found to have an ORF 
starting at nucleotide 217 (Met740). This ORF was translated and aligned with the mSlo3 protein sequence using SWISS MODEL (Peitsch, 1995; Arnold et 
al., 2006; Kiefer et al., 2009). The sequence was found to have a hundred percent sequence identity to the C-Terminus of mSlo3 sequence.    
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Figure 4.4 Physiological Expression of CV562866. As CV contains the epitope for the 
NeuroMab Anti-Slo3 antibody we were able to determine if ESTs are expressed at the 
protein level. Western blotting (A) was performed using CV and full length mSlo3 (α3) 
expressed in HEK293 cells as control. Tissues were retrieved from adult Wistar rats, 
homogenised and then lysed to isolate the membrane fraction. Membrane was probed with 
1:1000 mouse anti-mSlo3 antibodies and visualised with 1:1000 anti-mouse-HRP secondary 
antibody. Tissue staining of brain tissue (B), showed widespread non-specfic binding when 
probed with 1:1000 anti-mSlo3 antibody and visualised with Alexa 555. 
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4.2.4 Structural prediction of Slo3 RCK domains 
As the EST sequence contains the final 426 amino acids of the C-terminus of mSlo3, we 
determined if this region contains any RCK domains. Protein sequence alignment (Figure 
4.5) of the previously described two RCK domains of mSlo1 (Yusifov et al., 2008) and the 
homologus MthK RCK domain to the homologous regions of mSlo3 was performed. The 
RCK1 homologous region (4.5.A) showed a high sequence identity to the mSlo1 RCK1 and 
the MthK RCK domain. Whereas a lower sequence identity was observed when the 
homologous RCK2 region of mSlo3 was aligned to the mSlo1 RCK2 and the MthK RCK 
domain (4.5.B). Using the DomPred Protein Domain Prediction Server the secondary 
structures of the homologous regions to the mSlo1 RCK1 and RCK2 were determined. The 
homologous mSlo3 residues to the mSlo1 RCK βαβαβ Rossmann-fold structure (Lingle, 
2007) were underlined and if corresponding to the structural elements annotated above the 
predicted structure (Figure 4.6). The secondary structures of the first RCK homologue of 
mSlo3 WT are shown with the known mSlo1 secondary structures annotated show a 
reasonably high level of parity (4.6.A). However, the second RCK domain subsequent to the 
αd helix, the region homologous to the “Calcium bowl” of mSlo1, the predicted secondary 
structure of the mSlo3 RCK2 differs from the homologous mSlo1 βαβαβ Rossmann-fold 
structure (4.6.B).  
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A 
MthK K S R H V V I C G - - W S E S T L E C L R E L R G S E 140
Slo1 G R K H I V V C G H I T L E S V S N F L K D F L H K D 367
Slo3 G K K F I V V C G N I T V D S V T A F L R N F L H W K 357
MthK - - - - - - - - V F V L A E D E N V R K K V L R - - - 156
Slo1 R D D V N V E I V F L H N I S P N L E L E A L F K R H 394
Slo3 S G E I N I E I V F L G E T L P C L E L E T L L K C H 384
MthK - S G A N F V H G D P T R V S D L E K A N V R G A R A 182
Slo1 F T Q V E F Y Q G S V L N P H D L A R V K I E S A D A 421
Slo3 T S C T N F V C G T A L K F E D L K R V A V E N S E A 411
MthK V I V D L E - - - - - - - - S D S E T I H C I L G I R 201
Slo1 C L I L A N K Y C A D P D A E D A S N I M R V I S I K 448
Slo3 C L I L A N H F C S D L H D E D N S N I M R V L S I K 438
MthK K I D E S V R I I A E A E R Y E N - - - - - - I E Q L 222
Slo1 N Y H P K I R I I T Q M L Q Y H N K A H L L N I P S W 448
Slo3 N Y Y P Q T R V I I Q I L Q S Q N K V F L S K I P N W 465
MthK R M A G A D Q V I S P F V I S G R L M S R S I D D G Y 249
Slo1 N W K E G D D A I C L A E L K L G F I A Q S C L A Q G 475
Slo3 D W S A G D N I L C F A E L K L G F I A Q G C L V P G 492
MthK E A M F V Q D V L A E E S T R R M V E V P I P E G S K 276
Slo1 L S T M L A N L F S M R S F I K I E E D T W Q K - Y Y 501
Slo3 L C T F L T T L F I E Q N Q K V F P K H P W Q K - H F 518
MthK L E G V S - - - - - - V L D A D I H D V T G - - - - - 292
Slo1 L E G V S N E M Y T E Y L S S A F V G L S F P T V C E 528
Slo3 L N G L K N K I L T Q R L S N D F V G M T F P Q V S R 545
MthK - - - - - - - V I I I G V G R G D E - - - - - - L I I 306
Slo1 L C F V K L K L L M I A I E Y K S A N R E S R - I L I 554
Slo3 L C F V K L N L M L I A I Q H K P F F H S C C T L I L 572
MthK D P P R D Y S F R A G D I I L G I G - K P E E I E R L 333
Slo1 N P G N H L K I Q E G T L G F F I A S D A K E V K R A 581
Slo3 N P S S Q V R L N K D T L G F F I A D S S K A V K R A 599
MthK K N Y I S A - - - - - - - - - - - - - 338
Slo1 F F Y C K A C H D D I T D P K R I K K 600
Slo3 F F Y C S N C H S D V C N P E L I G K 618  
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B 
MthK H V V I C G W S E S - - T L E C L R E L R G S E V F V 143
mSlo1 H V V V C I F G D V S S A L I G L R N L V M P L R A S 867
mSlo3 H I V V C V F G D A Q C T L V G L R N F V M P L R A S 746
MthK L A E D E N V R K K V L R S G A N F V H G D P T R V S 170
mSlo1 N F H Y H E L K H I V F V G S I E Y L K R E W E T L H 894
mSlo3 N Y T R Q E L K D I V F I G S L E Y F Q R E W R F L R 773
MthK D L E K A N V R G - - - - A R A V I V D L E S D S E T 193
mSlo1 N F P K V S I L P G T P L S R A D L R A V N I N L C D 921
mSlo3 N F P K I H I M P G S A L Y M G D L I A V N V E Q C S 800
MthK I H C I L G I R K I D E S V R I I A E A E R Y E N I E 220
mSlo1 M C V I L S A N Q N N I D D T S L Q D K E C I L A S L 948
mSlo3 M C V I L A T P Y K A L S S Q I L V D T E A I M A T L 827
MthK Q L R - - - - - - - - - - - - - - - - - - - M A G A D 228
mSlo1 N I K S M Q F D D S I G V L Q A N S Q G F T P P G M D 975
mSlo3 N I Q S L R I T S P T - - - - - - - - - - - - P G S S 842
MthK Q V I S P F V I S G R L M S R S I D D G Y E A M F V Q 255
mSlo1 R S S P D N S P V H G M L R Q P S I T T G V N I P I I 1002
mSlo3 K S - - E V K P S S A F D S K E R K Q R Y K Q I P I L 867
MthK D V L A E E S T R R M V E V P I P E G - - - - - - - - 274
mSlo1 T E L V N D T N V Q F L D Q D D D D D - - - P D T E L 1026
mSlo3 T E L K N P S N I H F I E Q M G G L D G M L K G T S L 894
MthK - - - - - - - - - - - - - - - - - S K L E G V S V L D 284
mSlo1 Y L T Q P F A C G T A F A V S V L D S L M S A T Y F N 1053
mSlo3 H L S T S F S T G A V F S D T F L D S L L A T S F Y N 921
MthK A D I H D V T G V I I I G V G R G D E L I I D P P R D 311
mSlo1 D N I L T L I R T L V T G - G A T P E L E A L I A E E 1080
mSlo3 Y H V V E L L Q M L V T G - G I S S E M E H Y L V K E 947
MthK Y S F R A G D I I L G I G K P E E I E R L K N Y I S A 338
mSlo1 N A L R G G Y S T P Q T L A N R D R C R V A Q L A L L 1107
mSlo3 K P Y K T T D D Y E A I K S G R T R C K L G L L S L D 974
MthK - - - - - - - - - - - - - - -
mSlo1 D G P F A D L G D G G C Y G - 1121
mSlo3 Q T V L S G I N P R K T F G Q 989
 
 
Figure 4.5 Alignments of RCK Domains. The RCK domains of mSlo1 and MthK were 
aligned with the homologous regions in the mSlo3 protein structure. Red highlighted 
residues are fully conserved residues; orange residues are residues of strongly similar 
properties (e.g. polarity) - scoring > 0.5 in the Gonnet PAM 250 matrix and yellow residues 
are conserved between residues of weakly similar properties - scoring < 0.5 in the Gonnet 
PAM 250 matrix. The RCK1 homologous region (A) showed a high sequence identity to the 
mSlo1 RCK1 and the MthK RCK domain. Whereas a low sequence identity is seen in the 
mSlo3 RCK2 homologous region (B) alignment to the mSlo1 RCK2 and the MthK RCK 
domain.  
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Figure 4.6 Predicted secondary structures of mslo3 RCK domains. Secondary protein 
structures were predicted using the DomPred Protein Domain Prediction Server. The 
homologous mSlo3 residues to the mSlo1 RCK βαβαβ Rossmann-fold structure was 
underlined and if corresponding to the structural elements annotated above the predicted 
structure. This can be seen to align fairly well in the RCK1 structure a) however the RCK2 
structure b), subsequent to the αd helix, the predicted secondary structure of the mSlo3 
RCK2 differs from the homologous mSlo1 βαβαβ Rossmann-fold structure. 
  
a) b) 
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4.2.5 Electrophysiological effects of CV562866 Expression on Sloα subunits 
Oocytes were prepared and injected, as described in 2.3.3, with α-subunit mRNA diluted 
with either water or the respective accessory subunits (CV/hSloβ4) to ensure final 
concentrations were consistent within the experiments. Oocytes were then incubated for 2-3 
days at 18 OC before being voltage clamped at a -80 mV holding potential (2.3.4). I/V 
relationships were determined by subjecting the oocyte to a 100 ms voltage step of -100 to 
+140 mV in 10 mV increments. Interestingly mSlo3/CV562866 expressing oocytes had 
significantly reduced currents evoked by depolarisations greater than +120 mV (p<0.05, 
Two-way ANOVA; Bonferroni post hoc test) (n=20) in comparison to the currents in 
mSlo3/H2O injected oocytes (Figure 4.7). The current decrease caused by CV co-expression 
was on average 0.64 µA. In the absence of injected pore forming subunits the CV expressing 
oocyte currents were not significantly different from the endogenous currents (P>0.05, Two-
way ANOVA; Bonferroni post hoc test). In contrast to mSlo3, the effect on mSlo1 mediated 
currents was opposite in the presence of CV, figure 4.8, with significantly increased currents 
evoked by depolarising pulses greater than +120 mV (P<0.05, Two-way ANOVA; 
Bonferroni post hoc test) (n=37). The average current increase dependent on CV co-
expression with mSlo1 was 0.82 µA. 
 
mSlo3 with Sloβ4 co-expression resulted in a significant (P<0.05, Two-way ANOVA; 
Bonferroni post hoc test) increase at voltages greater than +100 mV compared to mSlo3 
currents (Figure 4.9). This is consistent with previous studies, however the size of the effect 
in our studies was less than the eight fold increase reported (Yang et al., 2009). Interestingly, 
this increase in current was abolished by CV co-expression (P>0.05, Two-way ANOVA; 
Bonferroni post hoc test) when compared to mSlo3 injected oocyte currents. Consistent with 
our previous experiment expression of CV with just mSlo3 again significantly reduced 
mSlo3 currents evoked by depolarising greater than +120 mV (P<0.05, Two-way ANOVA; 
Bonferroni post hoc test) (n=20).  
 
Activation constant (τ) at +100 mV to +140 mV depolarisation steps were analysed for all 
the experiments but no significant effects were found dependent on the CV co-expression 
(P>0.05, Two-way ANOVA; Bonferroni post hoc test). G-V relationships were not 
constructed for any of the combinations because as discussed earlier (3.3.1) the currents do 
not reach a defined GMax plateau. 
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Figure 4.7 Effects of CV562866 expression on mSlo3 currents. Functional effects of the 
CV protein were studied by expressing mSlo3 channels in Xenopus oocytes and recording 
membrane currents using two-electrode voltage clamp. Depolarisations were stepped in 10 
mV intervals from -100 mV to +140 mV. Surprisingly co-expression of CV significantly 
reduced mSlo3 mediated current evoked by depolarisations greater than +120 mV (P<0.05, 
Two-way ANOVA; Bonferroni post hoc test) (n=20). The average current decrease 
dependent on CV co-expression was 0.64 µA. 
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Figure 4.8 Effects of CV562866 expression on mSlo1 currents. Functional effects of the 
CV protein were studied by expressing mSlo1 channels in Xenopus oocytes and recording 
membrane currents using two-electrode voltage clamp. Depolarisations were stepped in 10 
mV intervals from -100 mV to +140 mV. CV expression with Slo1 channels, significantly 
increased currents evoked by depolarising pulses greater than +120 mV (P<0.05, Two-way 
ANOVA; Bonferroni post hoc test) (n=37). The average current increase dependent on CV 
co-expression with mSlo1 was 0.82 µA. 
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Figure 4.9 Effects of CV562866 expression on mSlo3/Sloβ4 currents. Functional effects 
of CV were studied by expressing mSlo3 channels in Xenopus oocytes and recording 
membrane currents using two-electrode voltage clamp. Depolarisations were stepped in 10 
mV intervals from -100 mV to +140 mV. The significant increase in Slo3 currents by Sloβ4 
co-assembly (P<0.05, Two-way ANOVA; Bonferroni post hoc test) were eliminated by CV 
co-expression (not significant) when compared to solitary Slo3 currents. Expression of CV 
with mSlo3 again significantly reduced mSlo3 currents evoked by depolarising greater than 
+120 mV (P<0.05, Two-way ANOVA; Bonferroni post hoc test) (n=20)  
  
105 
 
4.3 Chapter 4 Discussion 
 
4.3.1 A novel isoform of mSlo3 
Using the UniGene database we found several EST’s, expressed outside the 
testis/spermatozoa, that have a high sequence identity to the mSlo3 cDNA sequence. Three 
of the EST’s were isolated from adult male hippocampus (AK083174, BB428821 and 
BB653287), one from the subfornical organ and postrema (BQ175543), one from the upper 
head (CV562866) and one from the lateral wall of lateral ventricle (CX213584). We aligned 
EST’s to the mSlo3 cDNA sequence using ClustalW2 (4.2.1) and EST sequences 
homologous to the mSlo3 sequence were highlighted in grey. All the EST’s were found to 
be divergent from the mSlo3 sequence at the 5’ end; however there was internal consistency 
between the four EST sequences over this region. This divergence at the 5’ end of the 
sequence explains why Schreiber et al. (1998) only found expression restricted to testis, as 
their probes were designed to the full length, the S8-S9 domains and the S9-S10 domains. 
Whilst the EST’s encode most of the S9-S10 domains, the first 72 bases are in the divergent 
region, thus RT-PCR probes would be unable to bind as the target sequence is absent.  
 
It appears that all of the EST’s are not a 3’ fragment of degraded full length mSlo3 cDNA, 
but are splice variants in their own right. Using Marathon RACE PCR on mouse brain 
Marathon-readyTM cDNA (Clontech) any potential neuronal isoforms were isolated. 
Interestingly, whilst the forward EST internal primers in the second round of PCR gave high 
molecular weight bands (≈1.5 kb), the reverse EST internal primer reactions produced only 
low molecular weight bands, between 200-600 bp. If the CV sequence encoded a full length 
α-subunit, it would be expected that the reverse EST internal primer Marathon RACE PCR 
should show a band of ≈3.5 kb, thus CV only encodes a short length sequence. This finding 
was reinforced when PCR of mouse brain cDNA library was performed using a pore region 
specific primer against a CV reverse primer, resulting in a blank gel. The full length CV 
sequence was constructed and aligned to the mouse genomic and transcript library sequence 
using the NCBI nucleotide blast software (Altschul et al., 1990). The results of this 
alignment were the discovery of two new exons, 19a and 19b (named respective to the full 
length mSlo3), which align to sequence between exons 19 and 20 of the KCNU1 gene. The 
full length CV sequence contains exons 20-26 of the full length mSlo3 sequence. This 
supports our Marathon RACE PCR findings that CV is a novel isoform rather than a 
degraded mRNA sequence of a longer form.  
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The full CV sequence was found to contain an ORF starting at nucleotide 217 with a 
hundred percent sequence identity to the C-terminus of the mSlo3 subunit, starting at M740. 
This region in mSlo3 is the most divergent from the mSlo1 sequence (39% homology); thus 
it was used as the epitope (amino acids 1052-1121) for the NeuroMab Anti-Slo3 antibody. 
As the CV sequence also encodes this region we were able to determine if CV was 
expressed as a protein or if it was an untranslated RNA. Western blots of transiently 
transfected CV562866-HEK293 cells showed a band at ≈ 55 kDa which was not present in 
the mSlo3 or control HEK cells. Whilst not a precise measure of Mw this was consistent 
with the predicted Mw of CV, 47 kDa, suggesting that it is expressed as a distinct protein. 
Using a range of tissues we found a diverse expression profile in supernatant fractions, 
consistent with our finding that the CV protein lacks TM domains. The finding that the 
blood sample contains a corresponding band may explain why highly vascularised tissues 
like the liver and kidney also contain a ≈ 55 kDa band. This finding also probably 
contributes to the widespread non-specific binding observed in fixed brain slices. 
Interestingly, in the Western blots a high molecular weight band of ≈100 kDa was observed 
in the tissues that also express CV. This band appears to be approximately the same weight 
as the lower band found in the mSlo3 control transfected cells. However, it is unlikely that 
this band is due to full length rSlo3 α-subunit as previous studies were unable to find 
expression outside of the testis (Schreiber et al., 1998). This band is possibly due to the 
formation of CV dimers or non specific binding due to the high level of antibody required 
for visualisation. However, the band in the membrane fraction from testis is unlikely to be 
due to CV, as this protein lacks TM domains. This band may be due to degraded full length 
rSlo3, as this tissue is the only tissue that Slo3 has been shown to express in (Schreiber et 
al., 1998). 
 
4.3.2 Predicted structural features of the CV562866 protein 
Expression of a soluble C-terminus is similar to the MthK gene that generates a “soluble” 
form of the tail region that contains the single RCK domain, which is required so the 
octameric gating ring can be formed (Jiang et al., 2002b). Thus as the CV sequence contains 
the final 426 amino acids of the C-terminus of mSlo3, we determined if this region contains 
a RCK domain, which could act as in the MthK channel. Using alignment to the RCK 
domains of mSlo1 and MthK and prediction of the secondary protein structure of the 
homologous regions, we ascertained that in mSlo3 whilst RCK1 was intact RCK2 lacked the 
characteristic βαβαβ Rossmann-fold structure. This may mean that the octomeric RCK ring 
of mSlo3 does not form correctly; this may contribute to the requirement for higher 
concentration of mRNA in comparison with mSlo1 for recordable currents. For example, 
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when the internal start codon in MthK channels for the soluble RCK domain is mutated, 
M107I, the expression of the mutant MthK channel is drastically reduced in comparison 
with the wild type (Jiang et al., 2002). The presence of an intact RCK1 domain also suggests 
a possible mechanism for pH sensitivity of mSlo3 channels. Three residues in RCK1 of 
Slo1, D367 and H365/H394, are vital for the activation of the channel by low pH (Hou et al., 
2008). The mSlo3 RCK1 has homologous histadines in the structure; however the 
homologous D367 is replaced with lysine. This shift from an acidic amino acid interacting to 
a basic amino acid interacting may characterise the shift from activation in the presence of 
H+, to the inhibition. As in the current theory the interaction of the protonated histadines and 
D367 stabilises the RCK structure to preferentially open the channel gate (Hou et al., 2008). 
Therefore with the inversion of side chain charge, protonated histadines may stabilise the 
RCK1 structure to preferentially close the mSlo3 channel gate. 
 
4.3.3 Effects on α-subunit expression 
To test if CV had analogous effect on mSlo expression to the MthK increased surface 
expression due to the soluble C-terminus, we used co-injection experiments to establish any 
effects of CV expression on mSlo α-subunits. Interestingly currents from CV co-injected 
with mSlo3 oocytes were decreased at depolarisations greater than +120 mV in comparison 
to the mSlo3/H2O injected oocyte currents. This is possibly due to a range of potential 
effects of CV expression; saturation of forward trafficking motifs, saturation of protein 
synthesis mechanisms or disruption of formation of the channel tetramer by interactions with 
the C-terminus of the α-subunit. All of these effects would result in reduced trafficking to 
the oocyte membrane and reduced current. In contrast the effect on mSlo1 mediated currents 
was opposite in the presence of CV, with significantly increased currents evoked by 
depolarising pulses greater than +120 mV. This may be due to CV increasing surface 
expression of mSlo1 by saturating retention proteins and thus enhancing forward trafficking. 
Previous studies have shown that the surface expression of Slo1 channels can be regulated 
by the extreme C-terminus sequence (Kim et al., 2007). In Slo1 the presence of VEDEC 
rather than QEERL at the extreme C-terminus, requires the addition of growth factors to 
cause surface expression. The same study observed that, addition of a soluble protein of the 
final 42 amino acids was also able to increase surface expression, implicating that this region 
binds to proteins that cause retention of the VEDEC channels in intracellular stores. It is 
possible that the extreme end of mSlo3/CV protein sequence, DIVQEK, is also an 
intracellular retention signal. The theory that CV affects mSlo3 surface expression rather 
than causing changes in kinetics was supported by our findings that expression of CV 
abolished the current increase due to Sloβ4 co-expression with mSlo3. Previous studies have 
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shown that Sloβ4 increases the surface expression of mSlo3 (Yang et al., 2009). However, 
the increase in current we observed due to Sloβ4/mSlo3 was less than the eight-fold increase 
previously reported by C.-T. Yang et al (2009). This is possibly due to the difference of 
technique used; we used TEVC whereas they used macro-patches pulled from ooctyes. Thus 
it is possible that Sloβ4 not only causes an increase in surface expression but may also cause 
mSlo3 channel clustering. Measurement of the activation constants of the currents found no 
significant effect dependent on CV expression supporting the theory that the effects are due 
to changes in expression or trafficking rather than channel kinetics. As expected in the 
absence of injected α-subunits, CV injection had no effects on endogenous currents.  
 
4.3.4 Challenges for the future  
Challenges for the future will be to examine: (a) if the effects of the CV562866 protein on 
Slo1 expression is an artefact of the oocyte expression system by repetition in stable cell 
lines; (b) utilising macro-patches of oocyte membranes and patch cramming to see if the 
CV562866 protein causes increased recycling; (c) if CV562866 can be used to pull down 
other proteins that may be able to interact with mSlo3 and modify expression; (d) if it is 
possible to design a more specific antibody to mSlo3 (possibly using S8-S9 as an epitope) to 
allow more selective probing of tissues. 
 
4.3.5 Chapter Summary 
This data reveals a novel splice variant of the mSlo3 channel, CV562866, which lacks TM 
domains and has a wider apparent expression profile. This variant appears to be expressed as 
a protein in vivo, and contains most of the nominal RCK2 domain. Our investigation into the 
structure, however, suggests that the RCK2 domain of the splice variant and full length 
channel lacks the correct secondary architecture. CV562866 appears to affect the expression 
of both mSlo3 and mSlo1 channels, but has opposing effects.  
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Chapter V: 
Characterisation and Pharmacology of hSlo2 channels 
 
5.1 Chapter 5 Introduction 
 
5.1.1 Characteristics of the Slo2 Subfamily 
The Slo2.χ subfamily of channels was first identified in Caenorhabditis elegans from 
sequence homology with Slo1 and Slo3 channels. Expression of the encoded protein 
displayed a channel with synergistic activation by Ca2+ and Cl- with weak voltage 
dependence, due to the lack of positive charges in the S4 domain and a single-channel 
conductance of 110 pS in symmetrical K+ (Yuan et al., 2000). Soon after the identification of 
C.elegans Slo2, mammalian orthologues were identified in both mouse (mSlo2) and rat 
(rSlo2), originally called Slack - Sequence like a Ca2+ activated K+ channel. These channels 
differed from the C.elegans Slo2 in that rather than synergistic activation by Ca2+ and Cl- 
they were instead activated by Na+ and Cl- with a unitary conductance of 165 pS (Yuan et 
al., 2003). The rSlo2.2 channel had been previously identified as a member of the Slo family 
of channels when originally cloned, but activation of the channel by Na+ or Cl- had not been 
recognised (Yuan et al., 2003). Another homologue was also discovered, rSlo2.1, this sister 
channel was named Slick - Sequence like an intermediate conductance K channel, due to its 
resemblance to Slo2.2. The Slo2.1 channel was first described as being a functional hybrid 
between KNa and ATP-sensitive (KATP) K+ channels, as it is activated by Na+/Cl- but the 
channel is also inhibited by intracellular ATP. The sensitivity to these endogenous activators 
was shown to differ with Slo2.1 being less sensitive to Na+ and more sensitive to Cl- in 
comparison with Slo2.2 (Bhattacharjee et al., 2003).  
 
It has been difficult to determine separate physiological functions for Slo2.1 and Slo2.2 with 
regards to mediating the KNa current. This is partially due to the overlap between 
endogenous activators and the expression patterns of rSlo2.1 and rSlo2.2. In the rat brain, 
expression profiles have been explored utilising in-situ hybridisation (ISH) and 
immunohistochemical (IHC) methods (Bhattacharjee et al., 2002, 2005). These methods 
showed wide-spread and overlapping expression of the Slo2.χ channels throughout the brain. 
IHC staining of the Slo2.2 channel showed relatively high protein levels in the olfactory 
bulb, midbrain and brainstem. IHC staining, however, conflicted with the ISH results in 
regions such as the piriform cortex, ventral cochlear nucleus, CA3 of the hippocampus, and 
cerebellar nuclei (Bhattacharjee et al., 2002). However, this discrepancy was due to the 
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epitope chosen for the original anti-Slo2.2 antibody, the first 15 amino acids of the N-
terminus. This region of the protein is now known to be a site of variation due to splice 
variants (Brown et al., 2008). Their study found three major variants; Slo2.2a, Slo2.2b and 
Slo2.2m. Slo2.2b channels are the “classical” Slo2.2 channels, which have a long N-terminal 
domain. Slo2.2a channels, however, have a shorter N-terminal domain which has a high 
level of sequence identity (78.1%) to the Slo2.1 N-terminal sequence. Slo2.2a channels have 
distinct electrophysiological characteristics from Slo2.2b currents. Slo2.2a whole cell 
currents activate rapidly in response to a voltage step, in a manner akin to Slo2.1 channels. 
Slo2.2b channels activate in a biphasic manner, with an instantaneous component that is 
followed by a slow time dependent component that takes several hundred milliseconds to 
reach a level of steady state current. At the single channel level Slo2.2a channels have 
multiple sub-conductance states whereas Slo2.2b channels had one main sub-conductance 
state. Slo2.2b channels also had a mean open time six times longer than Slo2.2a, in part due 
to longer openings to the fully open state (Brown et al., 2008). Slo2.2a and Slo2.2b also 
differ in their ability to form heteromeric channels with the Slo2.1 subunit. rSlo2.2b 
subunits, in oocytes, have been shown to form intermediate conductance channels with 
rSlo2.1 subunits, whereas rSlo2.2a subunit are unable to form channels with these 
properties. Using co-immunopreciptation techniques on rat brain tissue it appears that these 
heteromeric channels are formed in vivo (Chen et al., 2009). 
 
5.1.2 Physiological Relevance of Slo2.χ channels in neuronal tissues 
Slo2.χ channels appear to have a variety of physiological functions depending on cell type 
and differing [Na]i levels in subcellular localisations. Three major functional roles of Slo2.χ 
channels in neurons have been reported, in the depolarising after-potential, spike frequency 
timing and establishment of the RMP. There was initially disagreement in the literature as to 
involvement of KNa currents in mediating the depolarising after-potential. This was due to 
initial studies finding the EC50’s for Na+ of ≈40 mM (rSlo2.2) and ≈80 mM (rSlo2.1), both 
of which are greater than the reported resting [Na+]i in neurons (4-15 mM). However, further 
studies have found that in the presence of NAD+ the EC50 is shifted to ≈20 mM [Na+]i, near 
the physiological range (Tamsett et al., 2009). Secondly Slo2.χ channels are assumed to co-
localise with Na+ channels (Dryer, 1994), and have been shown to co-localise with AMPA 
receptors (Nanou et al., 2008), thus localised [Na+]i may be higher than in the whole cell. In 
rat medium-diameter (25-35µm) DRG neurons and CA1 pyramidal cells, Slo2.χ have been 
shown to be able to mediate the depolarising after-potential of single action potentials (Gao 
et al., 2008). Interestingly whereas in rat it appears both Slo2.1 and Slo2.2 contribute to 
spinal cord KNa, it has been shown in lamprey spinal cord to be mediated solely by Slo2.2. In 
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lamprey spinal cord neurons, the role is slightly different; Slo2.2 mediates part of the slow 
afterhyperpolarisation (sAHP). The contribution of this channel is increased under high 
frequency firing of the neuron. This is theorised to be a safety mechanism to ensure 
frequency regulation (Wallén et al., 2007). This physiological function has also been 
determined for Slo2.χ in the medial nucleus of the trapezoid body (MNTB) in the auditory 
brainstem. In the MNTB increasing KNa augments the accuracy of timing of action potentials 
at high frequency firing of the neuron. This in turn increases the fidelity of the information 
encoded (Yang et al., 2007). Bischoff et al., (1998) concluded that the KNa current, mediated 
by Slo2.χ channels, contribute to the establishment of RMP in physiological conditions and 
have a secondary role of stabilising the neuron under pathophysiolgical conditions such as 
hypoxia. This conclusion may have been due to the cell type observed in the study, rat 
small-diameter (20-25 µm) DRG neurons. Small DRG neurons have an action potential 
frequency of 0.5-2 Hz, under physiological conditions, approximately 15-fold too low to 
cause a high localised Na+ concentration to activate KNa currents. Secondly small DRG 
neurons lack the anatomical architecture to facilitate Na+ accumulation such as the node of 
Ranvier or an axon hillock with a high density of Na+ channels (Bischoff et al., 1998). It has 
been suggested that KNa have a role in the mediation of inflammatory pain by DRG neurons. 
PKA activation has shown to be critical to mediation of inflammatory pain (Malmberg et al., 
1997). Thus the PKA dependent internalisation of Slo2.2 is thought to play a part in causing 
the hyper-excitability characteristic of nociceptive firing (Nuwer et al., 2010). 
 
5.1.3 Pharmacology of Slo2.χ channels  
Class I and IV anti-arrhythmic drugs, quinidine and bepridil (respectively), were originally 
shown to inhibit KNa currents in cardiac tissue (Mori et al., 1998). Further investigation of 
the affects of these compounds has determined their full profile against rSlo2.2b channels. 
Quinidine inhibition of rSlo2.2b appears to be voltage independent. In transfected human 
embryonic kidney (HEK) cells quinidine has an IC50 of 89.6 μM. Examination of channel 
kinetics indicated that quinidine produced a marked and reversible decrease in channel 
activity. This was due to a decrease in the mean open time of the channel. Bepridil inhibition 
of rSlo2.2b appears similar to quinidine in that it is also voltage independent and reversible. 
In transfected HEK cells bepridil was shown to more potent with an estimated IC50 of 1.0 
μM. Examination of channel kinetics displayed that bepridil also decreased the mean open 
time of the channel. These results signify that quinidine and bepridil inhibition has a direct 
effect on rSlo2.2b, rather than an effect on intracellular Na+ levels (Yang et al., 2006). 
Currently only one non-endogenous activator has been observed; bithionol, a bis-phenol 
anti-parasitic compound. Activation by bithionol (EC50 = 0.77 μM) showed an interesting 
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characteristic, the weak voltage dependence of the Slo2.2 currents was modified. In the 
presence of bithionol the activation voltage is shifted to more negative potentials, allowing 
more channels to be open for a given voltage (Yang et al., 2006). Bithionol has also been 
shown to increase the speed of decay of AMPA induced excitatory postsynaptic current in 
lamprey spinal neurons by enhancement of a KNa current, resulting in a decreased synaptic 
response (Nanou et al., 2008). These studies were either performed solely on rSlo2.2b 
channels or in native cells, without recourse to examination of the possible effects on either 
rSlo2.2a or rSlo2.1 channels, thus it is unknown if the pharmacology described is distinctive. 
 
5.1.4 Chapter Aims 
5.1.4.1 Characterisation of hSlo2.2a currents  
The majority of studies of the Slo2 subfamily have been performed using the initial isoform 
rSlo2.2b, with few studies performed on the rSlo2.1 and rSlo2.2a. However no study has 
examined the human homologues of these channels, which have the more selective GYG 
selectivity filter in the pore domain. We aim to study the hSlo2.2a isoform, in transfected 
HEK cells using whole cell patch clamp, in order to characterise the currents and the 
minimum sensitivity to intracellular NaCl concentrations.    
 
5.1.4.2 Are hSlo2.2a channels activated by bithionol? 
The bisphenol anthelmintic compound, bithionol has been shown previously to activate 
rSlo2.2b channels in transiently transfected HEK cells (Yang et al., 2006). We aim to test if 
the hSlo2.2a channels are sensitive to this compound. If hSlo2.2a channels are activated we 
aim to test if bithionol activation is affected by the intracellular [Na+] and [Cl-]. Secondly we 
aim to test the potency of bithionol and the related bithionol sulfoxide at hSlo2.2a channels 
is similar to the previously reported potency of bithionol on rSlo2.2b channels. Lastly using 
homology modelling to the hSlo1 channel structure, we aim to model the bithionol binding 
site of the hSlo2.2a channel. 
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5.1.4.3 Are the effects of bithionol channel specific? 
K+ channels are rarely expressed in physiological cells in isolation, normally a wide variety 
of K+ channels are expressed with overlapping sensitivities and functions. Thus we aimed to 
test the potency of bithionol on the endogenous HEK Kv channels as a control to our 
previous experiments. Also we aimed to test bithionol on the other KNa subunit hSlo2.1, to 
see if bithionol could be used to distinguish this subtype from hSlo2.2 channels. Lastly we 
also aim to test bithionol on KATP currents recorded from 832/13 INS cells. 
 
5.1.4.4 Can bithionol activate Slo2.χ in DRG neurons? 
Bithionol has been shown to be an activator of heterologously expressed rSlo2.2b channels 
and ex vivo lamprey KNa currents. Thus we aim to test the physiological effects of bithionol 
application on currents from ex vivo rat DRG cells. We aim to do this by whole cell patch 
clamp isolated rat DRG cells with 5 mM [Na+]i and subjected to -100 to 0 mV voltage 
ramps. Secondly we aim to test the effects of bithionol application on the RMP of rat DRG 
cells using a current clamp protocol.  
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5.2 Chapter 5 Results 
 
5.2.1 Characteristics of hSlo2.2a Currents 
hSlo2.2a-EGFP transiently transfected HEK MSR cells were whole cell patch clamped at -
80 mV for recording. Cells were clamped at -80 mV and then subjected to -100 to +100 mV 
voltage ramps over a 500 s period, at a frequency of 0.25 Hz, to allow currents to run up. 
Currents were measured during a 200 ms voltage step of -100 to +100 mV in 10 mV 
increments, from a -80 mV holding potential (Figure 5.1). The sample traces in the absence 
(Figure 5.1.A) and presence of 20 mM [NaCl]i (Figure 5.1.B), shown in response to a 
voltage step protocol from -100 to 20 mV, demonstrate that this pulse is of sufficient 
duration for currents to reach steady state activation. In the absence of [NaCl]i (Figure 
5.1.A), currents appear to be similar to endogenous Kv currents recorded from HEK cells. 
The presence of 20 mM [NaCl]i (Figure 5.1.B), appears to have an increased instantaneous 
current, increased peak current and a small inward current. Cell currents were normalised to 
individual cell capacitance before compiling to generate the (I/Ccell)/V plots (Figure 5.1.C). 
These plots showed a significant (P<0.05, Student’s t-test) increase in hSlo2.2a current 
density in the presence (n=8) of 20 mM [NaCl]i between -40 and +20 mV compared to 
absence (n=7). Interestingly, the hSlo2.2a currents in the presence of 20 mM [NaCl]i have 
differing characteristics compared to rSlo2.2a current recorded in CHO cells (Brown et al., 
2008). hSlo2.2a currents, unlike rSlo2.2a, display a linear current-voltage relationship with 
no rectification. Their study also observed that rSlo2.2a currents reverse at -50 mV, whereas 
our study the hSlo2.2a currents reverse at ≈ -75 mV in the presence of 20 mM [NaCl]i. The 
only similar characteristic between hSlo2.2a and rSlo2.2a is rapid channel activation.  
 
Conductance and reversal voltage recordings were also made over the 500 s that hSlo2.2a 
transiently transfected HEK MSR cells were subjected to -100 to +100 mV voltage ramps at 
a frequency of 0.25 Hz. Conductance and reversal potential measurements were recorded in 
the presence and absence of 20 mM [NaCl]i following breakthrough and over the 500 s of 
voltage ramps. Individual cell conductance recordings (n=6) were normalised to cell 
capacitance before collating and plotting. Interestingly although there is a clear increase in 
the conductance density (Figure 5.2.A) due to the presence of 20 mM [NaCl]i this was not 
found to be significantly different (P>0.05, Student’s t-test) compared to in the absence of 
20 mM [NaCl]i after 500s. If the significance threshold was relaxed to P<0.1, there is a 
significant increase due to the presence of 20 mM [NaCl]i. However, measurement of the 
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reversal potential (Figure 5.2.B) found a significant (P<0.05, Student’s t-test) negative shift 
in the presence of 20 mM [NaCl]i compared to recordings in the absence of 20 mM [NaCl]i.  
 
5.2.2 Cooperativity of Na+ and Bithionol Activation 
hSlo2.2a currents were recorded from transfected HEK MSR cells by whole cell patch 
clamp using a -100 to 100 mV voltage ramp with differing intracellular [Na+] and [Cl-]. Cells 
were left to equilibrate until the conductance reached a plateau, then 10 µM of bithionol 
(Figure 5.3.H) was applied until plateau for ten sweeps was attained, following which cells 
were washed with extracelluar solution. Average curves were plotted (± SEM) for each 
condition. [Na+]i was varied by addition of NaCl to the intracelullar solution and the effects 
of bithionol application on conductance density measured; 0 mM (Figure 5.3.A), 5 mM 
(Figure 5.3.C), 10 mM (Figure 5.3.E) and 20 mM (Figure 5.3.F). Conductance density 
measurements from the currents in figure 5.3 were collated and averaged. Application of 10 
µM bithionol, in all conditions, was found to significantly (P<0.05, Two-way ANOVA; 
Bonferroni post hoc test) increase the conductance density of hSlo2.2a transfected cells. The 
increase in conductance density due to bithionol application was reversible with washing 
with the exception of 20 mM [Na+] (Figure 5.3.F). 
 
To determine if the increase in current density with bithionol was sodium or chloride 
cooperative, low [Cl-]i solutions, 1 mM [Cl-]i, were made by substituting Cl- with gluconate. 
Current densities were measured as before, in low [Cl-]i solutions, with 0 mM [Na+]i (Figure 
5.3.B) and 5 mM [Na+]i (Figure 5.3.D). Comparison of conductance density (Figure 5.4) 
showed no significant difference in the conductance densities of the low [Cl-]i solutions 
(P>0.05, Two-way ANOVA; Bonferroni post hoc test) compared to high [Cl-]i solutions. As 
a control 10 µM bithionol was also tested on untransfected HEK cells with 20 mM [Na+]i 
(Figure 5.3.G). Bithionol application was found to have no significant (P>0.05, Two-way 
ANOVA; Bonferroni post hoc test) effect on the recorded conductance density in 
untransfected HEK cells.    
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Figure 5.1 Whole cell patch clamp recordings from HEK MSR cells transiently 
transfected with hSlo2.2a-EGFP. Cells were clamped at -80 mV and then subjected to -
100 to 100 mV voltage ramps over a 500 s period, and then a voltage step protocol was 
applied. Sample traces with (a) 0 mM and (b) 20 mM [Na+ ]i are shown in response to a 
voltage step protocol from -100 to +20 mV. Traces were compiled to generate the (I/Ccell)/V 
plots (c), over a -100mv to +100 mV range, which showed a significant (* = P<0.05, T-test) 
increase in current density between the presence (filled squares) (n=8) and absence (open 
circles) (n=7) of intracellular 20 mM NaCl between -40 and +20 mV.  
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Figure 5.2 Electrophysiological characteristics of HEK MSR cells transiently 
transfected with hSlo2.2a-EGFP. Cells were clamped at -80 mV and then subjected to -
100 to 100 mV voltage ramps over a 500 s period. Conductance density (A) and reversal 
potential (B) measurements were recorded in the presence (filled squares) and absence (open 
circles) of 20 mM [NaCl]i following breakthrough and over the 500s of voltage ramps. 
Conductance density was found to be not significantly different (P>0.05, T-test) between the 
presence and absence of 20 mM [NaCl]i. However, the reversal potential was found have a 
significant (P<0.05, T-test) negative shift in the presence of 20 mM [NaCl]i.  
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Figure 5.3 Cooperativity between [Na+]i and Bithionol activation of hSlo2.2a-EGFP. 
hSlo2.2a currents were recorded from transfected HEK MSR cells by whole cell patch 
clamp using a -100 to 100 mV voltage ramp with differing [Na+]i and [Cl-]i. Cells were left to 
equilibrate until the conductance plateaued (black trace). 10 µM of bithionol (H) was applied 
until the conductance reached a plateau (red trace) and then washed (green trace). Average 
curves were plotted (± SEM (dotted trace)) for each condition. [Na+]i was varied by addition 
of NaCl to the intracelullar solution; (A) 0 mM, (C) 5 mM, (E)10 mM and (F) 20 mM. To 
determine if the increase in current density with bithionol was sodium or chloride 
cooperative, low [Cl-]i solutions, 1 mM [Cl-]i, were made by substituting Cl- with gluconate. 
Current densities were measured as before in (B) 0 mM [Na+]i (D) 5 mM [Na+]i conditions. 
The lack of bithionol effect on untransfected HEK cells with 20 mM [Na+]i is shown in (G).
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Figure 5.4 Summary of the cooperativity between [Na+]i and Bithionol activation of 
hSlo2.2a-EGFP. Conductance density measurements from the currents in figure 5.3 were 
collated and averaged. Application of 10 µM bithionol (red trace) was found to significantly 
(P<0.05, Two-way ANOVA; Bonferroni post hoc test) increase the conductance density of 
hSlo2.2a transfected cells, in all conditions. Comparison of conductance density showed no 
significant difference in the conductance densities of the low [Cl-]i solutions (P>0.05, Two-
way ANOVA; Bonferroni post hoc test) compared to high [Cl-]i solutions. 
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5.2.3 Bithionol sensitivity of hSlo2.2a currents 
HEK MSR cells expressing hSlo2.2a were whole cell patch clamped with 0 mM [Na]i and 
subjected to a -100 to 100 mV ramp. Activation curves were generated by application of 
increasing concentrations of bithionol from 10 nM to 30 µM and recording the conductance. 
Data were first normalised to cell capacitance and then normalised to zero bithionol 
(averaged from before application and wash steps after 1, 10, 30 µM) before collating and 
plotting (Figure 5.5). Individual EC50 values were collated to give an average EC50 of 1.29 ± 
0.12 µM (n=5) and an average hill slope of 8.22 ± 3.89. 
 
5.2.4 Modelling the Bithionol binding site 
The RCK Domains of hSlo2.2a were modelled by Dr Jon Lippiat on the reported hSlo1 
RCK1 and RCK2 tetramer (Figure 5.6) (Yuan et al., 2010). Using the bithionol binding site 
described for glutamate dehydrogenase (Li et al., 2009) the structure was scanned to 
determine regions of homologous positively charged amino acids. Candidate amino acids 
were highlighted, including the proposed “Cl- bowl” (Yuan et al., 2000), that may contribute 
to bithionol binding and activation of the hSlo2.2a channel. 
 
5.2.5 Bithionol Sulfoxide sensitivity of hSlo2.2a currents 
hSlo2.2a-EGFP transfected HEK cells were whole cell patch clamped with 5 mM [Na]i 
subjected to a -100 to +100 mV voltage ramp at a frequency of 0.25 Hz. As can be seen in 
the sample recording of conductance density (Figure 5.7.A) cell conductance was allowed to 
plateau, then 10µM bithionol was applied to confirm channel activity, cells were then 
washed with extracelluar solution. After washing 10 µM bithionol sulfoxide was applied 
until plateau and then washed for a final time. Data were collated and summarised (n=3) 
(Figure 5.7.B) showing a significant increase (P<0.05, One-way ANOVA; Bonferroni post 
hoc test) dependent on 10 µM bithionol and a non significant (P>0.05, One-way ANOVA; 
Bonferroni post hoc test) effect due to 10 µM bithionol sulfoxide compared to the control 
and wash steps. 
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Figure 5.5 Concentration Response of Activation of hSlo2.2a-EGFP by Bithionol. HEK 
MSR cells expressing hSlo2.2a were whole cell patch clamped with 0 mM [Na]i and 
subjected to a -100 to 100 mV ramp. Drug concentrations were applied until the conductance 
reached a plateau. Data were then normalised to zero bithionol (averaged from before 
application and wash steps after 1, 10, 30 µM). Individual EC50 values were collated to give 
an average EC50 of 1.29 ± 0.12 µM (n=5). 
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Figure 5.6 Homology model of the Bithionol binding site in hSlo2.2a channels. 
Homology modelling of the hSlo2.2a RCK domains based on the published human Slo1 
crystal structure (Yuan et al., 2010). Highlighted residues are areas of positively charged 
amino acids, including the proposed “Cl- bowl” (Yuan et al., 2000), that may contribute to 
bithionol binding and activation of the channel.  
  
124 
 
 
Figure 5.7 Effects of Bithionol Sulfoxide on hSlo2.2a channels. hSlo2.2a-EGFP 
transfected HEK cells were subjected to a -100 to +100 mV voltage ramp with 5 mM [Na]i. 
As can be seen in the sample data (A) cell conductance was allowed to plateau, then 10 µM 
bithionol was applied (i), cells were then washed (ii), then 10µM bithionol sulfoxide was 
applied (iii) and a final wash was applied (iv). Data were collated and summarised (B) 
showing a significant increase (P<0.05, One-way ANOVA; Bonferroni post hoc test) 
dependent on 10 µM bithionol and a non significant (P>0.05, One-way ANOVA; Bonferroni 
post hoc test) increase due to 10 µM bithionol sulfoxide (n=3) compared to the control and 
wash steps. 
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5.2.6 hSlo2.1 activation by Bithionol 
HEK MSR cells were cotransfected with hSlo2.1 and EGFP, and subjected to a -100 to +100 
mV voltage ramp with 5 mM [Na]i. Cells were left to equilibrate until the conductance 
reached a plateau, then 10 µM of bithionol was applied until plateau for ten sweeps was 
attained, following which cells were washed with extracelluar solution. Conductance 
measurements were normalised to cell capacitance collating and averaging (Figure 5.8). 
Application of 10 µM bithionol was found to increase the conductance density compared to 
control. However, the observed increase in the conductance density of hSlo2.1 transfected 
cells was not significantly (P>0.05, Student’s t-test) different from the effects on 
endogenous currents from untransfected HEK cells. 
 
5.2.7 Effects of Bithionol on KATP 
832/13 INS cells, which are a rat pancreatic β-cell-derived line that express KATP channels, 
were whole cell patch clamped and subjected to a -100 to +100 mV voltage ramp with 5 mM 
[Na]i. As can be seen in the sample data (Figure 5.9.A), measurements of conductance were 
allowed to run up until plateau, then 10 µM bithionol was applied until a plateau, cells were 
then washed with extracellular solution. Changes in the conductance density of individual 
cells were collated and average (±SEM) data were plotted (Figure 5.9.B). 10 µM bithionol 
was found to cause a significant reduction in conductance density (P<0.5, One-way 
ANOVA; Bonferroni post hoc test) (n=5). The effect of bithionol application was found to 
be irreversible within the timeframe. 
 
5.2.8 Physiological effects of Bithionol  
To see the physiological effects of bithionol application, isolated rat DRG cells were whole 
cell patch clamped with 5 mM [Na+]i and subjected to -100 to 0 mV voltage ramps. DRGs 
were left to equilibrate until the conductance plateaued, then 10 µM of bithionol was applied 
until the conductance reached a plateau and then washed with extracellular solution, as can 
be seen in the sample trace (Figure 5.10.A). Conductance measurements were normalised to 
cell capacitance and then normalised to the control period (before application) and collated 
before plotting (Figure 5.10.B). 10 µM bithionol was found to significantly (P<0.05, One-
way ANOVA; Bonferroni post hoc test) increase the conductance density by 2.24 ± 0.54 
fold (n=7) compared to pre-application. The effect of bithionol application was found to be 
irreversible within the timeframe of the experiment. Assessment of the effects of bithionol 
found that no significant difference was observed (P>0.05, Two-way ANOVA; Bonferroni 
126 
 
post hoc test), if data were divided into small (<25 pF) and large (>25 pF) DRG cells. As we 
observed a change in the reversal potential of rat DRG cells therefore we investigated if 
bithionol affected the RMP of the cell. Isolated rat DRG cells were whole cell patch clamped 
in the current clamp configuration with 5 mM [Na+]i and subjected a constant 0 pA current. 
As can be seen in the sample trace (Figure 5.11.B) DRGs were left to equilibrate until the 
RMP plateaued then 10 µM of bithionol was applied until RMP reached a plateau and then 
washed with extracellular solution. Changes in the RMP of individual cells were plotted 
before collating and averaged (±SEM) data were plotted (Figure 5.11.B). 10 µM bithionol 
was found to cause an average significant hyperpolarisation (P<0.05, One-way ANOVA; 
Bonferroni post hoc test) of ≈10 mV (n=4). The effect of bithionol application was found to 
be irreversible within the timeframe of the experiment.  
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Figure 5.8 Bithionol activation of hSlo2.1. Conductance density measurements from the 
currents were collated and averaged. Application of 10 µM bithionol (red bar) was found to 
not significantly (P>0.05, T-test) increase the conductance density of hSlo2.1 transfected 
cells compared to HEK endogenous currents with 20 mM [Na+]i.  
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Figure 5.9 Bithionol Effect on KATP Currents. 832/13 INS cells were subjected to a -100 
to +100 mV voltage ramp with 5 mM [Na]i. As can be seen in the sample curve (A), currents 
were allowed to run up and plateau (i), then 10 µM bithionol was applied (ii) until plateau, 
cells were then washed (iii). Changes in the conductance density were collated and average 
(±SEM) data were plotted (filled triangles) (B). 10 µM bithionol was found to cause a 
significant reduction in conductance density (P<0.5, One-way ANOVA; Bonferroni post hoc 
test) compared to control (n=5). The effect of bithionol application was found to be 
irreversible within the timeframe.   
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Figure 5.10 Bithionol Effects on rat DRG currents. Rat DRG cells were whole cell patch 
clamped with 5 mM [Na+]i and subjected to -100 to 0 mV voltage ramps. DRGs were left to 
equilibrate until the conductance plateaued (black trace). 10 µM of bithionol was applied 
until the conductance reached a plateau (red trace) and then washed (green trace), as can be 
seen in the sample traces (A). Conductance densities were normalised to the control period 
(before application) and collated before plotting (B). 10 µM bithionol was found to 
significantly (P<0.05, One-way ANOVA; Bonferroni post hoc test) increase the conductance 
density by 2.24 ± 0.54 fold (n=7) compared to pre-application. The effect of bithionol 
application was found to be irreversible within the timeframe. 
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Figure 5.11 Effect of Bithionol on the resting membrane potential of DRGs. Rat DRG 
cells were whole cell patch clamped with 5 mM [Na+]i and subjected a constant 0 pA 
current. DRGs were left to equilibrate until the RMP plateaued. 10 µM of bithionol was 
applied until RMP reached a plateau and then washed, as can be seen in the sample trace 
(A). Changes in the RMP of individual cells (open diamonds) were plotted before collating 
and averaged data were plotted (filled diamonds) (B). 10 µM bithionol was found to cause 
an average significant hyperpolarisation (P<0.05, One-way ANOVA; Bonferroni post hoc 
test) of ≈10 mV (n=4). The effect of bithionol application was found to be irreversible 
within the timeframe.  
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5.3 Chapter 5 Discussion 
 
5.3.1 Characteristics of hSlo2.2a currents in HEK cells 
hSlo2.2a-EGFP currents in transiently transfected HEK MSR cells were recorded by whole 
cell patch clamp. Interestingly, the hSlo2.2a currents in the presence of 20 mM [NaCl]i have 
differing characteristics compared to rSlo2.2a current recorded in CHO cells (Brown et al., 
2008). The only similar characteristic we observed between hSlo2.2a and rSlo2.2a currents 
was rapid channel activation. This characteristic appears to be a function of the Slo2.2a N-
terminus, which has high sequence identity to the Slo2.1 N-terminus (Brown et al., 2008). 
hSlo2.2a currents, unlike rSlo2.2a, display a linear current-voltage relationship with no 
rectification. If a p/4 leak subtraction protocol was used on the voltage step protocols used to 
create the (I/Ccell)/V plots, currents became outwardly rectifying and thus similar to currents 
previously reported from rSlo2.2a channels. However previous studies are unclear if a p/4 
leak subtraction, or any other leak subtraction protocol, was used in their recording protocols 
(Brown et al., 2008). Their study also observed that rSlo2.2a currents reverse at -50 mV, 
whereas using the same solution composition in our study, hSlo2.2a currents reverse at ≈ -75 
mV in the presence of 20 mM [NaCl]i. This is possibly due to the heterologous expression 
system used, HEK cells have endogenously expressed Kv channels (Jiang et al., 2002a) 
which are absent from the CHO cell line. Due to these endogenous contaminating K+ 
currents, we needed to supplement our intracellular solution with 20 mM [NaCl]i in order to 
observe distinct currents. Whereas in CHO cells it is assumed that under their conditions 
there is adequate [Na+]i in the CHO cell, entering through a presumed Na+ leak channel or 
other pathways (Joiner et al., 1998; Bhattacharjee et al., 2003; Brown et al., 2008). Thus it is 
probable that our [Na+]i was higher, resulting in a relative increase in the number of open 
hSlo2.2a channels, which drive the reversal potential closer to the calculated EK of -83 mV. 
Alternatively, the difference in reversal potential may be due to the difference in selectivity 
filter sequence, as rSlo2.2a has the less K+ selective GFG pore sequence, thus there may be 
some contaminating Na+ flux. 
 
Our study also differs from previous studies as voltage step recordings were made once 
conductance densities has reached a plateau, due to our observation that hSlo2.2 currents 
“run up” after breakthrough. In comparison, the previous study recorded I/V relationships 
apparently shortly after breakthrough to the cell (Brown et al., 2008). Interestingly although 
we recorded a clear (≈ 8 fold) increase in the conductance density (Figure 5.2.A) due to the 
presence of 20mM [NaCl]i the increase was found to be not significantly different (P>0.5, 
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Student’s t-test) between the presence and absence of 20mM [NaCl]i. If the significance 
threshold was relaxed to P<0.1, there is a significant increase due to the presence of 20 mM 
[NaCl]i. This is probably due to the high variance in the recorded hSlo2.2a conductance 
density in the presence of 20 mM [NaCl]i, resultant from the unpredictability of channel 
expression level in transient transfections. Interestingly whilst the conductance density “ran 
up” after breakthrough the reversal potentials were fairly stable over the 500 s time period 
this suggesting that perfusion of the cell with intracellular solution was rapid, and a small 
increase in the conductance density due to hSlo2.2a activation results in a significant (P<0.5, 
Student’s t-test) negative shift (≈-25 mV) in the reversal potential of currents.      
 
5.3.2 Bithionol Activation of hSlo2.2a  
To test the sensitivity of hSlo2.2a currents to bithionol activation we recorded from 
transfected HEK MSR cells by whole cell patch clamp using a range of differing 
intracellular [Na+] and [Cl-]. 10 µM bithionol application, in all intracelluar conditions, 
increased the conductance density of hSlo2.2a transfected cells. [Na+]i was varied by 
addition of NaCl to the intracellular solution and bithionol application was observed to 
increase conductance density in a cooperative manner. Due to the previously observed 
sodium and chloride dependence of this family of channels (Joiner et al., 1998; Yuan et al., 
2000; Bhattacharjee et al., 2003; Brown et al., 2008) we decided to determine if the increase 
in current density with bithionol was sodium or chloride cooperative. As a consequence low 
[Cl-]i solutions, with 1 mM [Cl-]i, were made by substituting Cl- with gluconate. The 
conductance density measurements using the low [Cl-]i showed no significant difference 
(P>0.05, Two-way ANOVA; Bonferroni post hoc test) when compared to measurements in 
high [Cl-]i solutions. This finding suggests that bithionol activation of hSlo2.2a channels is 
cooperative with [Na+]i rather than [Cl-]i. The increases in conductance density due to 
bithionol application was reversible in all conditions with washing, except the 20 mM [Na+]i 
condition. This irreversibility is possibly due to one of two explanations. Firstly that the co-
operative activation may slow down the off rates for bithionol above a critical [Na+]i. 
Alternatively, this data suggests that at high [Na+]i the channels are “locked” open and thus 
are unable to close even after the agonist is removed. As a control, 10 µM bithionol was also 
tested on untransfected HEK cells with 20 mM [Na+]i and no significant (P>0.05, Two-way 
ANOVA; Bonferroni post hoc test) increase in the recorded conductance density was 
observed. Thus the increases we see due to bithionol application in the conductance density 
must be due to the hSlo2.2a channels rather than endogenous Kv channels. A concentration 
response relationship for bithionol activation of hSlo2.2a in 0 mM [Na]i was constructed 
with an average EC50 of 1.29 ± 0.12 µM (n=5). However, we are unable to determine if this 
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value is significantly different from the previously reported EC50 for rSlo2.2b channels (0.77 
µM) (Yang et al., 2006). This is predominantly due to the previous study utilising only four 
concentrations and high variability around the highest concentration leading to poor curve 
fitting. Thus we are unable to state if it is possible to use bithionol potency as an indicator 
for determining the identity of the Slo2.2 channels underlying KNa currents in vivo. Our plot 
of the concentration response relationship is not perfect however, as there is a high SEM 
value for the calculated average hill slope (8.22 ± 3.89). This is probably because of our lack 
of values in the 1-10 µM range which reduces the accuracy of the fit, this range would be 
filled in with further experimentation. 
 
Dr Jon Lippiat modelled the RCK Domains of hSlo2.2a on the reported hSlo1 RCK1 and 
RCK2 tetramer (Yuan et al., 2010). The structure was scanned to determine regions of 
positively charged amino acids homologous to the bithionol binding site described for 
glutamate dehydrogenase (Li et al., 2009). The model suggested that the bithionol binding 
site is formed by a dimer of RCK domains, with each α-subunit contributing one pair of 
RCK 1 and RCK2 domains. This implies that in the conducting tetrametic channel there are 
four potential binding sites between the monomers of the octomeric RCK complex. From the 
concentration response curve the average hill slope was calculated to be 8.22 ± 3.89. This 
suggests that like bithionol binding to glutamate dehydrogenase (Li et al., 2009), two 
molecules of bithionol have to bind to each binding site and all sites have to be occupied to 
result in channel activation. This requirement for all sites to be occupied may, however, be 
due to our experimental design for generating the concentration response relationship. As 
concentration response relationships were performed in the absence of [Na]i to eliminate any 
co-operativity of activation observed in earlier experiments. Thus it may be that in the 
presence of [Na]i the number of sites needed to be occupied by bithionol for channel 
activation is reduced. Interestingly, included in the candidate amino acids was the proposed 
“Cl- bowl” region (Yuan et al., 2000). The suggestion that the Cl- binding site in the 
hSlo2.2a structure also forms part of the bithionol binding site is concurrent with our 
findings that there is no significant (P>0.05, Two-way ANOVA; Bonferroni post hoc test) 
difference in the conductance densities of the low [Cl-]i solutions compared to high [Cl-]i 
solutions in the presence of 10 µM bithionol. It also appears that the bithionol binding site in 
hSlo2.2a channels may have a high specificity. Our experiments with bithionol sulfoxide, 
(which has a double bonded oxygen of the middle sulphur), found it was unable to activate 
hSlo2.2 currents. To ensure that this lack of activation was not due to low/non expressing 
HEK cells or a requirement for the presence of [Na]i, cells were patched with 5 mM [Na]i 
and responses to 10 µM bithionol were elicited before 10 µM bithionol sulfoxide was 
applied. The lack of activity of bithionol sulfoxide is not due to a difference in membrane 
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permability of the compounds, as when the Log P permeability coefficient was calculated 
using the MarvinSketch calculator (Chemaxon, 2011), both compounds gave a highly 
positive value of ≈ 5.95, suggesting that both of the compounds are highly membrane 
permeable. The lack of activity of bithionol sulfoxide is probably due to the large negative 
charge that is introduced by the sulfoxide group. This negative charge would prevent the 
back to back orientation of the two molecules required to bind to the binding site to activate 
the hSlo2.2a channel. 
 
5.3.3 Effects of Bithionol on other K+ channels  
From our experiments it appears that bithionol has specificity for hSlo2.2 channels over 
hSlo2.1. As whilst application of 10 µM bithionol increased the conductance density 
compared to the control condition, this increase was not significantly (P>0.05, Student’s t-
test) different from the increase observed of endogenous Kv currents from untransfected 
HEK cells. Bithionol activation, however, is probably not hSlo2.2 specific as the hSlo2.1 
transfections were performed with an untagged plasmid of hSlo2.1. Thus it is possible that 
the EGFP fluorescence used to identify transfected cells was due solely to EGFP expression 
rather than co-expression of hSlo2.1 with EGFP. This theory is supported by our attempts to 
transfect a RFP tagged hSlo2.1 (hSlo2.1-RFP) into HEK cells, in all cases fluorescence was 
only observed in rounded non-adherent cells. This suggests that hSlo2.1 expression may be 
toxic, possibly due to constitutive activity.    
 
We utilised 832/13 INS cells, that express KATP channels, composed of Kir6.2 and SUR1, 
which are K+ channels that are inhibited by [ATP] at Kir6.2 but activated by MgATP and 
MgADP at SUR1 (Seino, 2003). These cells were used as a model to observe neuronal KATP 
currents, which are mediated by channels that are composed of the same subunits (Liss & 
Roeper, 2001). These cells were whole cell patch clamped with 5 mM [Na]i and subjected to 
a -100 to +100 mV voltage ramp. As can be seen from our data these conditions evoked an 
initial run up of current as the cell was perfused with the intracellular solution which lacks 
ATP, activating the KATP channels. We found that application of 10 µM bithionol was found 
to cause significant reduction in the conductance density which was irreversible within the 
timeframe. However, this inhibition may not be due to direct action of bithionol on either of 
the subunits that form the KATP channel. The inhibition could be due to bithionol inhibiting 
glutamate dehydrogenase stopping the TCA cycle and thus the production of ATP (Li et al., 
2009), in the total absence of ATP, KATP currents run down. This run down is probably due 
to the depletion of PIP2, in the membrane and depletion of the MgATP stimulus at SUR1. 
This also may explain why currents were irreversible in the time frame, as [ATP] would 
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reach the level required to reset cell homeostasis to allow KATP channels to leave the inactive 
state. 
 
5.3.4 Physiological effects of Bithionol  
In our study we tested the effects of bithionol application in an ex vivo system, isolated rat 
DRG cells, DRG’s have been previously reported to express endogenous KNa currents 
(Bischoff et al., 1998; Gao et al., 2008). DRG’s were whole cell patch clamped with 5 mM 
[Na+]i and subjected to -100 to 0 mV voltage ramps, ramps to higher voltages were not used 
due to action potential firing which would change the [Na+]i. Application of 10 µM bithionol 
was found to increase the conductance density by 2.24 ± 0.54 fold compared to pre-
application. We found that the effects of bithionol application were found to be irreversible 
within the timeframe of the experiment. This irreversibility may be due to the fact that 
neurons have a resting [Na+]i of 4-15 mM, thus the irreversibility may be due to the channels 
becoming “locked open” in a similar manner as suggested by our heterologously expressed 
hSlo2.2a experiments with 20 mM [Na+]i (5.3.2). There may also be additional factors in 
DRG cells as these will also contain any accessory proteins or physiological modulators that 
may increase the sensitivity of Slo2.χ channels. The finding that the effects of bithionol are 
not DRG type specific suggests that all DRG’s contain KNa channels, however, the 
composition of these channels could not be determined. We also observed a change in the 
reversal potential of rat DRG cells thus we decided to investigate if bithionol activation of 
KNa channels affects the RMP of the cell. We found that on average application of 10 µM of 
bithionol, hyperpolarised the RMP towards EK by ≈10 mV, implicating the activation of a K+ 
current. This finding suggests that, as previously reported (Bischoff et al., 1998), KNa 
channels have a role in mediating the RMP of DRG cells. The irreversibility of the effect of 
bithionol application is probably due to the lack of depolarising channels active at ≈-70 mV 
that would be able to reset the RMP. 
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5.3.5 Challenges for the future  
Challenges for the future will be to examine: (a) if mutations of the amino acids suggested 
by our model effect the potency of bithionol activation of hSlo2.2a; (b) the specificity of the 
bithionol binding site in hSlo2.2a by testing the channel with the compounds 
Hexachlorophene (Pestanal), 2-Hydroxy-2’3’5’Tricholobenzophenone and Carbonylcyanide 
3-Cholro-Phenyl Hydrazone; (c) If application of a generalised K+ blocker, quinidine, to 
media allows for survival of hSlo2.1-RFP transfected cells to allow recordings; (d) if it is 
possible to clone the hSlo2.2b channel and observe if this has mediating effects on hSlo2.1 
expression through heterometric channel formation; (e) if application of bithionol can 
modify the spike timing frequency of ex vivo DRG neurons; (f) if application on bithionol in 
vivo to a neuropathic pain model has analgesic effects. 
 
5.3.6 Chapter Summary 
This data reveals that, unlike the previously reported rSlo2.2a channel, hSlo2.2a channels 
mediate a non rectifying K+ current. The bis-phenol anthelmintic compound, bithionol was 
found to activate this channel through binding to the large C-terminal domain near the Cl- 
binding site. Bithionol had converse effects on KATP mediated current, probably due to 
interrupting the upstream pathway, whereas it had no effect on the range of endogenous Kv 
channels expressed by HEK cells. Determination of the selectivity of bithionol application 
on the Slo2.χ family of channels was not possible due to toxicity of hSlo2.1 expression. Our 
data suggests that in vivo in neurons these channels act as background K+ conductance which 
is activated under a variety of conditions to stabilise the resting membrane potential of the 
cell.   
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Chapter VI: General Discussion 
 
6.1 Slo3 
 
This study provides evidence that supports the findings from experiments with mSlo3 KO 
mice (Santi et al., 2010; Zeng et al., 2011), in showing that the Slo3 channel mediates at 
least a component of the IKSper current. The IKSper current plays a vital role in the capacitation 
of spermatozoa, a critical step priming the spermatozoa for fertilisation (Navarro et al., 
2007). We suggest that there are two major applications for research into Slo3 channels, 
firstly pharmacological inhibition to reduce the viability of fertilisation as a male “pill”. This 
treatment should have a low risk of side effects due to the limited expression profile of Slo3. 
However, whilst this appears an attractive pathway for Slo3 research issues surrounding 
compliance may limit interest from pharmacological companies. The second application of 
Slo3 research is in treatment of some conditions that result in infertility. As has been shown 
by the mSlo3 KO mice models the absence of this channel results in the loss of the 
alkalinisation-activated hyperpolarisation required for capacitation and reduced motility of 
the spermatozoa resulting in infertility. Reduced expression of the CatSper channel forming 
CatSper1 subunit, another channel critical to the process of capacitation, can be correlated to 
sub-fertility in humans due to reduced spermatozoa motility. However, not all of the patients 
observed in this study showed this correlation (Nikpoor et al., 2004), therefore, suggesting 
there may be other pathways through which the same physiological effect can occur. 
 
Thus it is not unconceivable that some conditions underling reduced motility in humans may 
be due to a reduced Slo3 current. Further genetic screening for variations in the Slo3 gene 
(KCNU1) in infertile humans and an analysis of expression/properties is required to 
determine if this theory is correct. Pharmacological activators of Slo3 would be unlikely to 
be of use in treating conditions arising due to reduced mSlo3 expression. As the current 
understanding of capacitation (1.3.4.2) suggests that, unlike the CatSper channels, Slo3 
channels are unable to initiate the cascade that initiates capacitation. However, infertility 
conditions arising from reduced mSlo3 function could be treated in vitro by pharmacological 
activators. In vivo treatment would be complicated due to difficulty in targeting/delivery of 
the activator, as capacitation occurs in the fallopian tube.  
 
Conversely, infertility can also result from premature capacitation of the spermatozoa as the 
hyperactivation of the spermatozoan flagella cannot be sustained. Thus infertility conditions 
caused by this molecular mechanism could be treated with Slo3 inhibitors either in vivo or in 
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the process of in vitro fertilisation. Inhibition of the Slo3 channel would result in a reduced 
IKSper current, thus reducing the Ca2+ influx through the CatSper channels and in turn 
reducing the hyperactivation of the spermatozoan flagella. Our study also suggests a 
potential non-pharmacological method of modulating the IKSper current by over-expression of 
the CV562866 protein, as we found that expression of this protein reduced total mSlo3 
currents. However, directed transfection of this sequence may be difficult and undirected 
transfection may have unwanted side effects due to effects on Slo1 expression in 
surrounding tissues. 
   
The recent mSlo3 KO mice models (Santi et al., 2010; Zeng et al., 2011) have somewhat 
overshadowed our aim to pharmacologically profile mSlo3 currents to determine if 
properties are shared with the IKSper current from spermatozoa, as these studies are able to 
directly show that mSlo3 is a major component of the IKSper current. However, KO models 
often result in down-regulation of unintended targets or up-regulation of compensatory 
mechanisms. This is exemplified in smooth muscle in the bladder where undirected KO of 
the Slo1 α-subunit results in up-regulation of a range of compensatory proteins, which are 
absent when the Slo1 α-subunit is KO specifically in smooth muscle (Sprossmann et al., 
2009). Our pharmacological profile for mSlo3, in combination with the KO models, suggests 
that the mSlo3 channel is potentially a component of the K+ current which mediates volume 
regulation and motility of the spermatozoan. mSlo3 channels were previously discounted for 
these roles due to the reported TEA sensitivity of the mSlo3 channel. This led to Kv1.5 and 
TASK2 channels being theorised as the channels that mediate volume regulation and 
motility. However, the TEA concentrations used in the early studies were well below the 
mSlo3 sensitivity as shown by our and previous studies. Whilst the pharmacology we have 
described is not specific for the mSlo3 channel, it provides a basis for determining a more 
specific pharmacology in future studies. Unfortunately, our study is unable to define 
pharmacologically if mSlo3 is the sole channel mediating volume regulation and motility in 
the spermatozoan, due to the non specificity of the inhibitors. mSlo3 channels are a good 
pharmacological target, due to their highly limited expression profile to spermatozoa.  
 
The findings in Chapter IV show that whilst EST’s of Slo3 are expressed outside the testis, 
these EST’s encode a short soluble protein that lacks TM domains (CV562866) rather than a 
splice variant containing a pore forming domain. Thus any pharmacology involving the TM 
domains, including the pore, of Slo3 should not affect the CV562866 protein and its 
opposing affects on the expression of both mSlo3 and mSlo1 channels. However, 
pharmacologically targeting to the pore domain may also affect Slo1 channels, as this region 
has the highest sequence identity between these two channels. The limited expression of the 
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full length mSlo3 α-subunit bodes well for pharmacological modulation as many side-effects 
of drugs are due to expression of the drug target outside of the intended tissue of action.  
 
The findings of Chapter IV suggest that the current presumption that the mSlo3 α-subunit 
contains two RCK domains like the mSlo1 α-subunit may be incorrect. As our investigation 
into the secondary structure, suggests that the RCK2 domain of the CV562866 splice variant 
and full length channel lacks the correct βαβαβ Rossmann motif for a RCK domain. This 
observation suggests that earlier theories that the RCK2 domain is the major site for 
modulation by endogenous modulators may be incorrect as these theories are based on the 
Slo1 structure. However, our findings may be incorrect as they are based solely on a 
predicted secondary structure and not on an actual crystal structure. The crystal structure of 
mSlo3 may take a long time to solve as it is probable that there will be difficulty in 
expression in heterologous systems. Secondly due to the limited background research and 
general interest of the scientific community of mSlo3, it is likely that crystallisation of this 
channel will be of low priority in crystallography groups.  
 
Our study also shows that whilst the RCK domains differ between mSlo1 and mSlo3 
channels, we have uncovered a conserved Slo channel gating mechanism. Mutation of the 
conserved phenylalanine in the S6 domain (mSlo3- F304/hSlo1- F380) to tyrosine has 
similar effects on Slo channel properties, namely a negative shift in voltage dependence of 
activation and increased channel activity. This may be due to increased hydrophobicity of 
the residue, which in the open state faces away from the lumen and face the other TM α-
helices (Zhang et al., 1998). Thus increasing the hydrophobicity of the residue at 304 in 
mSlo3 or 380 in mSlo1 stabilises the open state. Interestingly a recent study, has shown that 
M379 in hSlo1, if replaced with histidine, stabilises the open state when protonated 
suggesting that this residue faces the lumen of the pore during the active state (Chen & 
Aldrich, 2011). These findings suggest that the S6 domain undergoes an anti-clockwise 
rotation, relative to the amino acid sequence, during activation of the channel. However, use 
of these mutants for pharmacological probing of the mSlo3 channel is problematic as, as our 
study shows, this mutation appears to be in the conserved quinoline binding site of K+ 
channels and thus results in an increased apparent potency of these compounds. Therefore, 
the potencies of other intracellular pore blockers may also be affected by mutations in the S6 
domain. Interestingly, extracellular pore blockers like Ba2+ are unaffected by the mutation as 
it does not affect their ability to access their binding site.   
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6.2 Slo2 
 
This study suggests that in vivo the Na+ activated hSlo2.2a channels are a component of the 
background K+ conductance that can be activated under a variety of conditions to 
hyperpolarise or stabilise the resting membrane potential of the cell. This differs from 
previous studies that have focused on the rSlo2.2a and rSlo2.2b channels, as hSlo2.2a 
channels mediate a non rectifying K+ current, rather than a voltage dependent outwardly 
rectifying K+ current. This observation suggests that the physiological roles of Slo2.2 may 
be more important in humans than in rats. hSlo2.2a channels only require the presence of 
intracellular Na+ rather than Na+ and depolarisation, as required for rSlo2.2a activation, thus 
the hSlo2.2a channel will activate at all physiological potentials. However, we also suggest 
that the rectification observed in rSlo2.2 currents may be either due to application of a p/4-
type leak subtraction protocol or the difference in the selectivity filter sequence. When we 
applied a p/4 protocol to our recordings currents became outwardly rectifying and thus 
similar to currents previously reported from rSlo2.2a channels. The previous studies do not 
state if any leak subtraction protocol, was used in the recording protocols (Brown et al., 
2008).  
 
This study also found that bithionol, a compound that has been shown to activate rSlo2.2b 
channels, is also able to activate heterologously expressed hSlo2.2a channels. Our study of 
the cooperativity of bithionol activation with [Na+]i over [Cl-]i and the model of potential 
bithionol binding sites generated by Dr. Lippiat, suggest that bithionol activates these 
channels by binding to the large C-terminal domain near the Cl- binding site. This model 
explains why bithionol activation was absent with the endogenous HEK cell Kv channels, as 
these channels lack the large C-terminal domain characteristic of Slo channels. This 
requirement for the large C-terminal domain seems to be contradicted by the inhibition of 
KATP mediated current by bithionol application however, we suggest that this may be due to 
inhibition of GDH in the upstream activation pathway for KATP. 
 
These findings suggest that activators of Slo2.χ, may have clinical relevance as targets for 
novel analgesics in inflammatory pain. This is suggested by our finding that bithionol 
application causes a shift in the RMP and activation of a K+ current in DRG neurons, 
including both the large and small nociceptive sub types. However, specificity of novel 
analgesics will have to be tested as whilst we were unable to determine if bithionol has 
specificity for hSlo2.2a over hSlo2.1. Bithionol may not be a viable novel analgesic for 
systemic application, as the side effects may include; cardiac arrhythmia (hSlo2.1 
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activation), hyperinsulinemia (KATP inhibition) and ototoxic effects (KNA activation in 
MNTB). However, these potential side effects many not manifest as bithionol has been used 
clinically for a number of years to treat fasciolosis in humans with no observed 
contraindications (Farag et al., 1988; Bassiouny et al., 1991; Bacq et al., 1991). Secondly 
bithionol activation of KNa neurones MNTB neurons, in vitro, has been shown to only 
increase the AHP and increase the temporal fidelity of the signal rather than affecting the 
RMP resulting in silencing of these neurons (Yang et al., 2007). However, it has yet to be 
shown if the increased fidelity of this signal is beneficial to the whole animal, or if it alters 
processing in the auditory pathway. There may also be a range of other side effects of 
bithionol application as unpublished results mentioned in the original study, suggest that 
Slo1 channels may also be activated by bithionol (Yang et al., 2006). These side effects 
could be largely counteracted by localised application to the nociceptive neurons. 
Alternatively design of more selective KNa channel activators, in particular with specificity 
for the Slo2.2 subtypes over Slo2.1, will also have reduced side effects in kidney and cardiac 
tissues where Slo2.2 is not currently thought to be expressed.   
 
6.3 Final Conclusions 
 
Thus in conclusion, Slo2 and Slo3 channels are under-researched members of the Slo 
channel sub-family. Our study has shown that both of these channels are viable targets for 
pharmacological modulation to treat inflammatory pain and infertility conditions 
respectively. However, the tools available that are used in this study are too non-specific for 
clinical use, and would result in a range of undesirable side effects.  
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